CHD8-Related Neurodevelopmental Disorder with Overgrowth

Mendelian MONDO:0014017 Pathograph 82 Show in embeddings browser Neurodevelopmental Disorder Genetic Disease

CHD8-related neurodevelopmental disorder with overgrowth is an autosomal dominant disorder associated principally with heterozygous loss-of-function variants in CHD8 at 14q11.2. CHD8 is an ATP-dependent chromatin regulator. The clinical spectrum includes variable macrocephaly and tall stature, developmental and speech delay, intellectual disability ranging from mild to severe, autism, sleep disturbance and gastrointestinal symptoms, particularly constipation. Hypotonia and seizures occur in a minority; dystonia can occasionally be a prominent presentation with limited cognitive involvement. Most pathogenic variants arise de novo, but transmission with markedly variable expression is documented. The frequency of each feature depends on ascertainment, age and reporting completeness. This entry concerns the molecularly defined CHD8 disorder; broad autism cohorts inform gene discovery, while CHD8-specific cohorts inform clinical frequencies. Contiguous deletions may add effects from neighboring genes.

Ask OpenScientist

Ask a research question about CHD8-Related Neurodevelopmental Disorder with Overgrowth. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

🏷

Classifications

Harrison's Part

🔗

Mappings

MONDO

MONDO:0014017 intellectual developmental disorder with autism and macrocephaly

MONDO:0014017 carries OMIM:615032 as an xref, links causally to HGNC:20153 (CHD8), and includes CHD8 overgrowth syndrome and AUTS18 as synonyms. These identifiers refer to the molecularly defined CHD8 disorder.

👪

Inheritance

Autosomal dominant inheritance HP:0000006

CHD8-NDD segregates as an autosomal dominant trait. The great majority of reported probands carry a de novo CHD8 pathogenic variant, but transmitted variants occur and can be associated with strikingly milder parental presentations, indicating variable expressivity.

Autosomal dominant inheritance Expressivity: VARIABLE

Show evidence (2 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"CHD8-NDD is inherited in an autosomal dominant fashion. However, most probands reported to date whose parents have undergone molecular genetic testing have the disorder as the result of a de novo CHD8 pathogenic variant."

GeneReviews states autosomal dominant inheritance with a predominance of de novo variants.

PMID:41407309 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We describe the case of IDDAM caused by a paternally inherited CHD8 variant. Our findings highlight the importance of considering parental inheritance in IDDAM diagnoses"

Documents transmitted (non-de novo) inheritance with variable expressivity in an IDDAM family.

◈

Mechanistic Hypotheses

Canonical CHD8 haploinsufficiency

chd8_canonical_haploinsufficiency CANONICAL

Heterozygous loss of functional CHD8 dosage perturbs developmental transcriptional programs. Genetic cohorts, engineered models and a characteristic methylation episignature support haploinsufficiency. The downstream response depends on allele, dosage, cell type, developmental stage and genetic background.

Remodelling-independent mechanism for a subset of missense alleles

chd8_remodeling_independent_missense EMERGING

Evidence balance 2 support

Selected missense alleles produce experimental phenotypes with or without loss of chromatin-remodeling activity. This does not establish the clinical pathogenicity or benignity of every tested allele. A mirror methylation pattern in one person with p.Gly1322Arg suggests an alternative mechanism, but that variant remained uncertain and gain of function was not functionally demonstrated.

Show evidence (2 references)

PMID:38438524 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Furthermore, we found that mutations with high scores cause ASD by mechanisms either dependent on or independent of loss of chromatin-remodeling function."

The experimental study supports mechanistic heterogeneity among tested missense alleles; mouse behavior does not itself classify human variants.

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"one analysis was inconclusive, and one showing a possible gain-of-function signature instead of the expected haploinsufficiency signature was observed"

A single uncertain variant produced a mirror methylation pattern; gain of function remains a hypothesis.

Discussions and Knowledge Gaps

Where exactly is the boundary between this monogenic CHD8 entity and the broad multifactorial autism spectrum disorder entry that also lists CHD8 as a risk gene?

INTERPRETATION chd8_nec_boundary_vs_multifactorial_asd

Pathogenic CHD8 variants define a molecular neurodevelopmental disorder with variable autism penetrance. Broad autism studies support gene discovery but cannot supply CHD8-specific phenotype frequencies without a separable genotype subgroup. CHD7, CHD2 and CHD4 disorders require their own evidence.

Is brain overgrowth causally upstream of the autistic and cognitive phenotype in CHD8-NDD, or are the two parallel consequences of the same progenitor lesion?

KNOWLEDGE GAP chd8_brain_overgrowth_causality_for_behaviour

Attached to

pathophysiology#Brain Overgrowth and Megalencephaly

Brain enlargement and neurobehavioral differences coexist in several models, but neither the human clinical cohorts nor the cited experiments establish brain size as the causal mediator. They are therefore represented as potentially parallel consequences; a causal edge from brain overgrowth to autism is not asserted.

Proposed experiments

Temporally restricted CHD8 restoration in a Chd8+/- mouse that normalises brain size after the neurogenic window, testing whether behaviour is rescued independently of size.

chd8_exp_brain_size_vs_behaviour_rescue

Human imaging-genetics comparison of CHD8 variant carriers stratified by head circumference against behavioural severity.

chd8_exp_imaging_genetics_ohc_vs_severity

Does the gut-to-brain contribution to behaviour demonstrated in Chd8 haploinsufficient mice operate in humans with CHD8-NDD?

HUMAN MODEL MISMATCH chd8_gut_brain_axis_human_translation

Attached to

pathophysiology#Intestinal Barrier Impairment pathophysiology#Gastrointestinal Dysmotility

Gut-epithelial conditional Chd8 loss increases selected anxiety measures while preserving sociability. Antibiotics improve selected behaviors in a separate systemic heterozygous model. Neither experiment establishes human gut-to-brain causality, a human barrier lesion, or antibiotic treatment efficacy. Stool transit is unchanged in the mouse permeability study.

Proposed experiments

Prospective characterisation of GI symptom burden, intestinal permeability and microbiome composition in a CHD8-NDD cohort with paired behavioural measures.

chd8_exp_human_gut_brain_cohort

Why do the reported CHD8-related dystonia cases show an apparent female preponderance, and how frequent is dystonia in unselected CHD8-NDD cohorts?

KNOWLEDGE GAP chd8_dystonia_female_preponderance

The 2021 and 2024 movement-disorder reports describe five women with variable cognitive involvement. Their ascertainment does not determine population frequency or an exclusive sex effect. The 2025 inherited-variant case includes dystonia with substantial developmental difficulties, further broadening the presentation.

Show evidence (1 reference)

PMID:38441608 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"This work validates our previous observation that dystonia is part of the phenotypic spectrum of CHD8-related"

Source of the dystonia observation and the female-preponderance suggestion.

How much do progenitor proliferation, neuronal production and gliogenesis each contribute to human CHD8-related brain overgrowth?

HUMAN MODEL MISMATCH chd8_megalencephaly_rodent_vs_primate_mechanism

Attached to

pathophysiology#Increased Gliogenesis pathophysiology#White Matter Expansion pathophysiology#Brain Overgrowth and Megalencephaly

Primate results support a glial contribution in a very small, heterogeneous edited series. Mouse effects vary with dosage and timing, and some heterozygotes show enlargement without detectable progenitor proliferation changes. These experiments do not isolate species as the explanation or establish a dominant glial mechanism in humans.

Proposed experiments

Cell-type-resolved quantification (single-nucleus RNA-seq or stereology) of glial versus neuronal number in post-mortem cortex from CHD8 variant carriers versus matched controls.

chd8_exp_human_postmortem_glia_neuron_ratio

Systematic volumetric and white-matter MRI characterisation of a CHD8-NDD cohort, testing whether white-matter expansion accounts for the increased head circumference as it does in the monkey.

chd8_exp_human_white_matter_imaging

Which phenotype frequencies should this entry assert, given that CHD8 cohorts were ascertained in systematically different ways and report materially different numbers for the same features?

INTERPRETATION chd8_frequency_ascertainment_discrepancy

The cohorts overlap and differ in recruitment, age, definitions and available-data denominators. Ever-macrocephalic status differs from macrocephaly at examination; combined autism/traits differs from formal diagnosis. The 2022 study assembled 106 individuals but excluded five uncertain variants from its main analysis. Context-specific frequencies preserve these distinctions instead of treating the estimates as independent population measurements.

Show evidence (1 reference)

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"a pattern of common features: macrocephaly (62.5%), tall stature (47%), developmental delay and/or intellectual disability (81%), ASDs (84%), sleep difficulties (50%), gastrointestinal problems (40%), and distinct facial features"

The protein-truncating-variant cohort figures used as the primary quantitative anchor for several bands in this entry.

Does CHD8-NDD carry an increased tumour risk, and should tumour surveillance be recommended?

KNOWLEDGE GAP chd8_neoplasia_not_established

The 2022 aggregation explicitly lists six neoplasms among 54 individuals with information: three glabellar hemangiomas, one fibroma, one fibrosarcoma and one uterine leiomyoma. Thus the tumor types are known, but an excess incidence or causal germline predisposition is not established. GeneReviews reports no evidence of increased malignancy risk and no published tumor-screening guidelines; this is not an explicit recommendation against surveillance. Somatic CHD8 alterations in cancer require separate interpretation.

Proposed experiments

Registry linkage of a molecularly confirmed CHD8-NDD cohort to national cancer registries, with age- and sex-standardised incidence ratios against population baseline.

chd8_exp_cancer_incidence_registry_linkage

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Neoplasia was seen in six individuals (11%, 6/54): glabellar hemangioma in three, fibroma in one, fibrosarcoma in one, and uterine leiomyoma in one individual."

The full text identifies the lesions; the retrospective count does not establish increased cancer incidence.

Is the marked clinical variability of CHD8-NDD - which extends from severe intellectual disability with autism to an isolated adult focal dystonia in a cognitively intact individual - driven by genetic background rather than chance?

OPEN QUESTION chd8_genetic_background_modifier

A single Chd8 allele tested across 33 mouse genetic backgrounds produces sex- and trait-dependent effects, including opposite directions and resilience for particular traits. This demonstrates model modifiers without identifying a human modifier locus or showing that every discrepancy between models is genetic background. Human allele, age, ascertainment and developmental differences also remain relevant.

Proposed experiments

Polygenic background and rare-variant modifier analysis within a molecularly confirmed CHD8-NDD cohort phenotyped on a common severity instrument.

chd8_exp_human_polygenic_modifier_analysis

Show evidence (1 reference)

PMID:36738737 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Some strains exhibited large effect-size trait disruptions, sometimes in opposite directions, and-remarkably-others expressed resilience."

Demonstrates background-dependent modification of the same Chd8 lesion, including resilience.

Does gastrointestinal pain contribute to self-injury specifically in CHD8-NDD?

KNOWLEDGE GAP chd8_pain_self_injury_specificity

Attached to

phenotypes#Self-Injurious Behavior

A 112-person mixed-gene cohort found an association between severe abdominal pain and self-injury, but did not establish a CHD8-specific effect or causal direction. Prospective symptom and pain assessment within CHD8 cohorts could test this possibility.

Show evidence (1 reference)

PMID:33175317 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"History of severe abdominal pain was associated with SIB status and severity in a cohort of 112 individuals with disruptive mutations to ASD-associated genes."

The pooled association motivates a CHD8-specific question without answering it.

Which CHD8-dependent outcomes remain reversible after neurodevelopment?

KNOWLEDGE GAP chd8_developmental_rescue_window

Attached to

pathophysiology#Premature Ventral Progenitor Differentiation pathophysiology#CHD8 Haploinsufficiency

Mouse endogenous-locus restoration prevents selected behavioral abnormalities when performed during midfetal development or in ventral progenitors. This does not establish postnatal reversal. A separate human neural-culture preprint supports enhancer-targeted dosage restoration. Human delivery, dosage control, developmental timing and outcome-specific reversibility remain open questions.

Show evidence (1 reference)

PMID:42203765 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The genetic rescue of Chd8 expression at E14.5 or before, but not at E17.5 or after, ameliorated autistic-like behavior"

Prenatal genetic restoration prevents selected mouse behavioral abnormalities; later restoration in the tested windows did not reproduce the benefit.

⚙

Pathophysiology

CHD8 Haploinsufficiency

Heterozygous truncating, splice-disrupting and deletion alleles reduce functional CHD8 dosage. Approximately half-normal protein is measured in several engineered models, rather than in every patient. Haploinsufficiency is the principal mechanism; selected missense alleles can alter function without the same remodeling defect.

CHD8 hgnc:20153

Genetic context CHD8 hgnc:20153 variant_origin: GERMLINE zygosity: HETEROZYGOUS functional_impact_category: LOSS_OF_FUNCTION

Constitutional heterozygous loss-of-function alleles are usually de novo but may be inherited.

ATP-dependent chromatin remodeler activity GO:0140658 ↓ DECREASED

Experimental models

Enhancer-targeted CHD8 CRISPR activation in human neural cultures ORGANOID Tests restoration of expression from an endogenous wild-type allele.

Downstream

Dysregulation of Neurodevelopmental Gene Networks CHD8 depletion changes neural transcriptional programs; binding maps alone do not measure remodeling failure.

Abnormal Neural Development CHD8 loss causes the neurodevelopmental syndrome; the cellular routes to individual clinical outcomes are incompletely defined.

Reduced Vagal Neural Crest Cell Pool Constitutive chd8 mutation reduces the early vagal neural crest pool in zebrafish.

Altered Intestinal Epithelial Differentiation Mouse epithelial deletion supports a local intestinal requirement for CHD8.

Developmental Glial Sleep Regulation Defect Loss of the shared fly CHD7/CHD8 ortholog in developing glia disrupts subsequent sleep; transfer to human CHD8 disease remains provisional.

Reduced Neuronal Chromatin Accessibility Reduced CHD8 dosage is a candidate cause of impaired accessibility; strong direct evidence comes from complete deletion in cultured neurons.

Premature Ventral Progenitor Differentiation Conditional midfetal heterozygous deletion directly perturbs the timing of ventral differentiation.

Show evidence (2 references)

PMID:30670789 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"confirms our suggestion that this is a syndromic disorder caused by haploinsufficiency or heterozygous loss of function of CHD8"

Clinical sequence and deletion reports support loss of function.

PMID:29668850 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we found no evidence for a truncated protein product"

The exon-3 mouse allele reduces full-length CHD8 without a detected truncated product.

Reduced Neuronal Chromatin Accessibility

Mechanism confidence: Provisional

Conditional CHD8 deletion in human stem-cell-derived excitatory neurons reduces accessibility at CHD8-bound promoters, especially ETS-motif-containing sites. The strong genome-wide result is from homozygous deletion; heterozygous changes are modest and not statistically significant at the highlighted sites. This supplies experimental support for a chromatin-accessibility mechanism without equating binding maps with remodeling failure in patients.

Experimental models

Conditional CHD8 human excitatory neuron chromatin model OTHER Measures genotype-dependent accessibility effects.

Downstream

Dysregulation of Neurodevelopmental Gene Networks Loss of accessibility accompanies reduced transcription at direct neuronal targets, most strongly after homozygous deletion.

Show evidence (3 references)

PMID:36575212 SUPPORT DIRECT PRIMARY RESULT In Vitro

"many more sites lost accessibility (1,481 peaks in homozygous KO) than gained accessibility (106 peaks in homozygous KO)"

ATAC-seq measures accessibility; the numerical result applies to complete deletion.

PMID:36575212 SUPPORT DIRECT PRIMARY RESULT In Vitro

"The ATAC-seq peaks in the heterozygous knockout experiment at sites with moderate change (no statistical significance) also revealed similar results for ETS motif enrichment"

The heterozygous result is weaker and does not establish genome-wide closure in human disease.

PMID:36575212 SUPPORT DIRECT PRIMARY RESULT In Vitro

"CHD8 binding was specifically lost at ETS motif-containing CHD8 peaks upon ELK1 knockdown"

ELK1 perturbation supports recruitment of CHD8 to selected neuronal targets; ELK1 overexpression did not restore binding.

Dysregulation of Neurodevelopmental Gene Networks

Mechanism confidence: Provisional

Human neural progenitor knockdown changes expression of chromatin regulators and a secondary network enriched for neurodevelopmental genes. Sugathan et al. reported 1,756 nominally significant genes, of which 369 passed false-discovery correction. Control-cell binding maps identified 7,324 sites, but most expression changes lacked a nearby CHD8-binding site. These results support direct and indirect regulation; pathway enrichment does not itself demonstrate reduced synapse assembly or axon guidance.

neural progenitor cell CL:0011020

regulation of transcription by RNA polymerase II GO:0006357 ⚠ ABNORMAL

Experimental models

Control-donor iPSC-derived CHD8-knockdown neural progenitors IPSC DERIVED MODEL Measures dose-associated transcriptional changes.

Engineered CHD8 exon-1 iPSC cerebral organoids ORGANOID Measures organoid transcription after engineered CHD8 loss.

Downstream

Impaired Wnt/beta-Catenin Signal Transduction Embryonic cortical knockdown reduces expression and activity of Wnt pathway components.

REST-Mediated Repression of Neuronal Genes REST target repression is enhanced in the Katayama mouse model; a physical interaction alone would not establish this effect.

Increased Neural Progenitor Proliferation Proliferation increases in selected organoid, zebrafish and hypomorphic mouse contexts, with important negative results in heterozygous mouse cortex.

Excitatory-Inhibitory Neuronal Trajectory Imbalance Engineered human organoids show stage-specific changes in neuronal lineage proportions.

Increased Gliogenesis Primate experiments suggest a glial contribution; the regulated intermediates and human contribution remain uncertain.

Aberrant Long-Range Functional Connectivity Transcriptional and regional fMRI changes coexist in the exon-3 mouse; the intervening circuit mechanism is unresolved.

Striatal Circuit Dysfunction Region-specific transcriptional changes accompany altered accumbens physiology in mice.

Shortened Neural Progenitor G1 Phase CHD8 disruption changes G1 timing in one engineered human progenitor clone; cyclin-E and ERK changes suggest possible mediators.

Impaired Myelination CHD8 regulates myelination-related transcription in mouse oligodendroglial models.

Reduced Aged-Cortex Proteostasis Response Signature An age-dependent transcriptional signature occurs in one mouse allele; direct versus secondary regulation remains unknown.

Delayed Cortical Spine Development Cortical transcriptional dysregulation accompanies an adolescent spine phenotype in constitutive mutant mice.

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/pmc/articles/PMC4210312/ SUPPORT DIRECT PRIMARY RESULT In Vitro

"1,756 genes were differentially expressed ... 369 of which were significant"

The full text distinguishes nominal and multiple-testing-adjusted differential expression.

PMID:25752243 SUPPORT DIRECT PRIMARY RESULT In Vitro

"When we considered genes that showed the strongest dysregulation due to CHD8 knockdown, we found that ASD risk genes tended to be downregulated"

The knockdown experiment supports altered regulation of conserved neural targets.

Impaired Wnt/beta-Catenin Signal Transduction

Mechanism confidence: Provisional

In embryonic mouse cortical knockdown, CHD8 supports expression of Wnt transducers and Wnt reporter activity. Stabilized beta-catenin rescues progenitor and selected adult neuronal/behavioral abnormalities. This direction is context-specific: knockdown in HEK293T cells and adult striatal transcriptomes do not show the same response.

canonical Wnt signaling pathway GO:0060070 ↓ DECREASED

Animal models

Embryonic cortical Chd8 knockdown mouse Mus musculus partially recapitulates Tests Wnt contribution through beta-catenin rescue.

Downstream

Reduced Cortical Progenitor Proliferation Beta-catenin rescue supports a Wnt contribution to the reduced proliferation caused by embryonic cortical knockdown.

Premature Neuronal Differentiation Wnt restoration also rescues early cell-cycle exit and differentiation in this knockdown context.

Show evidence (1 reference)

PMID:27694995 SUPPORT DIRECT PRIMARY RESULT Model Organism

"knockdown of Chd8 disrupts the expression of key transducers of Wnt signaling, and enhancing Wnt signaling rescues the transcriptional and behavioral deficits caused by Chd8 knockdown"

Rescue by Wnt enhancement establishes the causal role of the Wnt branch.

Reduced Cortical Progenitor Proliferation

Mechanism confidence: Provisional

E13 cortical Chd8 knockdown reduces progenitor proliferation by E16. This is the opposite of the increased proliferation observed in some other CHD8 models and cannot be used as evidence for progenitor expansion.

neural precursor cell proliferation GO:0061351 ↓ DECREASED

Animal models

Embryonic cortical Chd8 knockdown mouse Mus musculus partially recapitulates Perturbs embryonic progenitor maintenance.

Downstream

Abnormal Neural Development Restricted embryonic cortical perturbation alters neuronal maturation and selected adult behaviors; it is not a germline model of every human feature.

Show evidence (1 reference)

PMID:27694995 SUPPORT DIRECT PRIMARY RESULT Model Organism

"chd8 knockdown resulted in a premature depletion of the neural progenitor pool in the developing mouse cortex"

The primary cortical knockdown depletes the progenitor pool.

Premature Neuronal Differentiation

Mechanism confidence: Provisional

In the same cortical knockdown experiment, early cell-cycle exit and neuronal differentiation increase. CHD8 depletion also reduces PRC2 components, providing a candidate route to neuronal-gene derepression. This premature differentiation must be distinguished from delayed excitatory-neuron production in other models.

neuron differentiation GO:0030182 ↑ INCREASED

Animal models

Embryonic cortical Chd8 knockdown mouse Mus musculus partially recapitulates Measures early neuronal differentiation.

Downstream

Abnormal Neural Development Premature differentiation can alter the developmental sequence of cortical neurons.

Show evidence (1 reference)

PMID:27694995 SUPPORT DIRECT PRIMARY RESULT Model Organism

"This was accompanied by a concomitant increase in the percentage of cells positive for neuronal marker Tuj1"

The embryonic cortical experiment establishes the direction of the differentiation change.

REST-Mediated Repression of Neuronal Genes

Mechanism confidence: Provisional

Reduced CHD8 is associated with enhanced REST-mediated repression in the Katayama mouse model, most prominently around E14.5. Neurodevelopmental gene-set timing is delayed in that model. REST activity has not been shown to explain every CHD8 allele or all human manifestations.

negative regulation of transcription by RNA polymerase II GO:0000122 ↑ INCREASED

Animal models

Chd8 long-isoform and combined-isoform heterozygous mice Mus musculus partially recapitulates Models enhanced REST-associated repression during brain development.

Downstream

Abnormal Neural Development Enhanced repression is a candidate contributor to altered developmental timing in this mouse model.

Show evidence (1 reference)

PMID:27602517 SUPPORT DIRECT PRIMARY RESULT Model Organism

"reduced expression of CHD8 was associated with abnormal activation of RE-1 silencing transcription factor (REST), which suppresses the transcription of many neuronal genes"

Identifies REST derepression of the neuronal programme as a CHD8-dosage consequence.

Shortened Neural Progenitor G1 Phase

Mechanism confidence: Provisional

In one H9 embryonic-stem-cell-derived neural progenitor clone with heterozygous CHD8 disruption, live-cell FUCCI imaging shows a shorter G1 phase without an overt S/G2/M change. Increased cyclin-E expression and ERK phosphorylation accompany the change, but their necessity was not tested by rescue. Progenitor expansion and delayed differentiation are proposed consequences rather than directly measured fate outcomes. Other cerebral organoid experiments found increased proliferation without changed cell-cycle length.

Experimental models

H9 E11 CHD8-heterozygous neural progenitor cell-cycle model OTHER Directly measures cell-cycle phase duration.

Downstream

Increased Neural Progenitor Proliferation Shorter G1 offers a candidate route to faster expansion in this cultured progenitor model; the inference is not universal across alleles or models.

Show evidence (3 references)

DOI:10.1242/bio.058941 SUPPORT DIRECT PRIMARY RESULT In Vitro

"disruption of a single copy of CHD8 in human neural precursor cells (NPCs) markedly shortens the G1 phase of the cell cycle"

The published abstract identifies the same single-cell imaging result; assay-specific details remain supported by the full-text PDF.

url:https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf SUPPORT DIRECT PRIMARY RESULT In Vitro

"Comparative analysis of phase duration across genotypes revealed a marked shortening of G1"

FUCCI imaging compared a single H9-derived heterozygous exon-4 frameshift clone with wild type; G1 medians were 517 and 1,408 minutes, respectively.

url:https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf SUPPORT DIRECT PRIMARY RESULT In Vitro

"Total levels of Erk were not significantly changed in mutant cells"

Increased phosphorylated ERK reflects altered signaling rather than a measured increase in total ERK abundance.

Increased Neural Progenitor Proliferation

Mechanism confidence: Provisional

Progenitor proliferation increases in engineered human cerebral organoids and zebrafish morphants. In the Hurley mouse allelic series, increased TBR2-positive basal progenitor proliferation occurs in mild hypomorphs with approximately 36% residual protein, but was not detected in approximately 50% heterozygotes. More severe depletion instead produces apoptosis and brain hypoplasia; the response is not monotonic.

neural precursor cell proliferation GO:0061351 ↑ INCREASED

Animal models

Chd8 exon-3 heterozygous mouse Mus musculus fails to recapitulate Tests ventricular proliferation in the heterozygous cortex.

Chd8 hypomorphic allelic-series mouse Mus musculus partially recapitulates Models increased TBR2-positive basal proliferation at the mild hypomorphic dose.

chd8 zebrafish morphants Danio rerio partially recapitulates Measures proliferating cells in the developing brain.

Downstream

Brain Overgrowth and Megalencephaly Expanded progenitor output is one candidate contributor to model brain enlargement; it is not the only demonstrated route.

Show evidence (2 references)

PMID:33627187 SUPPORT DIRECT PRIMARY RESULT Model Organism

"a significant increase in the proliferation of non-ventricular (or basal) progenitors was observed"

The full results localize increased proliferation to mild hypomorphs.

url:https://www.ncbi.nlm.nih.gov/sites/pmc/articles/PMC4210312/ SUPPORT DIRECT PRIMARY RESULT Model Organism

"We counted an average of 408 p-histone H3 ... cells for controls compared with 518 p-histone H3 ... cells in embryos injected with ... MO1"

The zebrafish experiment reports increased proliferating-cell counts after morpholino suppression.

Premature Ventral Progenitor Differentiation

Mechanism confidence: Provisional

Midfetal induction of Chd8 heterozygous deletion in mouse neural stem cells accelerates ventral progenitor cell-cycle exit and differentiation toward interneuron and oligodendrocyte lineages. The corresponding dorsal cortical measures are unchanged. Genetic restoration in Olig1-expressing ventral progenitors normalizes differentiation and ameliorates behavioral abnormalities, supporting a developmental contribution in this mouse model.

Animal models

Timed and ventral-lineage Chd8 mutation and restoration mice Mus musculus partially recapitulates Models accelerated ventral cell-cycle exit.

Timed and ventral-lineage Chd8 mutation and restoration mice Mus musculus rescues Restores ventral differentiation genetically.

Downstream

Abnormal Neural Development Ventral genetic rescue reduces mouse behavioral phenotypes; the lineage-level route to adult circuitry and transfer to human symptoms remain incompletely defined.

Show evidence (2 references)

PMID:42203765 SUPPORT DIRECT PRIMARY RESULT Model Organism

"a significantly higher proportion of Ki67-negative EdU+ cells (cells that had exited the cell cycle) in the ganglionic eminence but not in the cortex"

E14.5-induced heterozygous deletion accelerates cell-cycle exit in ventral progenitors at E16.5.

PMID:42203765 SUPPORT DIRECT PRIMARY RESULT Model Organism

"restoration of Chd8 expression in ventral progenitor cells by Olig1-Cre resulted in normalization of the differentiation of progenitors of both interneurons and oligodendrocytes"

The genetic rescue supports a requirement for ventral CHD8 dosage.

Excitatory-Inhibitory Neuronal Trajectory Imbalance

Mechanism confidence: Provisional

Engineered female H9 embryonic-stem-cell cerebral organoids show earlier inhibitory-neuron production and delayed excitatory-neuron production around day 60, followed by excitatory expansion at day 120. These are transient lineage-proportion changes, not a measured functional excitation/inhibition ratio. The S62X allele, affecting only the long isoform, does not reproduce the enlargement of the other tested alleles.

neuron differentiation GO:0030182 ⚠ ABNORMAL

Experimental models

Engineered H9 hESC CHD8 cerebral organoids ORGANOID Measures stage-dependent neuronal lineage proportions.

Downstream

Abnormal Neural Development Asynchronous lineage production is a candidate developmental mechanism; its effect on human circuit physiology remains untested.

Show evidence (1 reference)

PMID:35385734 SUPPORT DIRECT PRIMARY RESULT In Vitro

"we find that CHD8 haploinsufficiency disrupted neurodevelopmental trajectories with an accelerated and delayed generation of, respectively, inhibitory and excitatory neurons that yields, at days 60 and 120, symmetrically opposite expansions in their proportions."

Directly demonstrates the excitatory-inhibitory trajectory imbalance in a human isogenic model of CHD8 haploinsufficiency.

Increased Gliogenesis

Mechanism confidence: Provisional

CHD8-disrupted cynomolgus monkey brains have increased astrocytic and oligodendroglial markers, and engineered newborn brain slices show enhanced glial proliferation. The embryo-edited series includes one aborted fetus, one stillborn animal and one surviving male. Different alleles, very small animal numbers and uncertain brain editing in the surviving animal limit inference about human disease.

gliogenesis GO:0042063 ↑ INCREASED

Experimental models

Newborn cynomolgus organotypic brain slices OTHER Measures glial proliferation in cultured primate brain tissue.

Animal models

Embryo-edited CHD8 cynomolgus monkeys Macaca fascicularis partially recapitulates Measures glial abundance in edited brain tissue.

Downstream

White Matter Expansion Increased oligodendroglial abundance accompanies enlarged white matter in edited primate tissue; a dominant human contribution is unestablished.

Show evidence (2 references)

PMID:36878905 SUPPORT DIRECT PRIMARY RESULT Model Organism

"CHD8 mutations selectively increased glial proteins but not neuronal proteins"

Brain tissue measurements distinguish glial from neuronal marker changes.

PMID:36878905 SUPPORT DIRECT PRIMARY RESULT In Vitro

"knocking down CHD8 via CRISPR/Cas9 in organotypic monkey brain slices from newborn monkeys also enhanced the proliferation of glial cells"

Slice culture supplies a separate experimental glial readout.

White Matter Expansion

Mechanism confidence: Provisional

Primate tissue and longitudinal imaging suggest altered white-matter growth, including an increased white-to-gray matter ratio in the surviving edited monkey. This is distinct from proving that glial excess is the principal cause of macrocephaly in people with CHD8 variants.

Animal models

Embryo-edited CHD8 cynomolgus monkeys Macaca fascicularis partially recapitulates Assesses white matter in histology and imaging.

Downstream

Brain Overgrowth and Megalencephaly White-matter expansion can contribute to overall brain enlargement in the primate model.

Show evidence (1 reference)

PMID:36878905 SUPPORT DIRECT PRIMARY RESULT Model Organism

"with enlarged white matter labeled by immunostaining of GFAP"

The stillborn edited monkey had enlarged brain tissue and white matter.

Brain Overgrowth and Megalencephaly

Mechanism confidence: Provisional

Increased brain or head size recurs across several animal models; selected human cerebral organoids also enlarge. Progenitor expansion and altered gliogenesis are candidate contributions. Brain enlargement does not demonstrate that macrocephaly causes autism or intellectual disability. A 2025 mouse preprint found increased cortical volume without increased total neuron number or soma size, so enlargement cannot be assumed to reflect excess neurons.

Experimental models

Engineered H9 hESC CHD8 cerebral organoids ORGANOID Models organoid enlargement in selected alleles.

Animal models

Chd8 exon-3 heterozygous mouse Mus musculus partially recapitulates Models modest volumetric enlargement.

Chd8 hypomorphic allelic-series mouse Mus musculus partially recapitulates Tests brain growth across CHD8 dosage.

Constitutive exon-5 and postmitotic Chd8 excitatory neuron mice Mus musculus measures Separates cortical size from neuron number.

Downstream

Macrocephaly Greater brain volume can increase head circumference; clinical macrocephaly remains variable.

Show evidence (3 references)

PMID:29668850 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Here, we report that Chd8 heterozygous mice display increased brain size, motor delay, hypertelorism, pronounced hypoactivity, and anomalous responses to social stimuli."

Mouse heterozygote recapitulates brain overgrowth and hypertelorism.

PMID:35385734 SUPPORT DIRECT PRIMARY RESULT In Vitro

"This imbalance is consistent with an enlargement of cerebral organoids as an in vitro correlate of patients' macrocephaly."

Human cerebral organoid model links the cellular imbalance to enlargement, the in vitro correlate of macrocephaly.

PMID:40501938 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We did not find significant differences in total neuron number in either the full cohort or sex-stratified analyses"

Stereology in the constitutive exon-5 mouse supports model-specific dissociation of cortical volume and neuron count; the source is a preprint.

Aberrant Long-Range Functional Connectivity

Mechanism confidence: Provisional

Resting-state fMRI in the exon-3 Chd8 heterozygous mouse shows increased synchronized activity in specific cortico-hippocampal and auditory-parietal networks. The result is a model observation, not an established human diagnostic signature. Organoid lineage proportions and transcriptional enrichment do not directly establish its cause. A separate awake Olig1-Cre mouse imaging study found regional microstructural differences and exploratory connectivity changes; the connectivity comparisons did not survive multiple-testing correction, and that cohort did not reproduce increased social-contact time. Neither result establishes a universal direction of connectivity change.

Animal models

Chd8 exon-3 heterozygous mouse Mus musculus partially recapitulates Measures regional resting-state synchronization.

Olig1-lineage Chd8 heterozygous myelination and imaging mouse Mus musculus measures Measures regional functional connectivity.

Downstream

Abnormal Neural Development Altered network organization is a candidate contributor to neurobehavioral effects; behavioral causality has not been isolated.

Show evidence (2 references)

PMID:29668850 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Resting-state functional MRI identified increased synchronized activity in cortico-hippocampal and auditory-parietal networks in Chd8 heterozygous mutant mice, implicating altered connectivity as a potential mechanism underlying the behavioral phenotypes."

Provides the functional-imaging evidence for altered long-range connectivity.

PMID:33228730 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Although these differences did not survive multiple corrections, uncorrected statistics supported the alterations of functional connectivity"

Regional connectivity findings are exploratory; anatomical DTI results used separate corrected analyses.

Striatal Circuit Dysfunction

Mechanism confidence: Provisional

Nucleus accumbens slices from Chd8 heterozygous mice show increased spontaneous excitatory currents and reduced miniature inhibitory-current amplitude, with unchanged miniature excitatory currents. Adult accumbens perturbation enhances acquired rotarod learning; this does not model impaired developmental motor milestones.

Experimental models

Chd8 heterozygous nucleus accumbens slices OTHER Measures accumbens synaptic physiology.

Show evidence (1 reference)

PMID:28402856 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Perturbation of Chd8 in adult mice recapitulates improved acquired motor learning behavior found in Chd8+/- animals"

Adult perturbation identifies a striatal contribution to enhanced learned motor performance.

Abnormal Neural Development

Mechanism confidence: Provisional

Human CHD8 disease causes variable developmental, cognitive and behavioral dysfunction. Cellular and animal experiments identify several plausible developmental and circuit routes, but none establishes a unique pathway to each clinical feature. Motor, seizure and tone manifestations likewise have unresolved cellular intermediates.

brain development GO:0007420 ⚠ ABNORMAL

Animal models

Chd8 long-isoform and combined-isoform heterozygous mice Mus musculus partially recapitulates Assesses behavioral and transcriptional consequences.

Chd8 mouse genetic-background panel Mus musculus partially recapitulates Tests background dependence of developmental and behavioral consequences.

Timed and ventral-lineage Chd8 mutation and restoration mice Mus musculus rescues Tests time-dependent prevention of behavioral phenotypes.

Downstream

Global Developmental Delay This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Delayed Speech and Language Development This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Motor Delay This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Intellectual Disability This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Autism Spectrum Disorder This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Hypotonia This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Seizures This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Anxiety This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Attention Deficit Hyperactivity Disorder This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Self-Injurious Behavior This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Behavioral Abnormality This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Developmental Regression This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Dystonia This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.

Aggressive Behavior Behavioral regulation may be affected by neural dysfunction, with multiple individual medical and environmental contributors.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Most, if not all, affected individuals have some degree of DD, most commonly speech and motor delays."

The clinical synthesis establishes the developmental spectrum, rather than a specific cellular mediator.

Reduced Vagal Neural Crest Cell Pool

Mechanism confidence: Provisional

Stable heterozygous p.Glu223* zebrafish have fewer vagal neural crest cells leaving the neural tube at 24 hours and an early migration delay. Later migration speed and arrival at the distal gut are preserved; a persistent failure of migration is not demonstrated.

Animal models

Stable chd8 p.Glu223* zebrafish Danio rerio partially recapitulates Measures early emigrating neural crest cells.

Downstream

Reduced Enteric Neuron Abundance A smaller initial neural crest pool is a candidate explanation for fewer mature enteric neurons.

Show evidence (1 reference)

PMID:36375841 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We observed a significant decrease in the number of NCCs released from the neural tube"

The early progenitor deficit is directly measured.

Reduced Enteric Neuron Abundance

Mechanism confidence: Provisional

CHD8-disrupted zebrafish have fewer enteric neurons. The 2014 morpholino study reports an approximately halved count; the stable 2022 heterozygous mutant has a smaller reduction. Serotonergic enteric neurons and non-neuronal enterochromaffin cells are also reduced in the stable mutant. Human enteric-neuron depletion has not been demonstrated.

Animal models

Stable chd8 p.Glu223* zebrafish Danio rerio partially recapitulates Measures enteric-neuron abundance.

Downstream

Gastrointestinal Dysmotility Reduced enteric innervation accompanies delayed transit in zebrafish morphants; neuron-specific rescue has not established sole causation.

Show evidence (1 reference)

PMID:36375841 SUPPORT DIRECT PRIMARY RESULT Model Organism

"a significant decrease in the number of enteric neurons in the heterozygous"

The stable heterozygous fish shows reduced enteric-neuron abundance.

Gastrointestinal Dysmotility

Mechanism confidence: Provisional

Zebrafish morphants show delayed intestinal transit alongside reduced innervation. This supplies a candidate mechanism for human constipation. The Chatterjee mouse model has increased permeability without a change in measured stool transit, so dysmotility and barrier impairment are distinct readouts.

Animal models

Chd8L systemic and intestinal epithelial heterozygous mice Mus musculus fails to recapitulate Tests stool transit.

chd8 zebrafish morphants Danio rerio partially recapitulates Measures microgavage transit and enteric innervation.

Downstream

Constipation Reduced motility is a candidate contribution to constipation; direct human enteric pathology and causal testing remain lacking.

Show evidence (2 references)

PMID:24998929 SUPPORT DIRECT PRIMARY RESULT Model Organism

"impairment of gastrointestinal motility due to a reduction in postmitotic enteric neurons"

The fish experiment connects altered innervation with impaired transit.

PMID:37783686 REFUTE DIRECT PRIMARY RESULT Model Organism

"no differences in colon length ... or in stool transit time were measured between the genotypes"

This mouse study does not reproduce the transit defect.

Altered Intestinal Epithelial Differentiation

Mechanism confidence: Provisional

Mouse Chd8L haploinsufficiency changes intestinal epithelial transcription and reduces selected tuft and goblet cell populations. Small-intestinal goblet loss and colonic mucus thinning are anatomically distinct findings. Stable zebrafish mutants also show epithelial changes, with several adult findings strongest in homozygotes.

Animal models

Chd8L systemic and intestinal epithelial heterozygous mice Mus musculus partially recapitulates Measures tuft and goblet cell populations.

Stable chd8 p.Glu223* zebrafish Danio rerio partially recapitulates Models altered epithelial, goblet-cell and mucus organization.

Downstream

Intestinal Barrier Impairment Changes in epithelial and mucus organization may contribute to permeability; no single deficient cell population has been shown to mediate the entire effect.

Show evidence (1 reference)

PMID:37783686 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The current study found that mice haploinsufficient for the large isoform of Chd8 (Chd8L) exhibited increased intestinal permeability, transcriptomic dysregulation in gut epithelial cells, reduced tuft cell and goblet cell counts in the gut, and an overall increase in microbial load."

Mammalian replication of the gut epithelial defect at a haploinsufficient Chd8 dose.

Intestinal Barrier Impairment

Mechanism confidence: Provisional

Increased tracer permeability is measured in male Chd8L heterozygous mice. The fish study suggests barrier disturbance from morphology and inflammatory changes without directly measuring permeability. Neither result establishes a corresponding permeability defect or inflammatory bowel disease in human CHD8-NDD.

Animal models

Chd8L systemic and intestinal epithelial heterozygous mice Mus musculus partially recapitulates Measures tracer permeability.

Show evidence (1 reference)

PMID:37783686 SUPPORT DIRECT PRIMARY RESULT Model Organism

"exhibited increased intestinal permeability, transcriptomic dysregulation in gut epithelial cells"

The systemic heterozygous mouse has a measured barrier defect.

Developmental Glial Sleep Regulation Defect

Mechanism confidence: Provisional

Developmental knockdown of fly kismet in glia, including subperineurial blood-brain-barrier glia, disrupts adult sleep. Adult-only knockdown does not reproduce the phenotype. Kismet is shared by the CHD7 and CHD8 families, limiting gene-specific human interpretation.

Animal models

Kismet-deficient fly glial model Drosophila melanogaster partially recapitulates Localizes a developmental glial requirement.

Downstream

Developmental Serotonin Excess Developmental glial kismet loss elevates serotonin in flies; this is not a measurement in CHD8 patients.

Show evidence (1 reference)

PMID:34088660 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We show that Kismet is required in glia for early developmental and adult sleep architecture. This role localizes to subperineurial glia constituting the blood-brain barrier."

Localises the sleep requirement to blood-brain-barrier glia in the sole CHD8/CHD7 ortholog.

Developmental Serotonin Excess

Mechanism confidence: Provisional

Kismet-deficient flies show increased serotonin during development. Developmental pharmacologic reduction improves later sleep fragmentation, whereas adult treatment does not. Serotonin direction is tissue- and species-dependent: the stable chd8 zebrafish gut instead has fewer serotonin-producing cells.

Downstream

Sleep Fragmentation Developmental pharmacologic experiments support a serotonin contribution to the fly sleep phenotype.

Show evidence (1 reference)

PMID:34088660 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We demonstrate that Kismet-related sleep disturbances are caused by high serotonin during development, paralleling a well-established but genetically unsolved autism endophenotype."

Identifies developmental hyperserotonemia as the mediator of the sleep defect.

Sleep Fragmentation

Mechanism confidence: Provisional

Kismet mutants show fragmented sleep and reduced total sleep time with preserved sleep latency. Adult sleep restriction improves sleep efficiency and fragmentation but not total sleep duration. CHD8 patient questionnaires independently identify both onset and maintenance difficulties; the precise human mechanism remains unresolved.

Animal models

Kismet-deficient fly glial model Drosophila melanogaster partially recapitulates Measures sleep architecture and behavioral rescue.

Downstream

Sleep Disturbance The fly mechanism is a candidate contributor to the human sleep-maintenance phenotype, with incomplete fidelity.

Show evidence (1 reference)

PMID:34088660 SUPPORT INDIRECT PRIMARY RESULT Model Organism

"Despite their developmental origin, Kismet's sleep architecture defects can be reversed in adulthood by a behavioral regime resembling human sleep restriction therapy."

Sleep restriction reverses selected sleep-architecture defects in Kismet-deficient flies. This supports a preclinical possibility of reversibility; efficacy in humans with CHD8-NDD has not been demonstrated.

Impaired Myelination

Mechanism confidence: Provisional

Mouse Chd8 haploinsufficiency and Olig1-lineage heterozygous deletion impair myelination. This differs from increased glial markers or greater white-matter volume in primate models. Olig1-Cre also marks ventral interneuron progenitors, so behavioral changes cannot be assigned exclusively to mature oligodendrocytes.

Animal models

Olig1-lineage Chd8 heterozygous myelination and imaging mouse Mus musculus partially recapitulates Models defective myelination.

Downstream

Slowed Axonal Conduction The primary oligodendrocyte study links myelination defects to slower action-potential propagation.

Show evidence (1 reference)

PMID:32142125 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Ablation of Chd8 specifically in oligodendrocytes of mice impaired myelination, slowed action potential propagation"

The primary mouse study reports myelination and conduction abnormalities; Olig1 lineage specificity requires caution in light of its ventral interneuron progenitor expression.

Slowed Axonal Conduction

Mechanism confidence: Provisional

Reduced action-potential propagation in Chd8-mutant mouse white matter accompanies myelination defects. Effects on human symptoms and individual functional-connectivity differences remain unresolved.

Downstream

Aberrant Long-Range Functional Connectivity Altered conduction is a candidate contributor to regional connectivity; the imaging study does not establish this causal route.

Show evidence (1 reference)

PMID:32142125 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Ablation of Chd8 specifically in oligodendrocytes of mice impaired myelination, slowed action potential propagation"

The primary mouse study reports myelination and conduction abnormalities; Olig1 lineage specificity requires caution in light of its ventral interneuron progenitor expression.

Reduced Aged-Cortex Proteostasis Response Signature

Mechanism confidence: Provisional

Twelve-month-old male Chd8 p.Val986* heterozygous mice have reduced expression of unfolded-protein-response and chaperone pathways, accompanied by lower phospho-S6 staining. Whether these changes reflect impaired proteostasis, lower stress, or a blunted response remains unresolved. Most effects are small, selected individual genes are only nominal trends, and human progressive neurodegeneration is not established.

Animal models

Chd8 p.Val986* lifespan mouse Mus musculus measures Measures an age-dependent cortical transcriptional signature.

Show evidence (1 reference)

PMID:33023670 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Pathways associated with the unfolded protein response (UPR), endoplasmic reticulum (ER) stress, and chaperone-mediated protein folding were reduced"

The result is a cortical transcriptional signature at 12 months, not a direct measurement of protein-folding capacity.

Delayed Cortical Spine Development

Mechanism confidence: Provisional

A 2025 preprint reports lower dendritic spine density and increased spine formation in adolescent constitutive Chd8 heterozygous mice. Adult spine density and dynamics are normal. This is a transient structural phenotype and does not establish persistent synapse loss in patients.

Animal models

Constitutive exon-5 and postmitotic Chd8 excitatory neuron mice Mus musculus measures Measures age-dependent spine structure in vivo.

Downstream

Abnormal Neural Development Altered adolescent spine development is a candidate contributor to circuit function; this link is provisional and based on a preprint.

Show evidence (1 reference)

PMID:40501938 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Adolescent Chd8+/− mice had lower spine density on the apical dendritic tufts of L5 PyrNs"

In vivo imaging in a 2025 preprint found reduced P30 spine density and increased formation, with normal P90 spine density and dynamics.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

Digestive 2

Constipation FREQUENT HP:0002019

Show evidence (3 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"The most common gastrointestinal issue is constipation with or without periods of diarrhea."

GeneReviews identifies constipation as the most common GI issue in a disorder in which GI issues are a listed core domain; "most common" maps to FREQUENT.

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Constipat ion (33%, 22/66) and diarrhoea (15%, 10/66) are ... reported recurrent abnormalities."

The full text gives separate symptom-specific frequencies.

PMID:24998929 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"12 patients (80%) reported significant GI problems, with 60% reporting specific difficulties characterized as recurrent and consistent problems with constipation."

The founding 15-person series distinguishes constipation from all gastrointestinal complaints.

Context-specific annotations (1)

Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded) FREQUENT

Constipation: 22/66 (33%) in the main clinical analysis.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Constipat ion (33%, 22/66) and diarrhoea (15%, 10/66) are ... reported recurrent abnormalities."

The full text gives separate symptom-specific frequencies.

Diarrhea OCCASIONAL HP:0002014

Show evidence (2 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"The most common gastrointestinal issue is constipation with or without periods of diarrhea."

GeneReviews records diarrhoea as an intermittent accompaniment; no frequency is stated, so none is asserted.

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Constipat ion (33%, 22/66) and diarrhoea (15%, 10/66) are ... reported recurrent abnormalities."

The full text gives separate symptom-specific frequencies.

Context-specific annotations (1)

Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded) OCCASIONAL

Diarrhea: 10/66 (15%); it need not be accompanied by constipation.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Constipat ion (33%, 22/66) and diarrhoea (15%, 10/66) are ... reported recurrent abnormalities."

The full text gives separate symptom-specific frequencies.

Ear 1

Large Ears Macrotia HP:0000400

Show evidence (1 reference)

PMID:31980904 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"dysmorphic features, including broad forehead with prominent supraorbital ridges, flat nasal bridge, telecanthus and large ears"

Clinical series naming large ears.

Eye 1

Hypertelorism HP:0000316

Show evidence (2 references)

PMID:30670789 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"similar dysmorphic features, including widely-spaced eyes, short nose with flat nasal bridge, long philtrum, prominent Cupid's bow of the upper lip, full lower lip, and auricular anomalies"

Clinical series describing widely spaced eyes in the CHD8 facies.

PMID:29668850 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Chd8 heterozygous mice display increased brain size, motor delay, hypertelorism, pronounced hypoactivity, and anomalous responses to social stimuli"

Hypertelorism is recapitulated in the mouse heterozygote.

Genitourinary 1

Genitourinary Abnormality Abnormality of the genitourinary system HP:0000119

Coarse binding: source unspecified

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Genitourinary abnormalities, now observed in 18% of the individuals"

The assembled cohort reports 10/55, with genital findings accounting for most reports; no specific anatomy can represent the entire group.

Context-specific annotations (1)

Dingemans 2022 main phenotype cohort, with trait-specific available records OCCASIONAL

Published cases overlap earlier cohorts and completeness of reporting varies by trait.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Genitourinary abnormalities, now observed in 18% of the individuals"

The assembled cohort reports 10/55, with genital findings accounting for most reports; no specific anatomy can represent the entire group.

Head and Neck 7

Macrocephaly FREQUENT HP:0000256

Show evidence (4 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"The most common findings are the development of macrocephaly (most often during infancy) and tall stature (most typically during puberty), which is often accompanied by ASD and/or DD/ID."

GeneReviews names macrocephaly as one of the two most common findings of the syndrome.

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

Quantifies macrocephaly at 62.5% in a 25-person CHD8 protein-truncating-variant cohort. This is the quantitative basis for the FREQUENT (30-79%) band; VERY_FREQUENT is deliberately NOT used because cohort figures range from about 52% to 80% depending on ascertainment (see the phenotype description and the frequency-ascertainment discussion).

PMID:24998929 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"In addition to a high likelihood of an ASD diagnosis among patients bearing CHD8 mutations, characteristics enriched in this group included macrocephaly, distinct faces, and gastrointestinal complaints."

The founding CHD8-ascertained cohort supports macrocephaly enrichment; later literature aggregations include overlapping patients.

+ 1 more reference

Context-specific annotations (1)

Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded) FREQUENT

Macrocephaly at examination: 46/88; birth measurements available in only 15. Published cohorts overlap and missing documentation can represent absence or nonreporting.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"macrocephaly is a striking feature that was common, at birth (53%, 8/15) and at the age of examination (52%, 46/88)"

The largest assembled cohort quantifies macrocephaly at 52% (46/88) at examination, the lower of the two directly quantified series and the reason the band is FREQUENT rather than VERY_FREQUENT. The 53% at-birth figure has a denominator of only 15 and is not used for banding.

Broad Forehead HP:0000337

Show evidence (1 reference)

PMID:31980904 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"dysmorphic features, including broad forehead with prominent supraorbital ridges, flat nasal bridge, telecanthus and large ears"

Clinical series describing the forehead and supraorbital features.

Prominent Supraorbital Ridges HP:0000336

Show evidence (1 reference)

PMID:31980904 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"dysmorphic features, including broad forehead with prominent supraorbital ridges, flat nasal bridge, telecanthus and large ears"

Clinical series naming prominent supraorbital ridges.

Depressed Nasal Bridge HP:0005280

Show evidence (1 reference)

PMID:30670789 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"similar dysmorphic features, including widely-spaced eyes, short nose with flat nasal bridge, long philtrum, prominent Cupid's bow of the upper lip, full lower lip, and auricular anomalies"

Clinical series describing the flat nasal bridge.

Long Philtrum HP:0000343

Show evidence (1 reference)

PMID:30670789 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"similar dysmorphic features, including widely-spaced eyes, short nose with flat nasal bridge, long philtrum, prominent Cupid's bow of the upper lip, full lower lip, and auricular anomalies"

Clinical series describing the long philtrum.

Downslanted Palpebral Fissures HP:0000494

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"wide-set eyes with down slanted palpebral ﬁssures"

Named as a typical dysmorphic feature of the entity. This sentence summarises the prior literature in the introduction of the largest cohort paper rather than reporting that cohort's own counts, so no frequency is asserted.

Pointed Chin HP:0000307

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"a broad nose with full nasal tip, and a pointed chin"

Named as a typical dysmorphic feature of the entity. As above, this is a literature-summary sentence, so no frequency is asserted.

Limbs 2

Pes Planus HP:0001763

Show evidence (1 reference)

PMID:31721432 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma"

The primary cohort identifies this individual skeletal manifestation.

Fifth-Finger Clinodactyly Clinodactyly of the 5th finger HP:0004209

Show evidence (1 reference)

PMID:31721432 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma"

The primary cohort identifies this individual skeletal manifestation.

Metabolism 1

Hyperbilirubinemia HP:0002904

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"hyperbilirubinemia was described in six of 53 individuals (11%)"

The assembled cohort reports 6/53; this is not a prospective incidence estimate.

Context-specific annotations (1)

Dingemans 2022 main phenotype cohort, with trait-specific available records OCCASIONAL

Published cases overlap earlier cohorts and completeness of reporting varies by trait.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"hyperbilirubinemia was described in six of 53 individuals (11%)"

The assembled cohort reports 6/53; this is not a prospective incidence estimate.

Musculoskeletal 3

Hypotonia OCCASIONAL HP:0001252

Show evidence (3 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare)."

GeneReviews gives an approximate 30% figure, sitting exactly on the OCCASIONAL/FREQUENT boundary.

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed"

Largest cohort reports 29%.

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"some had regression of speech (37%), seizures (27%) and hypotonia (27%)"

Second independent cohort reports 27%. Two independent quantified cohorts both fall below 30%, so the OCCASIONAL (5-29%) band is used rather than rounding GeneReviews' "about 30%" upward.

Musculoskeletal Abnormality FREQUENT Abnormality of the musculoskeletal system HP:0033127

Coarse binding: variable spectrum

Show evidence (2 references)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Furthermore, abnormalities in the digestive (53%), musculoskeletal (79%) and genitourinary systems (18%) were noted."

Quantifies composite musculoskeletal involvement at 79%, the top of the FREQUENT band.

PMID:31721432 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma"

Enumerates the individual musculoskeletal findings that make up the composite, each individually uncommon.

Context-specific annotations (1)

Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded) FREQUENT

A heterogeneous musculoskeletal category was recorded in 79% of individuals with information.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Furthermore, abnormalities in the digestive (53%), musculoskeletal (79%) and genitourinary systems (18%) were noted."

Quantifies composite musculoskeletal involvement at 79%, the top of the FREQUENT band.

Scoliosis HP:0002650

Show evidence (1 reference)

PMID:31721432 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma"

The primary cohort identifies this individual skeletal manifestation.

Nervous System 15

Global Developmental Delay HP:0001263

Show evidence (1 reference)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Most, if not all, affected individuals have some degree of DD, most commonly speech and motor delays."

"Most, if not all" maps to VERY_FREQUENT in the project's prose-to-enum table.

Delayed Speech and Language Development HP:0000750

Show evidence (1 reference)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Most, if not all, affected individuals have some degree of DD, most commonly speech and motor delays."

GeneReviews identifies speech delay as one of the two most common developmental domains within a near-universal developmental delay.

Motor Delay HP:0001270

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"When reported, delayed early motor milestones are present in 90% of affected individuals."

The review explicitly conditions this percentage on reporting.

Context-specific annotations (1)

GeneReviews synthesis of published CHD8 cases VERY_FREQUENT

GeneReviews reports 90% when motor milestones are reported; this is not an unselected cohort estimate.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"When reported, delayed early motor milestones are present in 90% of affected individuals."

The review explicitly conditions this percentage on reporting.

Intellectual Disability FREQUENT HP:0001249

Show evidence (4 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"When present, ID is most often in the mild-to-moderate range."

GeneReviews qualifies ID as present in a subset ("when present") with mild-to-moderate severity, so the band is set below the near-universal developmental delay.

PMID:30670789 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Children with the disorder present with developmental delay, intellectual disability, and/or autism spectrum disorder in addition to characteristic facies."

Independent clinical series confirming intellectual disability.

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed, as well as a wide variety of behavioural abnormalities (88%)."

The largest assembled cohort (n=106) quantifies intellectual disability at 68%, within the FREQUENT (30-79%) band.

+ 1 more reference

Context-specific annotations (1)

Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded) FREQUENT

The main analysis reports intellectual disability in 68%; 70 previously published and 36 new individuals were assembled before excluding five uncertain-variant cases.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed, as well as a wide variety of behavioural abnormalities (88%)."

The largest assembled cohort (n=106) quantifies intellectual disability at 68%, within the FREQUENT (30-79%) band.

Autism Spectrum Disorder HP:0000717

Show evidence (2 references)

PMID:24998929 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation."

Establishes CHD8 disruption as defining a distinct, monogenic autism subtype.

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"developmental delay and/or intellectual disability (81%), ASDs (84%), sleep difficulties (50%)"

The truncating-variant clinical series reports an 84% autism rate.

Context-specific annotations (1)

Douzgou 2019 truncating-variant cohort VERY_FREQUENT

Autism spectrum disorders reported in 84% of this clinically ascertained truncating-variant cohort. It overlaps later literature aggregations.

Show evidence (1 reference)

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"developmental delay and/or intellectual disability (81%), ASDs (84%), sleep difficulties (50%)"

The truncating-variant clinical series reports an 84% autism rate.

Sleep Disturbance FREQUENT HP:0002360

Show evidence (4 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Sleep disturbance is characterized by difficulty with both initiation (delayed sleep onset) and maintenance (frequent night awakenings) of sleep."

GeneReviews characterises the sleep phenotype qualitatively (initiation and maintenance) but does not quantify it; the FREQUENT band comes from the 50% figure in PMID:31001818 below, not from this source.

PMID:30670789 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Gastrointestinal and sleep problems are notable."

Independent clinical series flagging sleep problems as notable.

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"ASDs (84%), sleep difficulties (50%), gastrointestinal problems (40%), and distinct facial features"

Quantifies sleep difficulties at 50%, the basis for the FREQUENT band.

+ 1 more reference

Context-specific annotations (1)

Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded) OCCASIONAL

The retrospective series reports sleep disturbance in 29%; absence of documentation is not uniform assessment.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Most frequently observed behavioural problems included autism spectrum disorder (76%), short attention span (32%), abnormal social behaviour (31%), sleep disturbance (29%) and impaired social interactions (28%)."

The largest cohort reports a substantially lower figure (29%). This retrospective HPO-coded aggregation almost certainly undercounts sleep problems relative to prospectively questioned cohorts; the discrepancy is recorded rather than hidden. See the frequency-ascertainment discussion.

Seizures OCCASIONAL HP:0001250

Show evidence (3 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare)."

GeneReviews gives 10%-15%, which falls in the 5-29% OCCASIONAL band.

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"some had regression of speech (37%), seizures (27%) and hypotonia (27%)"

An independent cohort reports 27%, at the upper end of but still within the OCCASIONAL band.

PMID:31526516 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"less severe adaptive deficits in communication skills, similar functional language, more social motivation challenges in those with ASD, larger head circumference, higher weight, and lower seizure prevalence relative to the other gene group"

CHD8 carriers have LOWER seizure prevalence than other autism-risk-gene carriers, reinforcing that epilepsy is not a defining feature of this disorder.

Dystonia HP:0001332

Show evidence (3 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare)."

GeneReviews describes dystonia as rare, mapping to the VERY_RARE band.

PMID:38441608 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"This work validates our previous observation that dystonia is part of the phenotypic spectrum of CHD8-related"

Dedicated case series validating dystonia as part of the CHD8-NDD spectrum.

PMID:34415117 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We further expand the CHD8-related phenotype with the description of two unrelated patients who presented with childhood-onset progressive dystonia."

The original report establishing childhood-onset progressive dystonia as a CHD8 presentation. Note this is the one phenotype in the entry described as progressive.

Chiari Type I Malformation HP:0007099

Show evidence (1 reference)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare)."

GeneReviews describes Chiari I malformation as rare, mapping to VERY_RARE.

Anxiety HP:0000739

Show evidence (3 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"monitor for signs and symptoms of anxiety, attention-deficit/hyperactivity disorder, and aggressive or self-injurious behavior"

GeneReviews surveillance guidance identifies anxiety as an expected manifestation; no frequency is given, so none is asserted.

PMID:38622540 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Patterns of mental health features varied by group, with anxiety most prominent for CHD8"

Genotype-first CBCL comparison across ADNP, CHD8 and DYRK1A identifies anxiety as the psychiatric feature most characteristic of CHD8 specifically. The CHD8 subgroup is n=18, so this establishes the qualitative profile, not a frequency.

PMID:38622540 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"our data are cross-sectional in nature ... data will be needed to confirm these patterns"

The primary report explicitly limits inference about change over time.

Attention Deficit Hyperactivity Disorder HP:0007018

Show evidence (2 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"monitor for signs and symptoms of anxiety, attention-deficit/hyperactivity disorder, and aggressive or self-injurious behavior"

GeneReviews surveillance guidance identifies ADHD as an expected manifestation.

PMID:41407309 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"who exhibited a subtle feature, including traits consistent with attention-deficit/hyperactivity disorder"

Illustrates ADHD traits as the minimal expression in a transmitting parent.

Self-Injurious Behavior HP:0100716

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Aggression and self-injury have also been noted in several individuals"

The clinical synthesis documents both behaviors in affected individuals.

Behavioral Abnormality VERY_FREQUENT Atypical behavior HP:0000708

Show evidence (2 references)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed, as well as a wide variety of behavioural abnormalities (88%)."

Quantifies composite behavioural abnormality at 88% in the largest cohort, supporting the VERY_FREQUENT (80-100%) band.

PMID:31721432 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Behavioral problems were reported in the majority of patients (78%), with over half (56%) either formally diagnosed with an autistic spectrum disorder or described as having autistic traits."

Independent cohort reporting behavioural problems in 78%.

Context-specific annotations (1)

Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded) VERY_FREQUENT

Composite behavioral findings: 88% in the main phenotype analysis.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed, as well as a wide variety of behavioural abnormalities (88%)."

Quantifies composite behavioural abnormality at 88% in the largest cohort, supporting the VERY_FREQUENT (80-100%) band.

Developmental Regression FREQUENT HP:0002376

Show evidence (2 references)

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"some had regression of speech (37%), seizures (27%) and hypotonia (27%)"

Quantifies speech regression at 37%, inside the FREQUENT (30-79%) band. Note the source measures regression of speech specifically; regression of social and motor skills is described qualitatively elsewhere and is not separately banded.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Developmental regression of social, speech, and/or motor skills in infancy and early childhood is reported in up to half of affected individuals"

The chapter expands the reported domains of regression.

Aggressive Behavior HP:0000718

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Aggression and self-injury have also been noted in several individuals"

The clinical synthesis documents both behaviors in affected individuals.

Respiratory 1

Respiratory Distress HP:0002098

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"mainly respiratory distress (in three individuals)"

Respiratory findings were documented in only ten individuals; three had distress, so the selected denominator cannot estimate syndrome-wide frequency.

Growth 2

Tall Stature FREQUENT HP:0000098

Show evidence (3 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"The most common findings are the development of macrocephaly (most often during infancy) and tall stature (most typically during puberty), which is often accompanied by ASD and/or DD/ID."

GeneReviews identifies tall stature as one of the two most common findings, qualified by pubertal timing.

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

Quantifies tall stature at 47%, within the FREQUENT (30-79%) band.

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"macrocephaly is a striking feature that was common, at birth (53%, 8/15) and at the age of examination (52%, 46/88), as well as tall stature (50%, 39/78)"

The largest assembled cohort quantifies tall stature at 50% (39/78), independently reproducing the 47% figure from PMID:31001818 and placing the FREQUENT band on two concordant denominators rather than on one.

Context-specific annotations (1)

Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded) FREQUENT

Tall stature was reported in 39/78 evaluable individuals.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"macrocephaly is a striking feature that was common, at birth (53%, 8/15) and at the age of examination (52%, 46/88), as well as tall stature (50%, 39/78)"

Overweight FREQUENT HP:0025502

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"as well as tall stature (50%, 39/78) and being overweight (34%, 24/71)"

The full clinical series provides the available-data denominator; this is not an unbiased population prevalence.

Context-specific annotations (1)

Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded) FREQUENT

Overweight was recorded in 24/71; unreported findings were not uniformly assessed.

Show evidence (1 reference)

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"as well as tall stature (50%, 39/78) and being overweight (34%, 24/71)"

The full clinical series provides the available-data denominator; this is not an unbiased population prevalence.

🧬

Genetic Associations

CHD8

Gene: CHD8 hgnc:20153 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (7 references)

PMID:22495309 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"In proband exomes, recurrent protein-altering mutations were observed in two genes: CHD8 and NTNG1."

Gene-discovery evidence: the original sporadic-autism exome study that identified recurrent de novo CHD8 mutations. Cited for discovery only, not for CHD8-specific phenotype frequencies.

PMID:24998929 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"we resequenced the ASD-associated gene CHD8 in 3,730 children with developmental delay or ASD. We identified a total of 15 independent mutations; no truncating events were identified in 8,792 controls, including 2,289 unaffected siblings."

Establishes the mutational burden and the absence of truncating CHD8 events in controls.

PMID:31980904 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"HELIC domain mutations were associated with a severe phenotype defined by a greater number of clinical features, lower verbal IQ, and a prominent, consistent pattern of overgrowth as measured by weight, height and head circumference."

The small 2020 study proposed a domain association; the larger subsequent study did not establish a clear domain correlation.

+ 4 more references

🔬

Variants

CHD8 helicase-C (HELIC) domain truncating and missense variants

Gene: CHD8 hgnc:20153

The 2020 clinical study proposed greater severity for HELIC-domain variants. The larger 2022 aggregation did not show a clear domain-level correlation, so location alone should not determine prognosis or variant classification.

Show evidence (1 reference)

PMID:31980904 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"we compiled a comprehensive list of CHD8 variants from the literature and databases, which revealed constitutive and somatic truncating variants in the HELIC (Helicase-C) domain in ASD and in cancer patients, respectively, but not in the general population."

Documents the HELIC-domain variant class and its absence from the general population.

CHD8 missense variants of uncertain causality

Gene: CHD8 hgnc:20153

A CHD8 missense variant requires clinical and genetic interpretation. Biochemical assays, cellular phenotypes, segregation and methylation signatures can contribute; computational scores or mouse behavior alone do not prove pathogenicity or benignity. Tested alleles can act with or without loss of remodeling activity.

Show evidence (1 reference)

PMID:38438524 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Only mutations with high prediction scores gave rise to ASD-like phenotypes in mice, suggesting that not all CHD8 missense mutations detected in ASD patients are directly responsible for the development of ASD."

This experimental study demonstrates heterogeneity among tested alleles, not a diagnostic rule for every human missense variant.

💊

Medical Actions

Sleep Disturbance Management

Action: behavioral counseling Ontology label: Behavioral Counseling NCIT:C181743

Platform: Behavioral / lifestyle

Behavioral sleep assessment and intervention are recommended; GeneReviews includes cognitive behavioral approaches and sleep restriction therapy. Medication may be considered individually, but the chapter does not establish a CHD8-specific drug. Fly sleep rescue is mechanistic evidence, not a human treatment trial.

Target Phenotypes: Sleep disturbance HP:0002360

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"For example, cognitive behavioral therapy, including sleep restriction therapy"

The full management table explicitly includes these behavioral approaches.

Management of Bowel Dysfunction

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Platform: Other

Constipation management may include fluids, dietary fiber and individualized bulk, osmotic, stimulant or emollient laxatives. Ongoing clinical assessment guides treatment; an enteric-neuron deficit is not established in patients and does not dictate a specific regimen.

Target Phenotypes: Constipation HP:0002019

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Fluids, dietary fiber, bulk laxatives, osmotic agents, stimulant laxatives, or emollients as needed"

The full chapter specifies standard bowel-management options.

Developmental and Educational Intervention

Action: speech and language therapy Ontology label: Speech Language Therapy NCIT:C159273

Platform: Behavioral / lifestyle

Early intervention, individualized education and speech-language therapy address developmental and adaptive needs. Augmentative and alternative communication assessment can support individuals with expressive-language difficulties.

Target Phenotypes: Delayed speech and language development HP:0000750 Global developmental delay HP:0001263

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy"

The chapter recommends multidisciplinary developmental support.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Consider evaluation for alternative means of communication"

The communication section discusses individualized AAC assessment.

Antiseizure Pharmacotherapy

Action: Anticonvulsant Therapy NCIT:C64172

Platform: Other

Seizures receive standard individualized management by an experienced neurologist. No antiseizure medicine is established as preferentially effective for CHD8-NDD.

Target Phenotypes: Seizure HP:0001250

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Many ASMs may be effective; none has been demonstrated effective specifically"

The chapter notes the absence of demonstrated CHD8-specific antiseizure efficacy.

Surgical Treatment of Chiari I Malformation

Action: surgical procedure Ontology label: Surgical Procedure NCIT:C15329

Platform: Surgery

Symptomatic Chiari I malformation may require neurosurgical treatment, including foramen-magnum and C1 decompression. Imaging and intervention depend on symptoms and specialist assessment.

Target Phenotypes: Chiari type I malformation HP:0007099

Show evidence (1 reference)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"if Chiari I malformation is present, surgical treatment may be required"

GeneReviews management recommendation for Chiari I malformation.

Growth and Neurologic Surveillance

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Platform: Other

Monitor growth including head circumference into adulthood, development, sleep, bowel and feeding symptoms, psychiatric symptoms and new neurological or movement findings. MRI and EEG are indication-driven. The 2022 clinical series also proposes a one-time renal ultrasound after diagnosis and attention to skeletal and dental findings; these are author recommendations rather than outcome-tested screening protocols.

Show evidence (3 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"At each visit: measurement of growth parameters (including head circumference); assessment of developmental progress and educational needs"

GeneReviews surveillance schedule.

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"assess for new manifestations, such as seizures, changes in tone, and signs/symptoms of cerebrospinal fluid obstruction and/or spinal cord dysfunction"

GeneReviews surveillance for new neurologic manifestations.

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We also recommend a single renal ultrasound for abnormalities of the genitourinary system."

The authors propose renal assessment after diagnosis.

Deep Brain Stimulation for Refractory Dystonia

Action: deep brain stimulation Ontology label: Deep Brain Stimulation NCIT:C21024

Platform: Device

Two women with childhood-onset progressive dystonia underwent pallidal deep brain stimulation at ages 50 and 17. Both improved, but benefit was partial: approximately 30% over three years in the older patient and modest scale changes after six months in the adolescent. These uncontrolled cases do not establish comparative superiority or a universal response.

Target Phenotypes: Dystonia HP:0001332

Show evidence (1 reference)

PMID:34415117 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Deep brain stimulation led to clinical improvement in both cases."

Both reported individuals with CHD8-related progressive dystonia improved with deep brain stimulation.

Genetic Counseling

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Platform: Other

Parental testing distinguishes inherited from apparently de novo variants and informs recurrence counseling. Each child of a variant carrier has a 50% chance of inheriting the variant, with variable expression. When neither parent has the variant in blood, GeneReviews gives an estimated sibling recurrence risk of 1% because of possible germline mosaicism; this is an estimate rather than an observed CHD8-specific rate. Prenatal and preimplantation testing can be discussed once the familial variant is known.

Show evidence (1 reference)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Each child of an individual with CHD8-NDD has a 50% chance of inheriting the CHD8 pathogenic variant. Once the CHD8 pathogenic variant has been identified in an affected family member, prenatal and preimplantation genetic testing are possible."

GeneReviews genetic counselling guidance.

Physical Therapy

Action: Physical Therapy NCIT:C15302

Platform: Behavioral / lifestyle

Individualized physical therapy and appropriate mobility aids support gross-motor function.

Target Phenotypes: Motor delay HP:0001270

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Physical therapy is recommended to maximize mobility."

The full chapter explicitly recommends this functional intervention.

Occupational Therapy

Action: Occupational Therapy NCIT:C121351

Platform: Behavioral / lifestyle

Occupational therapy addresses fine-motor and adaptive activities such as feeding, dressing and writing.

Target Phenotypes: Motor delay HP:0001270

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function"

The full chapter explicitly recommends this functional intervention.

Levodopa Trial for Dystonia

Action: Pharmacotherapy NCIT:C15986

Agent: Levodopa CHEBI:15765

Platform: Small molecule

Responses are inconsistent. The 2024 series records partial benefit in one child and no benefit in another patient; both 2021 DBS cases had failed levodopa. A 2025 child had carbidopa-levodopa-responsive intermittent dystonia. These observations support individualized specialist assessment, not syndrome-wide efficacy.

Target Phenotypes: Dystonia HP:0001332

Show evidence (3 references)

PMID:38441608 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"she was thus treated with levodopa (with partial response)"

One child with mild CSF dopamine/biopterin deficiency had partial benefit.

PMID:34415117 REFUTE DIRECT PRIMARY RESULT Human Clinical

"Dystonic symptoms did not respond to levodopa, trihexyphenidyl, and tetrabenazine."

A separate patient had no benefit from these drugs.

PMID:41407309 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She also exhibited intermittent dystonia responsive to carbidopa‐levodopa therapy"

The case reports benefit from the combination, without controlled efficacy testing.

Tizanidine and Botulinum Toxin Symptomatic Treatment

Action: Pharmacotherapy NCIT:C15986

Agent: Tizanidine CHEBI:63629 Botulinum Toxin

Platform: Other

One woman in the 2024 series received tizanidine for spasticity and intramuscular botulinum toxin for dystonia, with a positive symptomatic response. Concurrent treatment and uncontrolled observation prevent attribution of an independent effect size to either agent.

Target Phenotypes: Dystonia HP:0001332

Show evidence (1 reference)

PMID:38441608 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She received symptomatic treatment with tizanidine and botulinum toxin injections, with positive response."

The primary case records combined symptomatic care; it is not a controlled efficacy comparison.

🔬

Diagnosis

Molecular Genetic Diagnosis of CHD8-NDD

Diagnosis rests on a heterozygous pathogenic or likely pathogenic CHD8 variant interpreted with the phenotype. Broad neurodevelopmental/overgrowth panels, exome or genome sequencing, and copy-number analysis are appropriate routes; single-gene testing is rarely the preferred initial approach. A variant of uncertain significance does not establish or exclude the diagnosis. Episignature testing can provide adjunctive evidence; 11 positive results among 13 selected samples in the 2022 study are not a diagnostic sensitivity estimate. Protein structural modeling is computational evidence, not measured functional loss.

Show evidence (3 references)

PMID:36302072 SUPPORT DIRECT REVIEW SYNTHESIS Other

"The diagnosis of CHD8-NDD is established in a proband by identification of a heterozygous pathogenic (or likely pathogenic) variant in CHD8 by molecular genetic testing."

GeneReviews diagnostic criterion.

PMID:41407309 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Pathogenicity was confirmed through epigenetic signature testing (EpiSign), demonstrating characteristic methylation patterns and structural biology analysis, predicting significant protein destabilization."

The report combines an inherited missense variant, characteristic methylation findings and computational structural analysis; the latter is not a protein assay.

PMID:36182950 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Methylation analysis was performed for 13 patients, 11 of which showed the previously established episignature for IDDAM (85%) associated with CHD8 haploinsufficiency"

This selected-sample result supports an adjunctive role, not validated sensitivity or specificity.

Targeted Neurological and Developmental Assessment

Characterize developmental domains and psychiatric, sleep, gastrointestinal and movement symptoms. GeneReviews recommends brain MRI for head circumference at least 3 SD above the mean, rapidly increasing head circumference or signs of obstruction/compression; MRI may also be considered above 2 SD without symptoms. Obtain EEG when seizure symptoms warrant it and spine imaging for suspected cord dysfunction.

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"To incl brain MRI if HC ... 3 SDs above mean"

The full evaluation table ties MRI to head growth and neurological indications.

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"To incl EEG if history of signs/symptoms suggestive of seizures"

EEG is symptom-directed.

🔀

Differential Diagnoses

Conditions with similar clinical presentations that must be differentiated from CHD8-Related Neurodevelopmental Disorder with Overgrowth:

Autism Spectrum Disorder (multifactorial) MONDO:0005258

Overlapping Features Autism has many genetic and non-genetic contributors. A pathogenic CHD8 variant identifies a molecularly defined neurodevelopmental disorder that may include autism, overgrowth, sleep and gastrointestinal findings.

Distinguishing Features

A pathogenic or likely pathogenic CHD8 variant, interpreted with the phenotype, distinguishes this disorder; macrocephaly and tall stature are useful but not obligatory clues.

Show evidence (1 reference)

PMID:24998929 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation."

Explicitly frames CHD8 disruption as defining a distinct subtype separable from autism at large.

CHARGE Syndrome (CHD7) MONDO:0008965

Overlapping Features This distinct disorder involves the paralogous gene CHD7. Similar gene names and overlapping developmental features do not make its evidence interchangeable with CHD8-NDD.

Distinguishing Features

Molecular confirmation of the responsible CHD7 variant distinguishes this diagnosis from a CHD8-associated disorder.

Sifrim-Hitz-Weiss Syndrome (CHD4) MONDO:0014946

Overlapping Features This distinct disorder involves the paralogous gene CHD4. Similar gene names and overlapping developmental features do not make its evidence interchangeable with CHD8-NDD.

Distinguishing Features

Molecular confirmation of the responsible CHD4 variant distinguishes this diagnosis from a CHD8-associated disorder.

14q11.2 Microdeletion Syndrome

Overlapping Features A contiguous deletion that includes CHD8 can produce CHD8 haploinsufficiency while additional deleted genes contribute to the presentation.

Distinguishing Features

Copy-number analysis defines the deletion and other affected genes, including SUPT16H in the recurrent small interval. This is a route to CHD8 loss with potential additional effects, rather than an exclusion from the CHD8 spectrum.

Show evidence (1 reference)

PMID:25257502 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The minimal critical region, considering present and previous cases, contains the SUPT16H and CHD8 genes."

Defines the minimal critical region and shows it is not CHD8 alone.

14q11.2 Microduplication (CHD8-SUPT16H) Syndrome Not Yet Curated MONDO:0016835

Overlapping Features The reciprocal dosage disorder. Duplication of the same 14q11.2 segment containing CHD8 and SUPT16H also produces a neurodevelopmental phenotype, which is why CHD8 is described as requiring tight dosage control in both directions. Duplication cases are a separate entity and must not be folded into this entry.

Distinguishing Features

Detected as a copy-number GAIN on chromosomal microarray rather than a loss-of-function sequence variant; neurodevelopmental severity is variable and at least one reported individual had normal intelligence; the duplication also spans SUPT16H so single-gene CHD8 triplosensitivity is not established.

Show evidence (2 references)

PMID:31823155 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Recently, a 14q11.2 microduplication syndrome, encompassing CHD8 and SUPT16H, has been described, highlighting the importance of a tight control of at least CHD8 gene-dosage for a normal development."

Establishes the duplication entity and the bidirectional dosage sensitivity.

PMID:31823155 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Here, we report on two patients with 14q11.2 microduplication encompassing CHD8 and SUPT16H, one of whom had normal intelligence."

Documents the milder end of the duplication phenotype, distinguishing it from the deletion/loss-of-function disorder.

PTEN Hamartoma Tumor Syndrome MONDO:0017623

Overlapping Features PTEN-related disease can also present with macrocephaly and autism and carries an established tumor-predisposition phenotype.

Distinguishing Features

PTEN-related hamartomas and characteristic tumor risk distinguish the condition. CHD8 overgrowth is variable and may be disproportionately cranial; head-to-height proportionality is not a reliable exclusion rule. An increased germline malignancy risk has not been established for CHD8-NDD.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/ SUPPORT DIRECT REVIEW SYNTHESIS Other

"there is no current evidence that individuals with ... are at increased risk for developing cancer"

The chapter distinguishes somatic cancer observations from established germline risk.

Other Overgrowth-with-Intellectual-Disability Syndromes

Overlapping Features Sotos, Weaver, Tatton-Brown-Rahman and Malan syndromes are overlapping overgrowth/neurodevelopmental diagnoses. Beckwith-Wiedemann syndrome is an overgrowth differential with a different characteristic phenotype; intellectual disability is not its defining feature.

Distinguishing Features

Molecular diagnosis and syndrome-specific findings distinguish these conditions. Lateralized overgrowth, macroglossia and embryonal tumor risk particularly support Beckwith-Wiedemann syndrome. Methylation testing can contribute in appropriate cases but is not uniformly diagnostic across this differential.

Show evidence (1 reference)

PMID:31001818 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"CHD8 is one of the causative genes for OGID (overgrowth and ID)"

Places CHD8 explicitly within the overgrowth-and-intellectual-disability disease group that constitutes this differential.

🔬

Clinical Trials

NCT01238250 RECRUITING

Simons Searchlight is an observational international research program for people with rare genetic changes, including CHD8. It collects medical, behavioral, learning and developmental information; it is not a CHD8-directed interventional treatment trial.

Target Phenotypes: Autism HP:0000717 Global developmental delay HP:0001263

Show evidence (1 reference)

clinicaltrials:NCT01238250 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism."

Describes the registry that provides longitudinal natural-history data for CHD8 variant carriers.

🧫

Experimental Models

Control-donor iPSC-derived CHD8-knockdown neural progenitors IPSC_DERIVED_MODEL

Six shRNAs in a control-donor iPSC neural progenitor line reduce CHD8 RNA by 38–69%. RNA sequencing and control-cell ChIP-seq distinguish transcriptional changes from binding. Morphology and selected neural ectoderm markers remain unchanged.

Publication

PMID:25294932

Pathograph links

Dysregulation of Neurodevelopmental Gene Networks partially recapitulates fidelity: moderate observes: molecular Measures dose-associated transcriptional changes.

Limitations: Stable knockdown from one donor; 1,756 nominal changes versus 369 false-discovery-adjusted changes. Enrichment does not directly measure synapse formation.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/pmc/articles/PMC4210312/ SUPPORT DIRECT PRIMARY RESULT In Vitro

"1,756 genes were differentially expressed ... 369 of which were significant"

The full text distinguishes nominal and multiple-testing-adjusted differential expression.

Engineered CHD8 exon-1 iPSC cerebral organoids ORGANOID

Four engineered heterozygous frameshift clones and two control clones derive from one healthy donor. The model shows approximately halved protein and altered developmental transcription, including DLX6-AS1 and DLX1 upregulation.

Publication

PMID:28321286

Pathograph links

Dysregulation of Neurodevelopmental Gene Networks partially recapitulates fidelity: moderate observes: molecular Measures organoid transcription after engineered CHD8 loss.

Limitations: One donor background, heterogeneous organoids and expression-based pathway inference; physiological excitation/inhibition was not measured.

Show evidence (1 reference)

PMID:28321286 SUPPORT DIRECT PRIMARY RESULT In Vitro

"there were 559 DEGs when the CHD8+/+ organoids were compared with CHD8+/−"

The primary RNA-sequencing result replaces the former title-only evidence.

Engineered H9 hESC CHD8 cerebral organoids ORGANOID

Female H9 embryonic stem cells carry isogenic S62X, E1114X or exon-20 disruption alleles. These are engineered patient-associated alleles, not patient-derived iPSCs. Mosaic cultures test cell autonomy.

Publication

PMID:35385734

Pathograph links

Excitatory-Inhibitory Neuronal Trajectory Imbalance partially recapitulates fidelity: moderate observes: cellular Measures stage-dependent neuronal lineage proportions.

Limitations: No direct physiological E/I assay; inhibitory expansion around day 60 is followed by excitatory expansion at day 120.

Show evidence (1 reference)

PMID:35385734 SUPPORT DIRECT PRIMARY RESULT In Vitro

Directly demonstrates the excitatory-inhibitory trajectory imbalance in a human isogenic model of CHD8 haploinsufficiency.

Brain Overgrowth and Megalencephaly partially recapitulates fidelity: moderate observes: tissue Models organoid enlargement in selected alleles.

Limitations: The long-isoform-specific S62X allele does not enlarge organoids at day 120; a single female genetic background limits generalization.

Show evidence (1 reference)

PMID:35385734 SUPPORT DIRECT PRIMARY RESULT In Vitro

"This imbalance is consistent with an enlargement of cerebral organoids as an in vitro correlate of patients' macrocephaly."

Human cerebral organoid model links the cellular imbalance to enlargement, the in vitro correlate of macrocephaly.

Show evidence (1 reference)

url:https://research-explorer.ista.ac.at/download/11160/11164/2022_CellReports_Villa.pdf SUPPORT DIRECT PRIMARY RESULT In Vitro

"Human H9 embryonic stem (ES) cells (WA09) are available from commercial sources (WiCell)."

The institutional PDF of Villa et al. (PMID:35385734) supplies the methods statement identifying the commercial H9 embryonic stem-cell line.

Newborn cynomolgus organotypic brain slices OTHER

CRISPR-mediated CHD8 perturbation in newborn monkey brain slices provides an ex vivo glial-proliferation assay distinct from the edited-founder animals.

Publication

PMID:36878905

Pathograph links

Increased Gliogenesis partially recapitulates fidelity: moderate observes: cellular Measures glial proliferation in cultured primate brain tissue.

Limitations: Short ex vivo developmental window; slice replicates do not replace independent donor animals.

Show evidence (1 reference)

PMID:36878905 SUPPORT DIRECT PRIMARY RESULT In Vitro

"knocking down CHD8 via CRISPR/Cas9 in organotypic monkey brain slices from newborn monkeys also enhanced the proliferation of glial cells"

Slice culture supplies a separate experimental glial readout.

Chd8 heterozygous nucleus accumbens slices OTHER

Acute slices allow recordings from medium spiny neurons. Increased spontaneous excitatory currents coexist with unchanged miniature excitatory currents and lower miniature inhibitory-current amplitude, suggesting a circuit-dependent effect.

Publication

PMID:28402856

Pathograph links

Striatal Circuit Dysfunction partially recapitulates fidelity: moderate observes: tissue Measures accumbens synaptic physiology.

Limitations: Mouse regional physiology is not a direct readout of human autism, dystonia or developmental motor delay.

Show evidence (1 reference)

PMID:28402856 SUPPORT DIRECT PRIMARY RESULT In Vitro

"We also find altered synaptic physiology in medium spiny neurons of the nucleus accumbens."

The electrophysiological component is an ex vivo tissue assay.

H9 E11 CHD8-heterozygous neural progenitor cell-cycle model OTHER

Coakley-Youngs et al. (Biology Open, 2022) used a single H9 hESC clone with a heterozygous exon-4 one-base insertion differentiated into cortical neural progenitors. FUCCI imaging measures single-cell cycle timing; independent clones and a genetic rescue were not presented. Assay details are supported by the institutional full-text PDF.

Publication

DOI:10.1242/bio.058941

Pathograph links

Shortened Neural Progenitor G1 Phase measures fidelity: moderate observes: cellular Directly measures cell-cycle phase duration.

Limitations: One engineered clone; proposed cell-fate and organ-growth consequences are not direct measurements.

Show evidence (1 reference)

url:https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf SUPPORT DIRECT PRIMARY RESULT In Vitro

"Comparative analysis of phase duration across genotypes revealed a marked shortening of G1"

FUCCI imaging compared a single H9-derived heterozygous exon-4 frameshift clone with wild type; G1 medians were 517 and 1,408 minutes, respectively.

Conditional CHD8 human excitatory neuron chromatin model OTHER

Engineered hESC and iPSC conditional alleles permit heterozygous or homozygous CHD8 deletion in induced excitatory neurons. ATAC-seq, RNA-seq and ELK1 perturbation distinguish occupancy, accessibility and transcription. Standard intrinsic and excitatory synaptic physiology was unchanged.

Publication

PMID:36575212

Pathograph links

Reduced Neuronal Chromatin Accessibility measures fidelity: moderate observes: molecular Measures genotype-dependent accessibility effects.

Limitations: Strong closure is observed after complete deletion; heterozygous changes are weaker. ELK1 overexpression did not significantly improve CHD8 binding.

Show evidence (2 references)

PMID:36575212 SUPPORT DIRECT PRIMARY RESULT In Vitro

"many more sites lost accessibility (1,481 peaks in homozygous KO) than gained accessibility (106 peaks in homozygous KO)"

ATAC-seq measures accessibility; the numerical result applies to complete deletion.

+ 1 more reference

Show evidence (1 reference)

PMID:36575212 SUPPORT DIRECT PRIMARY RESULT In Vitro

"evoked excitatory postsynaptic currents (EPSCs) were unchanged in heterozygous and homozygous mutant cells"

Negative cultured-neuron physiology constrains extrapolation from transcriptional changes.

Enhancer-targeted CHD8 CRISPR activation in human neural cultures ORGANOID

The March 2026 version of a preprint describes enhancer-targeted CRISPR activation in hPSC-derived excitatory neurons and forebrain organoids. CHD8 and SCN2A are separate targets. Increased CHD8 expression supports an experimental dosage-restoration approach; pooled abstract claims about physiological rescue cannot be assigned specifically to CHD8. Human safety and efficacy are untested in this study.

Publication

DOI:10.1101/2024.03.13.584921

Pathograph links

CHD8 Haploinsufficiency rescues fidelity: moderate observes: molecular Tests restoration of expression from an endogenous wild-type allele.

Limitations: Preprint evidence; rescue is limited here to the directly supported expression endpoint, not clinical benefit.

Show evidence (1 reference)

DOI:10.1101/2024.03.13.584921 Preprint · not peer-reviewed SUPPORT DIRECT PRIMARY RESULT In Vitro

"We found that CRISPR-A induced a sustained increase in CHD8 and SCN2A expression in neurons and organoids"

The preprint abstract directly supports expression upregulation but does not separate gene-specific physiological endpoints.

🐁

Animal Models

Chd8 exon-3 heterozygous mouse

Approximately half-normal full-length protein, modest brain enlargement, delayed early motor reflexes and adult hypoactivity. The study reports heightened sociability, with no clear anxiety or repetitive-behavior phenotype; this is not uniform recapitulation of human autism.

Species

Mus musculus

Genotype

Constitutive exon-3 frameshift heterozygote on C57BL/6 background

Publication

PMID:29668850

Pathograph links

Brain Overgrowth and Megalencephaly partially recapitulates fidelity: moderate observes: tissue Models modest volumetric enlargement.

Limitations: Total brain increase is approximately 2.7% and depends on statistical threshold; body weight is reduced rather than generalized overgrowth.

Show evidence (1 reference)

PMID:29668850 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Here, we report that Chd8 heterozygous mice display increased brain size, motor delay, hypertelorism, pronounced hypoactivity, and anomalous responses to social stimuli."

Mouse heterozygote recapitulates brain overgrowth and hypertelorism.

Aberrant Long-Range Functional Connectivity partially recapitulates fidelity: moderate observes: tissue Measures regional resting-state synchronization.

Limitations: Regional mouse fMRI under experimental conditions; no established human biomarker or causal behavioral mediation.

Show evidence (1 reference)

PMID:29668850 SUPPORT DIRECT PRIMARY RESULT Model Organism

Provides the functional-imaging evidence for altered long-range connectivity.

Increased Neural Progenitor Proliferation fails to recapitulate fidelity: moderate observes: cellular Tests ventricular proliferation in the heterozygous cortex.

Limitations: Negative at the examined developmental stages and compartments; other cell populations or time windows may differ.

Show evidence (1 reference)

PMID:29668850 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we did not detect any significant differences in cortical ventricular zone (VZ) proliferation"

The study reports no detected ventricular proliferation difference.

Chd8 long-isoform and combined-isoform heterozygous mice

Katayama et al. report brain enlargement and selected behavioral abnormalities, with enhanced REST-associated repression. Their extended data also show behavioral tests without abnormalities.

Species

Mus musculus

Genotype

Chd8+/ΔL (exons 11–13) or Chd8+/ΔSL

Publication

PMID:27602517

Pathograph links

REST-Mediated Repression of Neuronal Genes partially recapitulates fidelity: moderate observes: molecular Models enhanced REST-associated repression during brain development.

Limitations: Strongest around E14.5; this mechanism does not explain every allele, developmental stage or model.

Show evidence (1 reference)

PMID:27602517 SUPPORT DIRECT PRIMARY RESULT Model Organism

"reduced expression of CHD8 was associated with abnormal activation of RE-1 silencing transcription factor (REST), which suppresses the transcription of many neuronal genes"

Identifies REST derepression of the neuronal programme as a CHD8-dosage consequence.

Abnormal Neural Development partially recapitulates fidelity: moderate observes: organism Assesses behavioral and transcriptional consequences.

Limitations: Social and repetitive readouts differ across published Chd8 lines; mouse tests do not establish a human autism diagnosis.

Show evidence (1 reference)

PMID:27602517 SUPPORT DIRECT PRIMARY RESULT Model Organism

"mice heterozygous for Chd8 mutations manifest ASD-like behavioural characteristics including increased anxiety, repetitive behaviour, and altered social behaviour"

The primary report supports selected behavioral abnormalities in these specific lines.

Embryonic cortical Chd8 knockdown mouse

Restricted embryonic cortical knockdown reduces proliferation and accelerates early differentiation. CHD8 or stabilized beta-catenin expression rescues selected developmental and adult outcomes.

Species

Mus musculus

Genotype

In utero cortical shRNA electroporation at E13 or E15

Publication

PMID:27694995

Pathograph links

Reduced Cortical Progenitor Proliferation partially recapitulates fidelity: moderate observes: cellular Perturbs embryonic progenitor maintenance.

Limitations: Spatially restricted knockdown differs from a constitutional heterozygous allele.

Show evidence (1 reference)

PMID:27694995 SUPPORT DIRECT PRIMARY RESULT Model Organism

"chd8 knockdown resulted in a premature depletion of the neural progenitor pool in the developing mouse cortex"

The primary cortical knockdown depletes the progenitor pool.

Premature Neuronal Differentiation partially recapitulates fidelity: moderate observes: cellular Measures early neuronal differentiation.

Limitations: The direction differs from delayed excitatory-neuron generation in engineered human organoids.

Show evidence (1 reference)

PMID:27694995 SUPPORT DIRECT PRIMARY RESULT Model Organism

"This was accompanied by a concomitant increase in the percentage of cells positive for neuronal marker Tuj1"

The embryonic cortical experiment establishes the direction of the differentiation change.

Impaired Wnt/beta-Catenin Signal Transduction partially recapitulates fidelity: moderate observes: molecular Tests Wnt contribution through beta-catenin rescue.

Limitations: Wnt effects are cell- and stage-dependent; this is not evidence for a human Wnt-directed treatment.

Show evidence (1 reference)

PMID:27694995 SUPPORT DIRECT PRIMARY RESULT Model Organism

"knockdown of Chd8 disrupts the expression of key transducers of Wnt signaling, and enhancing Wnt signaling rescues the transcriptional and behavioral deficits caused by Chd8 knockdown"

Rescue by Wnt enhancement establishes the causal role of the Wnt branch.

Chd8 hypomorphic allelic-series mouse

Approximately 50%, 36% and 9% residual protein produce nonmonotonic effects. Mild hypomorphs enlarge the brain and increase basal progenitor proliferation; severe hypomorphs and neural knockouts produce hypoplasia. Reduced Trp53 partially rescues the conditional-knockout cell-loss phenotype.

Species

Mus musculus

Genotype

Chd8+/−, Chd8neo/neo, Chd8neo/−; separate Sox1-Cre conditional knockout

Publication

PMID:33627187

Pathograph links

Increased Neural Progenitor Proliferation partially recapitulates fidelity: moderate observes: cellular Models increased TBR2-positive basal proliferation at the mild hypomorphic dose.

Limitations: Increased proliferation was not detected at the heterozygous or severe hypomorphic doses; mild hypomorphs are below a usual haploinsufficient dosage.

Show evidence (1 reference)

PMID:33627187 SUPPORT DIRECT PRIMARY RESULT Model Organism

"a significant increase in the proliferation of non-ventricular (or basal) progenitors was observed"

The full results localize increased proliferation to mild hypomorphs.

Brain Overgrowth and Megalencephaly partially recapitulates fidelity: moderate observes: tissue Tests brain growth across CHD8 dosage.

Limitations: Brain hypoplasia and p53-mediated cell loss after severe depletion are not equivalent to the typical human overgrowth presentation.

Show evidence (1 reference)

PMID:33627187 SUPPORT DIRECT PRIMARY RESULT Model Organism

"with heterozygotes and mild hypomorphs ... brain overgrowth, and severe hypomorphs ... brain hypoplasia"

The primary results establish the direction reversal at severe depletion.

Chd8 mouse genetic-background panel

A panel of 1,041 F1 animals of both sexes tests variation in behavior, growth and other traits. Effects and their direction depend on strain, sex and measured trait.

Species

Mus musculus

Genotype

B6 Chd8 heterozygous females crossed with 33 inbred paternal strains

Publication

PMID:36738737

Pathograph links

Abnormal Neural Development partially recapitulates fidelity: moderate observes: organism Tests background dependence of developmental and behavioral consequences.

Limitations: Resilience applies to particular traits; no corresponding human modifier locus was identified.

Show evidence (1 reference)

PMID:36738737 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Trait disruptions mimicked those seen clinically, with robust strain and sex differences."

The designed panel tests effects beyond a single inbred background.

Chd8L systemic and intestinal epithelial heterozygous mice

Male mice show genotype- and tissue-specific intestinal and behavioral findings. Systemic mutants have increased permeability and unchanged stool transit. Conditional epithelial mutants have selected anxiety changes but preserved sociability. Antibiotics were tested in systemic mutants.

Species

Mus musculus

Genotype

Systemic Chd8L+/− or Villin-Cre intestinal epithelial Chd8L conditional heterozygote

Publication

PMID:37783686

Pathograph links

Altered Intestinal Epithelial Differentiation partially recapitulates fidelity: moderate observes: tissue Measures tuft and goblet cell populations.

Limitations: Affected cell types and intestinal segments differ between systemic and conditional mutants.

Show evidence (1 reference)

PMID:37783686 SUPPORT DIRECT PRIMARY RESULT Model Organism

Mammalian replication of the gut epithelial defect at a haploinsufficient Chd8 dose.

Intestinal Barrier Impairment partially recapitulates fidelity: moderate observes: tissue Measures tracer permeability.

Limitations: Male mouse assay; the corresponding human lesion is unverified.

Show evidence (1 reference)

PMID:37783686 SUPPORT DIRECT PRIMARY RESULT Model Organism

"exhibited increased intestinal permeability, transcriptomic dysregulation in gut epithelial cells"

The systemic heterozygous mouse has a measured barrier defect.

Gastrointestinal Dysmotility fails to recapitulate fidelity: moderate observes: tissue Tests stool transit.

Limitations: Increased permeability occurs without the transit delay found in zebrafish morphants.

Show evidence (1 reference)

PMID:37783686 SUPPORT DIRECT PRIMARY RESULT Model Organism

"no differences in colon length ... or in stool transit time were measured between the genotypes"

The negative transit result supports failure to reproduce this readout.

chd8 zebrafish morphants

Transient suppression produces enlarged head size, reduced enteric-neuron abundance and delayed gut transit. Sugathan et al. additionally quantified increased proliferating cells. These manipulations do not assign a stable heterozygous genotype to every larva.

Species

Danio rerio

Genotype

Splice-blocking morpholinos; founding study also used mosaic F0 CRISPR disruption

Publication

PMID:24998929

Pathograph links

Gastrointestinal Dysmotility partially recapitulates fidelity: moderate observes: tissue Measures microgavage transit and enteric innervation.

Limitations: Morpholino dose and transient suppression differ from human constitutional heterozygosity.

Show evidence (1 reference)

PMID:24998929 SUPPORT DIRECT PRIMARY RESULT Model Organism

"impairment of gastrointestinal motility due to a reduction in postmitotic enteric neurons"

The fish experiment connects altered innervation with impaired transit.

Increased Neural Progenitor Proliferation partially recapitulates fidelity: moderate observes: cellular Measures proliferating cells in the developing brain.

Limitations: Proliferating-cell counts and head size support a developmental effect; cell-specific causal mediation was not isolated.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/sites/pmc/articles/PMC4210312/ SUPPORT DIRECT PRIMARY RESULT Model Organism

"We counted an average of 408 p-histone H3 ... cells for controls compared with 518 p-histone H3 ... cells in embryos injected with ... MO1"

The zebrafish experiment reports increased proliferating-cell counts after morpholino suppression.

Stable chd8 p.Glu223* zebrafish

Stable first-coding-exon mutants reproduce enlarged head size and reduced enteric neurons. Heterozygous larvae have an early neural crest deficit with later migration preserved. Adult immune single-cell profiling used homozygous males, which must not be treated as a heterozygous human-dose assay.

Species

Danio rerio

Genotype

chd8sa19827/+ and chd8sa19827/sa19827

Publication

PMID:36375841

Pathograph links

Reduced Vagal Neural Crest Cell Pool partially recapitulates fidelity: moderate observes: cellular Measures early emigrating neural crest cells.

Limitations: Early induction and migration are difficult to separate; later migration reaches the distal intestine.

Show evidence (1 reference)

PMID:36375841 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We observed a significant decrease in the number of NCCs released from the neural tube"

The early progenitor deficit is directly measured.

Reduced Enteric Neuron Abundance partially recapitulates fidelity: moderate observes: tissue Measures enteric-neuron abundance.

Limitations: Approximately 24% reduction in the cited heterozygote comparison, rather than the approximately 50% morphant reduction.

Show evidence (1 reference)

PMID:36375841 SUPPORT DIRECT PRIMARY RESULT Model Organism

"a significant decrease in the number of enteric neurons in the heterozygous"

The stable heterozygous fish shows reduced enteric-neuron abundance.

Altered Intestinal Epithelial Differentiation partially recapitulates fidelity: moderate observes: tissue Models altered epithelial, goblet-cell and mucus organization.

Limitations: Several adult findings are strongest in homozygotes. Barrier permeability and excessive Th17 activity were proposed, not directly established.

Show evidence (1 reference)

PMID:36375841 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The tissue examination of chd8 mutants revealed a thinner intestinal epithelium accompanied by an accumulation of neutrophils and the decreased numbers of goblet cells and eosinophils."

The study documents structural and cellular intestinal abnormalities.

Embryo-edited CHD8 cynomolgus monkeys

The three founders differ in allele and developmental outcome. Histology compares individual edited and control brains; serial imaging concerns one surviving male. More glial markers and white-matter changes support a candidate primate mechanism.

Species

Macaca fascicularis

Genotype

CRISPR founder M1 biallelic fetus, M2 heterozygous +16 stillborn, M3 heterozygous −1 surviving male

Publication

PMID:36878905

Pathograph links

Increased Gliogenesis partially recapitulates fidelity: low observes: tissue Measures glial abundance in edited brain tissue.

Limitations: Very small independent-animal numbers; section counts are not biological replication. Genotype and developmental-stage differences confound a species comparison.

Show evidence (1 reference)

PMID:36878905 SUPPORT DIRECT PRIMARY RESULT Model Organism

"CHD8 mutations selectively increased glial proteins but not neuronal proteins"

Brain tissue measurements distinguish glial from neuronal marker changes.

White Matter Expansion partially recapitulates fidelity: low observes: tissue Assesses white matter in histology and imaging.

Limitations: No corresponding cellular demonstration in human CHD8-NDD; brain editing of the surviving founder is incompletely characterized.

Show evidence (1 reference)

PMID:36878905 SUPPORT DIRECT PRIMARY RESULT Model Organism

"with enlarged white matter labeled by immunostaining of GFAP"

The stillborn edited monkey had enlarged brain tissue and white matter.

Kismet-deficient fly glial model

Developmental glial knockdown causes adult sleep fragmentation, whereas adult-only knockdown does not. Developmental serotonin manipulation and adult sleep restriction probe different portions of the phenotype.

Species

Drosophila melanogaster

Genotype

kis heterozygotes and temporally restricted glial/subperineurial-glial RNAi

Publication

PMID:34088660

Pathograph links

Developmental Glial Sleep Regulation Defect partially recapitulates fidelity: moderate observes: cellular Localizes a developmental glial requirement.

Limitations: Kismet is the shared ortholog of CHD7 and CHD8; the human gene-specific mechanism remains uncertain.

Show evidence (1 reference)

PMID:34088660 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We show that Kismet is required in glia for early developmental and adult sleep architecture. This role localizes to subperineurial glia constituting the blood-brain barrier."

Localises the sleep requirement to blood-brain-barrier glia in the sole CHD8/CHD7 ortholog.

Sleep Fragmentation partially recapitulates fidelity: moderate observes: organism Measures sleep architecture and behavioral rescue.

Limitations: Mutant sleep latency is normal; restriction improves fragmentation and efficiency but not total sleep duration. Patient evidence is mainly questionnaire-based.

Show evidence (1 reference)

PMID:34088660 SUPPORT INDIRECT PRIMARY RESULT Model Organism

"Despite their developmental origin, Kismet's sleep architecture defects can be reversed in adulthood by a behavioral regime resembling human sleep restriction therapy."

Timed and ventral-lineage Chd8 mutation and restoration mice

A 2026 study pairs timed neural deletion with restoration at the endogenous locus. Midfetal ventral differentiation and later social-contact/anxiety measures improve after early or ventral-lineage rescue. Macrocephaly remains after the timed E14.5 and Olig1-lineage rescues; these are developmental prevention experiments, not demonstrated treatment of established human disease.

Species

Mus musculus

Genotype

Nestin-CreERT2/Chd8+/F and conditional Chd8+/LSL restoration with Nestin-Cre or Olig1-Cre

Publication

PMID:42203765

Pathograph links

Premature Ventral Progenitor Differentiation partially recapitulates fidelity: moderate observes: cellular Models accelerated ventral cell-cycle exit.

Limitations: Mouse developmental timing does not define a human therapeutic window.

Show evidence (1 reference)

PMID:42203765 SUPPORT DIRECT PRIMARY RESULT Model Organism

"a significantly higher proportion of Ki67-negative EdU+ cells (cells that had exited the cell cycle) in the ganglionic eminence but not in the cortex"

E14.5-induced heterozygous deletion accelerates cell-cycle exit in ventral progenitors at E16.5.

Premature Ventral Progenitor Differentiation rescues fidelity: moderate observes: cellular Restores ventral differentiation genetically.

Limitations: Olig1-Cre includes interneuron and oligodendrocyte progenitors.

Show evidence (1 reference)

PMID:42203765 SUPPORT DIRECT PRIMARY RESULT Model Organism

"restoration of Chd8 expression in ventral progenitor cells by Olig1-Cre resulted in normalization of the differentiation of progenitors of both interneurons and oligodendrocytes"

The genetic rescue supports a requirement for ventral CHD8 dosage.

Abnormal Neural Development rescues fidelity: moderate observes: organism Tests time-dependent prevention of behavioral phenotypes.

Limitations: Behavior improves after restoration at E14.5 or earlier, not E17.5 or later in the tested paradigms; macrocephaly is not corrected by these timed rescues.

Show evidence (1 reference)

PMID:42203765 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The genetic rescue of Chd8 expression at E14.5 or before, but not at E17.5 or after, ameliorated autistic-like behavior"

Prenatal genetic restoration prevents selected mouse behavioral abnormalities; later restoration in the tested windows did not reproduce the benefit.

Olig1-lineage Chd8 heterozygous myelination and imaging mouse

Lineage-targeted mice have myelination and conduction abnormalities. A separate 2020 male-mouse MRI study identifies regional DTI changes and exploratory connectivity associations, without reproducing a group difference in social-contact time.

Species

Mus musculus

Genotype

Olig1-Cre/Chd8L+/F

Publication

PMID:32142125

Pathograph links

Impaired Myelination partially recapitulates fidelity: moderate observes: tissue Models defective myelination.

Limitations: Olig1-Cre also marks ventral interneuron progenitors; behavioral effects are not exclusively attributable to oligodendrocytes.

Show evidence (1 reference)

PMID:32142125 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Ablation of Chd8 specifically in oligodendrocytes of mice impaired myelination, slowed action potential propagation"

The primary mouse study reports myelination and conduction abnormalities; Olig1 lineage specificity requires caution in light of its ventral interneuron progenitor expression.

Aberrant Long-Range Functional Connectivity measures fidelity: moderate observes: tissue Measures regional functional connectivity.

Limitations: Connectivity comparisons did not survive multiple-testing correction; correlations do not establish behavioral causality.

Show evidence (1 reference)

PMID:33228730 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Although these differences did not survive multiple corrections, uncorrected statistics supported the alterations of functional connectivity"

Regional connectivity findings are exploratory; anatomical DTI results used separate corrected analyses.

Chd8 p.Val986* lifespan mouse

A heterozygous stop allele corresponding to human p.Val984* reduces brain CHD8 by half. Male cortical transcriptomes were compared at E14.5 and 1, 6 and 12 months; older animals show a reduced proteostasis-response transcriptional signature.

Species

Mus musculus

Genotype

Chd8V986*/+ on C57BL/6J

Publication

PMID:33023670

Pathograph links

Reduced Aged-Cortex Proteostasis Response Signature measures fidelity: moderate observes: molecular Measures an age-dependent cortical transcriptional signature.

Limitations: Gene-set inference and phospho-S6 do not establish misfolded-protein accumulation or human neurodegeneration.

Show evidence (1 reference)

PMID:33023670 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Pathways associated with the unfolded protein response (UPR), endoplasmic reticulum (ER) stress, and chaperone-mediated protein folding were reduced"

The result is a cortical transcriptional signature at 12 months, not a direct measurement of protein-folding capacity.

Constitutive exon-5 and postmitotic Chd8 excitatory neuron mice

A 2025 preprint combines constitutive mutation with postmitotic excitatory-neuron deletion. The conditional model was studied for bulk transcription only. Constitutive mice show enlarged cortex without extra neurons, transient adolescent spine changes, and altered sleep states. Slice calcium activity is less correlated despite unchanged overall activity.

Species

Mus musculus

Genotype

Chd8+/5bpdel on C57BL/6N; Camk2a-Cre Chd8+/flox on C57BL/6J

Publication

PMID:40501938

Pathograph links

Brain Overgrowth and Megalencephaly measures fidelity: moderate observes: tissue Separates cortical size from neuron number.

Limitations: Preprint; volume increases without additional neurons or larger somata.

Show evidence (1 reference)

PMID:40501938 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We did not find significant differences in total neuron number in either the full cohort or sex-stratified analyses"

Stereology in the constitutive exon-5 mouse supports model-specific dissociation of cortical volume and neuron count; the source is a preprint.

Delayed Cortical Spine Development measures fidelity: moderate observes: cellular Measures age-dependent spine structure in vivo.

Limitations: Preprint; P90 spine density and dynamics are normal. Conditional mice were not tested for the structural or behavioral outcomes.

Show evidence (1 reference)

PMID:40501938 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Adolescent Chd8+/− mice had lower spine density on the apical dendritic tufts of L5 PyrNs"

In vivo imaging in a 2025 preprint found reduced P30 spine density and increased formation, with normal P90 spine density and dynamics.

{ }

Source YAML

click to show

name: CHD8-Related Neurodevelopmental Disorder with Overgrowth
creation_date: "2026-07-31T00:00:00Z"
category: Mendelian
synonyms:
- intellectual developmental disorder with autism and macrocephaly
- IDDAM
- CHD8 overgrowth syndrome
- CHD8-related neurodevelopmental disorder
- CHD8-NDD
- autism, susceptibility to, 18
- AUTS18
description: >-
  CHD8-related neurodevelopmental disorder with overgrowth is an autosomal dominant disorder associated principally with heterozygous loss-of-function variants in CHD8 at 14q11.2. CHD8 is an ATP-dependent chromatin regulator. The clinical spectrum includes variable macrocephaly and tall stature, developmental and speech delay, intellectual disability ranging from mild to severe, autism, sleep disturbance and gastrointestinal symptoms, particularly constipation. Hypotonia and seizures occur in a minority; dystonia can occasionally be a prominent presentation with limited cognitive involvement. Most pathogenic variants arise de novo, but transmission with markedly variable expression is documented. The frequency of each feature depends on ascertainment, age and reporting completeness. This entry concerns the molecularly defined CHD8 disorder; broad autism cohorts inform gene discovery, while CHD8-specific cohorts inform clinical frequencies. Contiguous deletions may add effects from neighboring genes.
disease_term:
  preferred_term: intellectual developmental disorder with autism and macrocephaly
  term:
    id: MONDO:0014017
    label: intellectual developmental disorder with autism and macrocephaly
parents:
- Neurodevelopmental Disorder
- Genetic Disease
classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
    notes: >-
      The core manifestations - developmental delay, intellectual disability,
      autism, hypotonia, seizures, dystonia and structural brain anomalies - are
      neurologic.
    evidence:
    - reference: PMID:36302072
      reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        CHD8-related neurodevelopmental disorder with overgrowth (CHD8-NDD) is characterized by generalized overgrowth, developmental delay / intellectual disability (DD/ID), autism spectrum disorder (ASD), neuropsychiatric issues, neurologic problems, sleep disturbance, and gastrointestinal issues
      explanation: >-
        GeneReviews defines the condition as a neurodevelopmental disorder with
        neurologic and neuropsychiatric problems at its core.
      quote_role: REVIEW_SYNTHESIS
      directness: DIRECT
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    notes: >-
      Autosomal dominant Mendelian disorder caused by heterozygous loss-of-function
      CHD8 variants acting through haploinsufficiency.
    evidence:
    - reference: PMID:30670789
      reference_title: A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        confirms our suggestion that this is a syndromic disorder caused by haploinsufficiency or heterozygous loss of function of CHD8
      explanation: >-
        Establishes the Mendelian haploinsufficiency genetic basis of the syndrome.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0014017
      label: intellectual developmental disorder with autism and macrocephaly
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      MONDO:0014017 carries OMIM:615032 as an xref, links causally to HGNC:20153 (CHD8), and includes CHD8 overgrowth syndrome and AUTS18 as synonyms. These identifiers refer to the molecularly defined CHD8 disorder.
inheritance:
- name: Autosomal dominant inheritance
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >-
    CHD8-NDD segregates as an autosomal dominant trait. The great majority of
    reported probands carry a de novo CHD8 pathogenic variant, but transmitted
    variants occur and can be associated with strikingly milder parental
    presentations, indicating variable expressivity.
  expressivity: VARIABLE
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      CHD8-NDD is inherited in an autosomal dominant fashion. However, most probands reported to date whose parents have undergone molecular genetic testing have the disorder as the result of a de novo CHD8 pathogenic variant.
    explanation: >-
      GeneReviews states autosomal dominant inheritance with a predominance of de
      novo variants.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:41407309
    reference_title: "Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural Analyses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We describe the case of IDDAM caused by a paternally inherited CHD8 variant. Our findings highlight the importance of considering parental inheritance in IDDAM diagnoses
    explanation: >-
      Documents transmitted (non-de novo) inheritance with variable expressivity in
      an IDDAM family.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
pathophysiology:
- name: CHD8 Haploinsufficiency
  conforms_to: "epigenetic_machinery_neurodevelopmental_dysregulation#Epigenetic Machinery Component Haploinsufficiency"
  biological_scale: MOLECULAR
  role: TRIGGER
  description: >-
    Heterozygous truncating, splice-disrupting and deletion alleles reduce functional CHD8 dosage. Approximately half-normal protein is measured in several engineered models, rather than in every patient. Haploinsufficiency is the principal mechanism; selected missense alleles can alter function without the same remodeling defect.
  gene:
    preferred_term: CHD8
    term:
      id: hgnc:20153
      label: CHD8
  molecular_functions:
  - preferred_term: ATP-dependent chromatin remodeler activity
    term:
      id: GO:0140658
      label: ATP-dependent chromatin remodeler activity
    modifier: DECREASED
  genetic_context:
    gene:
      preferred_term: CHD8
      term:
        id: hgnc:20153
        label: CHD8
    variant_origin: GERMLINE
    zygosity: HETEROZYGOUS
    functional_impact_category: LOSS_OF_FUNCTION
    description: >-
      Constitutional heterozygous loss-of-function alleles are usually de novo but may be inherited.
  evidence:
  - reference: PMID:30670789
    reference_title: A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: confirms our suggestion that this is a syndromic disorder caused by haploinsufficiency or heterozygous loss of function of CHD8
    explanation: Clinical sequence and deletion reports support loss of function.
  - reference: PMID:29668850
    reference_title: Altered Neocortical Gene Expression, Brain Overgrowth and Functional Over-Connectivity in Chd8 Haploinsufficient Mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we found no evidence for a truncated protein product
    explanation: The exon-3 mouse allele reduces full-length CHD8 without a detected truncated product.
  downstream:
  - target: Dysregulation of Neurodevelopmental Gene Networks
    description: CHD8 depletion changes neural transcriptional programs; binding maps alone do not measure remodeling failure.
    causal_link_type: DIRECT
  - target: Abnormal Neural Development
    description: CHD8 loss causes the neurodevelopmental syndrome; the cellular routes to individual clinical outcomes are incompletely defined.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Reduced Vagal Neural Crest Cell Pool
    description: Constitutive chd8 mutation reduces the early vagal neural crest pool in zebrafish.
    causal_link_type: DIRECT
  - target: Altered Intestinal Epithelial Differentiation
    description: Mouse epithelial deletion supports a local intestinal requirement for CHD8.
    causal_link_type: DIRECT
  - target: Developmental Glial Sleep Regulation Defect
    description: Loss of the shared fly CHD7/CHD8 ortholog in developing glia disrupts subsequent sleep; transfer to human CHD8 disease remains provisional.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Reduced Neuronal Chromatin Accessibility
    description: Reduced CHD8 dosage is a candidate cause of impaired accessibility; strong direct evidence comes from complete deletion in cultured neurons.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Premature Ventral Progenitor Differentiation
    description: Conditional midfetal heterozygous deletion directly perturbs the timing of ventral differentiation.
    causal_link_type: DIRECT
- name: Reduced Neuronal Chromatin Accessibility
  description: Conditional CHD8 deletion in human stem-cell-derived excitatory neurons reduces accessibility at CHD8-bound promoters, especially ETS-motif-containing sites. The strong genome-wide result is from homozygous deletion; heterozygous changes are modest and not statistically significant at the highlighted sites. This supplies experimental support for a chromatin-accessibility mechanism without equating binding maps with remodeling failure in patients.
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:36575212
    reference_title: The autism risk factor CHD8 is a chromatin activator in human neurons and functionally dependent on the ERK-MAPK pathway effector ELK1.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: many more sites lost accessibility (1,481 peaks in homozygous KO) than gained accessibility (106 peaks in homozygous KO)
    explanation: ATAC-seq measures accessibility; the numerical result applies to complete deletion.
  - reference: PMID:36575212
    reference_title: The autism risk factor CHD8 is a chromatin activator in human neurons and functionally dependent on the ERK-MAPK pathway effector ELK1.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The ATAC-seq peaks in the heterozygous knockout experiment at sites with moderate change (no statistical significance) also revealed similar results for ETS motif enrichment
    explanation: The heterozygous result is weaker and does not establish genome-wide closure in human disease.
  - reference: PMID:36575212
    reference_title: The autism risk factor CHD8 is a chromatin activator in human neurons and functionally dependent on the ERK-MAPK pathway effector ELK1.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: CHD8 binding was specifically lost at ETS motif-containing CHD8 peaks upon ELK1 knockdown
    explanation: ELK1 perturbation supports recruitment of CHD8 to selected neuronal targets; ELK1 overexpression did not restore binding.
  downstream:
  - target: Dysregulation of Neurodevelopmental Gene Networks
    description: Loss of accessibility accompanies reduced transcription at direct neuronal targets, most strongly after homozygous deletion.
    causal_link_type: DIRECT
- name: Dysregulation of Neurodevelopmental Gene Networks
  description: Human neural progenitor knockdown changes expression of chromatin regulators and a secondary network enriched for neurodevelopmental genes. Sugathan et al. reported 1,756 nominally significant genes, of which 369 passed false-discovery correction. Control-cell binding maps identified 7,324 sites, but most expression changes lacked a nearby CHD8-binding site. These results support direct and indirect regulation; pathway enrichment does not itself demonstrate reduced synapse assembly or axon guidance.
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/pmc/articles/PMC4210312/
    reference_title: CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors - PMC
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: 1,756 genes were differentially expressed ... 369 of which were significant
    explanation: The full text distinguishes nominal and multiple-testing-adjusted differential expression.
  - reference: PMID:25752243
    reference_title: The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: When we considered genes that showed the strongest dysregulation due to CHD8 knockdown, we found that ASD risk genes tended to be downregulated
    explanation: The knockdown experiment supports altered regulation of conserved neural targets.
  biological_processes:
  - preferred_term: regulation of transcription by RNA polymerase II
    term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    modifier: ABNORMAL
  cell_types:
  - preferred_term: neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  conforms_to: epigenetic_machinery_neurodevelopmental_dysregulation#Dysregulated Neurodevelopmental Transcriptional Program
  downstream:
  - target: Impaired Wnt/beta-Catenin Signal Transduction
    description: Embryonic cortical knockdown reduces expression and activity of Wnt pathway components.
    causal_link_type: DIRECT
  - target: REST-Mediated Repression of Neuronal Genes
    description: REST target repression is enhanced in the Katayama mouse model; a physical interaction alone would not establish this effect.
    causal_link_type: DIRECT
  - target: Increased Neural Progenitor Proliferation
    description: Proliferation increases in selected organoid, zebrafish and hypomorphic mouse contexts, with important negative results in heterozygous mouse cortex.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Excitatory-Inhibitory Neuronal Trajectory Imbalance
    description: Engineered human organoids show stage-specific changes in neuronal lineage proportions.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Increased Gliogenesis
    description: Primate experiments suggest a glial contribution; the regulated intermediates and human contribution remain uncertain.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Aberrant Long-Range Functional Connectivity
    description: Transcriptional and regional fMRI changes coexist in the exon-3 mouse; the intervening circuit mechanism is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Striatal Circuit Dysfunction
    description: Region-specific transcriptional changes accompany altered accumbens physiology in mice.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Shortened Neural Progenitor G1 Phase
    description: CHD8 disruption changes G1 timing in one engineered human progenitor clone; cyclin-E and ERK changes suggest possible mediators.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Impaired Myelination
    description: CHD8 regulates myelination-related transcription in mouse oligodendroglial models.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Reduced Aged-Cortex Proteostasis Response Signature
    description: An age-dependent transcriptional signature occurs in one mouse allele; direct versus secondary regulation remains unknown.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Delayed Cortical Spine Development
    description: Cortical transcriptional dysregulation accompanies an adolescent spine phenotype in constitutive mutant mice.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Impaired Wnt/beta-Catenin Signal Transduction
  description: 'In embryonic mouse cortical knockdown, CHD8 supports expression of Wnt transducers and Wnt reporter activity. Stabilized beta-catenin rescues progenitor and selected adult neuronal/behavioral abnormalities. This direction is context-specific: knockdown in HEK293T cells and adult striatal transcriptomes do not show the same response.'
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:27694995
    reference_title: "Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      knockdown of Chd8 disrupts the expression of key transducers of Wnt signaling, and enhancing Wnt signaling rescues the transcriptional and behavioral deficits caused by Chd8 knockdown
    explanation: >-
      Rescue by Wnt enhancement establishes the causal role of the Wnt branch.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  biological_processes:
  - preferred_term: canonical Wnt signaling pathway
    term:
      id: GO:0060070
      label: canonical Wnt signaling pathway
    modifier: DECREASED
  downstream:
  - target: Reduced Cortical Progenitor Proliferation
    description: Beta-catenin rescue supports a Wnt contribution to the reduced proliferation caused by embryonic cortical knockdown.
    causal_link_type: DIRECT
  - target: Premature Neuronal Differentiation
    description: Wnt restoration also rescues early cell-cycle exit and differentiation in this knockdown context.
    causal_link_type: DIRECT
- name: Reduced Cortical Progenitor Proliferation
  description: E13 cortical Chd8 knockdown reduces progenitor proliferation by E16. This is the opposite of the increased proliferation observed in some other CHD8 models and cannot be used as evidence for progenitor expansion.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:27694995
    reference_title: Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: chd8 knockdown resulted in a premature depletion of the neural progenitor pool in the developing mouse cortex
    explanation: The primary cortical knockdown depletes the progenitor pool.
  biological_processes:
  - preferred_term: neural precursor cell proliferation
    term:
      id: GO:0061351
      label: neural precursor cell proliferation
    modifier: DECREASED
  downstream:
  - target: Abnormal Neural Development
    description: Restricted embryonic cortical perturbation alters neuronal maturation and selected adult behaviors; it is not a germline model of every human feature.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Premature Neuronal Differentiation
  description: In the same cortical knockdown experiment, early cell-cycle exit and neuronal differentiation increase. CHD8 depletion also reduces PRC2 components, providing a candidate route to neuronal-gene derepression. This premature differentiation must be distinguished from delayed excitatory-neuron production in other models.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:27694995
    reference_title: Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: This was accompanied by a concomitant increase in the percentage of cells positive for neuronal marker Tuj1
    explanation: The embryonic cortical experiment establishes the direction of the differentiation change.
  biological_processes:
  - preferred_term: neuron differentiation
    term:
      id: GO:0030182
      label: neuron differentiation
    modifier: INCREASED
  downstream:
  - target: Abnormal Neural Development
    description: Premature differentiation can alter the developmental sequence of cortical neurons.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: REST-Mediated Repression of Neuronal Genes
  description: Reduced CHD8 is associated with enhanced REST-mediated repression in the Katayama mouse model, most prominently around E14.5. Neurodevelopmental gene-set timing is delayed in that model. REST activity has not been shown to explain every CHD8 allele or all human manifestations.
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:27602517
    reference_title: "CHD8 haploinsufficiency results in autistic-like phenotypes in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      reduced expression of CHD8 was associated with abnormal activation of RE-1 silencing transcription factor (REST), which suppresses the transcription of many neuronal genes
    explanation: >-
      Identifies REST derepression of the neuronal programme as a CHD8-dosage
      consequence.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  biological_processes:
  - preferred_term: negative regulation of transcription by RNA polymerase II
    term:
      id: GO:0000122
      label: negative regulation of transcription by RNA polymerase II
    modifier: INCREASED
  downstream:
  - target: Abnormal Neural Development
    description: Enhanced repression is a candidate contributor to altered developmental timing in this mouse model.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Shortened Neural Progenitor G1 Phase
  description: In one H9 embryonic-stem-cell-derived neural progenitor clone with heterozygous CHD8 disruption, live-cell FUCCI imaging shows a shorter G1 phase without an overt S/G2/M change. Increased cyclin-E expression and ERK phosphorylation accompany the change, but their necessity was not tested by rescue. Progenitor expansion and delayed differentiation are proposed consequences rather than directly measured fate outcomes. Other cerebral organoid experiments found increased proliferation without changed cell-cycle length.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: DOI:10.1242/bio.058941
    reference_title: Autism-associated CHD8 keeps proliferation of human neural progenitors in check by lengthening the G1 phase of the cell cycle
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: disruption of a single copy of CHD8 in human neural precursor cells (NPCs) markedly shortens the G1 phase of the cell cycle
    explanation: The published abstract identifies the same single-cell imaging result; assay-specific details remain supported by the full-text PDF.
  - reference: url:https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf
    reference_title: https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Comparative analysis of phase duration across genotypes revealed a marked shortening of G1
    explanation: FUCCI imaging compared a single H9-derived heterozygous exon-4 frameshift clone with wild type; G1 medians were 517 and 1,408 minutes, respectively.
  - reference: url:https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf
    reference_title: https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Total levels of Erk were not significantly changed in mutant cells
    explanation: Increased phosphorylated ERK reflects altered signaling rather than a measured increase in total ERK abundance.
  downstream:
  - target: Increased Neural Progenitor Proliferation
    description: Shorter G1 offers a candidate route to faster expansion in this cultured progenitor model; the inference is not universal across alleles or models.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Increased Neural Progenitor Proliferation
  description: Progenitor proliferation increases in engineered human cerebral organoids and zebrafish morphants. In the Hurley mouse allelic series, increased TBR2-positive basal progenitor proliferation occurs in mild hypomorphs with approximately 36% residual protein, but was not detected in approximately 50% heterozygotes. More severe depletion instead produces apoptosis and brain hypoplasia; the response is not monotonic.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:33627187
    reference_title: Distinct, dosage-sensitive requirements for the autism-associated factor CHD8 during cortical development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: a significant increase in the proliferation of non-ventricular (or basal) progenitors was observed
    explanation: The full results localize increased proliferation to mild hypomorphs.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/pmc/articles/PMC4210312/
    reference_title: CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors - PMC
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We counted an average of 408 p-histone H3 ... cells for controls compared with 518 p-histone H3 ... cells in embryos injected with ... MO1
    explanation: The zebrafish experiment reports increased proliferating-cell counts after morpholino suppression.
  biological_processes:
  - preferred_term: neural precursor cell proliferation
    term:
      id: GO:0061351
      label: neural precursor cell proliferation
    modifier: INCREASED
  downstream:
  - target: Brain Overgrowth and Megalencephaly
    description: Expanded progenitor output is one candidate contributor to model brain enlargement; it is not the only demonstrated route.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Premature Ventral Progenitor Differentiation
  description: Midfetal induction of Chd8 heterozygous deletion in mouse neural stem cells accelerates ventral progenitor cell-cycle exit and differentiation toward interneuron and oligodendrocyte lineages. The corresponding dorsal cortical measures are unchanged. Genetic restoration in Olig1-expressing ventral progenitors normalizes differentiation and ameliorates behavioral abnormalities, supporting a developmental contribution in this mouse model.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:42203765
    reference_title: Defective ventral neurogenesis due to midfetal Chd8 mutation drives autistic-like behavior in mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: a significantly higher proportion of Ki67-negative EdU+ cells (cells that had exited the cell cycle) in the ganglionic eminence but not in the cortex
    explanation: E14.5-induced heterozygous deletion accelerates cell-cycle exit in ventral progenitors at E16.5.
  - reference: PMID:42203765
    reference_title: Defective ventral neurogenesis due to midfetal Chd8 mutation drives autistic-like behavior in mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: restoration of Chd8 expression in ventral progenitor cells by Olig1-Cre resulted in normalization of the differentiation of progenitors of both interneurons and oligodendrocytes
    explanation: The genetic rescue supports a requirement for ventral CHD8 dosage.
  downstream:
  - target: Abnormal Neural Development
    description: Ventral genetic rescue reduces mouse behavioral phenotypes; the lineage-level route to adult circuitry and transfer to human symptoms remain incompletely defined.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Excitatory-Inhibitory Neuronal Trajectory Imbalance
  description: Engineered female H9 embryonic-stem-cell cerebral organoids show earlier inhibitory-neuron production and delayed excitatory-neuron production around day 60, followed by excitatory expansion at day 120. These are transient lineage-proportion changes, not a measured functional excitation/inhibition ratio. The S62X allele, affecting only the long isoform, does not reproduce the enlargement of the other tested alleles.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:35385734
    reference_title: "CHD8 haploinsufficiency links autism to transient alterations in excitatory and inhibitory trajectories."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      we find that CHD8 haploinsufficiency disrupted neurodevelopmental trajectories with an accelerated and delayed generation of, respectively, inhibitory and excitatory neurons that yields, at days 60 and 120, symmetrically opposite expansions in their proportions.
    explanation: >-
      Directly demonstrates the excitatory-inhibitory trajectory imbalance in a
      human isogenic model of CHD8 haploinsufficiency.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  biological_processes:
  - preferred_term: neuron differentiation
    term:
      id: GO:0030182
      label: neuron differentiation
    modifier: ABNORMAL
  downstream:
  - target: Abnormal Neural Development
    description: Asynchronous lineage production is a candidate developmental mechanism; its effect on human circuit physiology remains untested.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Increased Gliogenesis
  description: CHD8-disrupted cynomolgus monkey brains have increased astrocytic and oligodendroglial markers, and engineered newborn brain slices show enhanced glial proliferation. The embryo-edited series includes one aborted fetus, one stillborn animal and one surviving male. Different alleles, very small animal numbers and uncertain brain editing in the surviving animal limit inference about human disease.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:36878905
    reference_title: CHD8 mutations increase gliogenesis to enlarge brain size in the nonhuman primate.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: CHD8 mutations selectively increased glial proteins but not neuronal proteins
    explanation: Brain tissue measurements distinguish glial from neuronal marker changes.
  - reference: PMID:36878905
    reference_title: CHD8 mutations increase gliogenesis to enlarge brain size in the nonhuman primate.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: knocking down CHD8 via CRISPR/Cas9 in organotypic monkey brain slices from newborn monkeys also enhanced the proliferation of glial cells
    explanation: Slice culture supplies a separate experimental glial readout.
  biological_processes:
  - preferred_term: gliogenesis
    term:
      id: GO:0042063
      label: gliogenesis
    modifier: INCREASED
  downstream:
  - target: White Matter Expansion
    description: Increased oligodendroglial abundance accompanies enlarged white matter in edited primate tissue; a dominant human contribution is unestablished.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: White Matter Expansion
  description: Primate tissue and longitudinal imaging suggest altered white-matter growth, including an increased white-to-gray matter ratio in the surviving edited monkey. This is distinct from proving that glial excess is the principal cause of macrocephaly in people with CHD8 variants.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:36878905
    reference_title: CHD8 mutations increase gliogenesis to enlarge brain size in the nonhuman primate.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: with enlarged white matter labeled by immunostaining of GFAP
    explanation: The stillborn edited monkey had enlarged brain tissue and white matter.
  downstream:
  - target: Brain Overgrowth and Megalencephaly
    description: White-matter expansion can contribute to overall brain enlargement in the primate model.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Brain Overgrowth and Megalencephaly
  description: Increased brain or head size recurs across several animal models; selected human cerebral organoids also enlarge. Progenitor expansion and altered gliogenesis are candidate contributions. Brain enlargement does not demonstrate that macrocephaly causes autism or intellectual disability. A 2025 mouse preprint found increased cortical volume without increased total neuron number or soma size, so enlargement cannot be assumed to reflect excess neurons.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:29668850
    reference_title: "Altered Neocortical Gene Expression, Brain Overgrowth and Functional Over-Connectivity in Chd8 Haploinsufficient Mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Here, we report that Chd8 heterozygous mice display increased brain size, motor delay, hypertelorism, pronounced hypoactivity, and anomalous responses to social stimuli.
    explanation: Mouse heterozygote recapitulates brain overgrowth and hypertelorism.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:35385734
    reference_title: "CHD8 haploinsufficiency links autism to transient alterations in excitatory and inhibitory trajectories."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      This imbalance is consistent with an enlargement of cerebral organoids as an in vitro correlate of patients' macrocephaly.
    explanation: >-
      Human cerebral organoid model links the cellular imbalance to enlargement,
      the in vitro correlate of macrocephaly.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:40501938
    reference_title: Persistent cortical excitatory neuron dysregulation in adult Chd8 haploinsufficient mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We did not find significant differences in total neuron number in either the full cohort or sex-stratified analyses
    explanation: Stereology in the constitutive exon-5 mouse supports model-specific dissociation of cortical volume and neuron count; the source is a preprint.
  downstream:
  - target: Macrocephaly
    description: Greater brain volume can increase head circumference; clinical macrocephaly remains variable.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Aberrant Long-Range Functional Connectivity
  description: Resting-state fMRI in the exon-3 Chd8 heterozygous mouse shows increased synchronized activity in specific cortico-hippocampal and auditory-parietal networks. The result is a model observation, not an established human diagnostic signature. Organoid lineage proportions and transcriptional enrichment do not directly establish its cause. A separate awake Olig1-Cre mouse imaging study found regional microstructural differences and exploratory connectivity changes; the connectivity comparisons did not survive multiple-testing correction, and that cohort did not reproduce increased social-contact time. Neither result establishes a universal direction of connectivity change.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:29668850
    reference_title: "Altered Neocortical Gene Expression, Brain Overgrowth and Functional Over-Connectivity in Chd8 Haploinsufficient Mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Resting-state functional MRI identified increased synchronized activity in cortico-hippocampal and auditory-parietal networks in Chd8 heterozygous mutant mice, implicating altered connectivity as a potential mechanism underlying the behavioral phenotypes.
    explanation: >-
      Provides the functional-imaging evidence for altered long-range connectivity.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:33228730
    reference_title: Chd8 mutation in oligodendrocytes alters microstructure and functional connectivity in the mouse brain.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Although these differences did not survive multiple corrections, uncorrected statistics supported the alterations of functional connectivity
    explanation: Regional connectivity findings are exploratory; anatomical DTI results used separate corrected analyses.
  downstream:
  - target: Abnormal Neural Development
    description: Altered network organization is a candidate contributor to neurobehavioral effects; behavioral causality has not been isolated.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Striatal Circuit Dysfunction
  description: Nucleus accumbens slices from Chd8 heterozygous mice show increased spontaneous excitatory currents and reduced miniature inhibitory-current amplitude, with unchanged miniature excitatory currents. Adult accumbens perturbation enhances acquired rotarod learning; this does not model impaired developmental motor milestones.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:28402856
    reference_title: Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Perturbation of Chd8 in adult mice recapitulates improved acquired motor learning behavior found in Chd8+/- animals
    explanation: Adult perturbation identifies a striatal contribution to enhanced learned motor performance.
- name: Abnormal Neural Development
  description: Human CHD8 disease causes variable developmental, cognitive and behavioral dysfunction. Cellular and animal experiments identify several plausible developmental and circuit routes, but none establishes a unique pathway to each clinical feature. Motor, seizure and tone manifestations likewise have unresolved cellular intermediates.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Most, if not all, affected individuals have some degree of DD, most commonly speech and motor delays.
    explanation: The clinical synthesis establishes the developmental spectrum, rather than a specific cellular mediator.
  biological_processes:
  - preferred_term: brain development
    term:
      id: GO:0007420
      label: brain development
    modifier: ABNORMAL
  downstream:
  - target: Global Developmental Delay
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Delayed Speech and Language Development
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Motor Delay
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Intellectual Disability
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Autism Spectrum Disorder
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Hypotonia
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Seizures
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Anxiety
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Attention Deficit Hyperactivity Disorder
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Self-Injurious Behavior
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Behavioral Abnormality
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Developmental Regression
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Dystonia
    description: This clinical manifestation may reflect CHD8-related neural dysfunction; the intervening circuit mechanism remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Aggressive Behavior
    description: Behavioral regulation may be affected by neural dysfunction, with multiple individual medical and environmental contributors.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Reduced Vagal Neural Crest Cell Pool
  description: Stable heterozygous p.Glu223* zebrafish have fewer vagal neural crest cells leaving the neural tube at 24 hours and an early migration delay. Later migration speed and arrival at the distal gut are preserved; a persistent failure of migration is not demonstrated.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:36375841
    reference_title: Loss of autism-candidate CHD8 perturbs neural crest development and intestinal homeostatic balance.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We observed a significant decrease in the number of NCCs released from the neural tube
    explanation: The early progenitor deficit is directly measured.
  downstream:
  - target: Reduced Enteric Neuron Abundance
    description: A smaller initial neural crest pool is a candidate explanation for fewer mature enteric neurons.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Reduced Enteric Neuron Abundance
  description: CHD8-disrupted zebrafish have fewer enteric neurons. The 2014 morpholino study reports an approximately halved count; the stable 2022 heterozygous mutant has a smaller reduction. Serotonergic enteric neurons and non-neuronal enterochromaffin cells are also reduced in the stable mutant. Human enteric-neuron depletion has not been demonstrated.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:36375841
    reference_title: Loss of autism-candidate CHD8 perturbs neural crest development and intestinal homeostatic balance.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: a significant decrease in the number of enteric neurons in the heterozygous
    explanation: The stable heterozygous fish shows reduced enteric-neuron abundance.
  downstream:
  - target: Gastrointestinal Dysmotility
    description: Reduced enteric innervation accompanies delayed transit in zebrafish morphants; neuron-specific rescue has not established sole causation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Gastrointestinal Dysmotility
  description: Zebrafish morphants show delayed intestinal transit alongside reduced innervation. This supplies a candidate mechanism for human constipation. The Chatterjee mouse model has increased permeability without a change in measured stool transit, so dysmotility and barrier impairment are distinct readouts.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:24998929
    reference_title: Disruptive CHD8 mutations define a subtype of autism early in development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: impairment of gastrointestinal motility due to a reduction in postmitotic enteric neurons
    explanation: The fish experiment connects altered innervation with impaired transit.
  - reference: PMID:37783686
    reference_title: CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis.
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: no differences in colon length ... or in stool transit time were measured between the genotypes
    explanation: This mouse study does not reproduce the transit defect.
  downstream:
  - target: Constipation
    description: Reduced motility is a candidate contribution to constipation; direct human enteric pathology and causal testing remain lacking.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Altered Intestinal Epithelial Differentiation
  description: Mouse Chd8L haploinsufficiency changes intestinal epithelial transcription and reduces selected tuft and goblet cell populations. Small-intestinal goblet loss and colonic mucus thinning are anatomically distinct findings. Stable zebrafish mutants also show epithelial changes, with several adult findings strongest in homozygotes.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:37783686
    reference_title: "CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The current study found that mice haploinsufficient for the large isoform of Chd8 (Chd8L) exhibited increased intestinal permeability, transcriptomic dysregulation in gut epithelial cells, reduced tuft cell and goblet cell counts in the gut, and an overall increase in microbial load.
    explanation: >-
      Mammalian replication of the gut epithelial defect at a haploinsufficient
      Chd8 dose.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  downstream:
  - target: Intestinal Barrier Impairment
    description: Changes in epithelial and mucus organization may contribute to permeability; no single deficient cell population has been shown to mediate the entire effect.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Intestinal Barrier Impairment
  description: Increased tracer permeability is measured in male Chd8L heterozygous mice. The fish study suggests barrier disturbance from morphology and inflammatory changes without directly measuring permeability. Neither result establishes a corresponding permeability defect or inflammatory bowel disease in human CHD8-NDD.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:37783686
    reference_title: CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: exhibited increased intestinal permeability, transcriptomic dysregulation in gut epithelial cells
    explanation: The systemic heterozygous mouse has a measured barrier defect.
- name: Developmental Glial Sleep Regulation Defect
  description: Developmental knockdown of fly kismet in glia, including subperineurial blood-brain-barrier glia, disrupts adult sleep. Adult-only knockdown does not reproduce the phenotype. Kismet is shared by the CHD7 and CHD8 families, limiting gene-specific human interpretation.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:34088660
    reference_title: "The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We show that Kismet is required in glia for early developmental and adult sleep architecture. This role localizes to subperineurial glia constituting the blood-brain barrier.
    explanation: >-
      Localises the sleep requirement to blood-brain-barrier glia in the sole
      CHD8/CHD7 ortholog.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  downstream:
  - target: Developmental Serotonin Excess
    description: Developmental glial kismet loss elevates serotonin in flies; this is not a measurement in CHD8 patients.
    causal_link_type: DIRECT
- name: Developmental Serotonin Excess
  description: 'Kismet-deficient flies show increased serotonin during development. Developmental pharmacologic reduction improves later sleep fragmentation, whereas adult treatment does not. Serotonin direction is tissue- and species-dependent: the stable chd8 zebrafish gut instead has fewer serotonin-producing cells.'
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:34088660
    reference_title: "The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We demonstrate that Kismet-related sleep disturbances are caused by high serotonin during development, paralleling a well-established but genetically unsolved autism endophenotype.
    explanation: >-
      Identifies developmental hyperserotonemia as the mediator of the sleep defect.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  downstream:
  - target: Sleep Fragmentation
    description: Developmental pharmacologic experiments support a serotonin contribution to the fly sleep phenotype.
    causal_link_type: DIRECT
- name: Sleep Fragmentation
  description: Kismet mutants show fragmented sleep and reduced total sleep time with preserved sleep latency. Adult sleep restriction improves sleep efficiency and fragmentation but not total sleep duration. CHD8 patient questionnaires independently identify both onset and maintenance difficulties; the precise human mechanism remains unresolved.
  biological_scale: ORGANISM
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:34088660
    reference_title: "The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Despite their developmental origin, Kismet's sleep architecture defects can be reversed in adulthood by a behavioral regime resembling human sleep restriction therapy.
    explanation: >-
      Sleep restriction reverses selected sleep-architecture defects in Kismet-deficient flies. This supports a preclinical possibility of reversibility; efficacy in humans with CHD8-NDD has not been demonstrated.
    quote_role: PRIMARY_RESULT
    directness: INDIRECT
  downstream:
  - target: Sleep Disturbance
    description: The fly mechanism is a candidate contributor to the human sleep-maintenance phenotype, with incomplete fidelity.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Impaired Myelination
  description: Mouse Chd8 haploinsufficiency and Olig1-lineage heterozygous deletion impair myelination. This differs from increased glial markers or greater white-matter volume in primate models. Olig1-Cre also marks ventral interneuron progenitors, so behavioral changes cannot be assigned exclusively to mature oligodendrocytes.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:32142125
    reference_title: Oligodendrocyte dysfunction due to Chd8 mutation gives rise to behavioral deficits in mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Ablation of Chd8 specifically in oligodendrocytes of mice impaired myelination, slowed action potential propagation
    explanation: The primary mouse study reports myelination and conduction abnormalities; Olig1 lineage specificity requires caution in light of its ventral interneuron progenitor expression.
  downstream:
  - target: Slowed Axonal Conduction
    description: The primary oligodendrocyte study links myelination defects to slower action-potential propagation.
    causal_link_type: DIRECT
- name: Slowed Axonal Conduction
  description: Reduced action-potential propagation in Chd8-mutant mouse white matter accompanies myelination defects. Effects on human symptoms and individual functional-connectivity differences remain unresolved.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:32142125
    reference_title: Oligodendrocyte dysfunction due to Chd8 mutation gives rise to behavioral deficits in mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Ablation of Chd8 specifically in oligodendrocytes of mice impaired myelination, slowed action potential propagation
    explanation: The primary mouse study reports myelination and conduction abnormalities; Olig1 lineage specificity requires caution in light of its ventral interneuron progenitor expression.
  downstream:
  - target: Aberrant Long-Range Functional Connectivity
    description: Altered conduction is a candidate contributor to regional connectivity; the imaging study does not establish this causal route.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Reduced Aged-Cortex Proteostasis Response Signature
  description: Twelve-month-old male Chd8 p.Val986* heterozygous mice have reduced expression of unfolded-protein-response and chaperone pathways, accompanied by lower phospho-S6 staining. Whether these changes reflect impaired proteostasis, lower stress, or a blunted response remains unresolved. Most effects are small, selected individual genes are only nominal trends, and human progressive neurodegeneration is not established.
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:33023670
    reference_title: Chd8 haploinsufficiency impairs early brain development and protein homeostasis later in life.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Pathways associated with the unfolded protein response (UPR), endoplasmic reticulum (ER) stress, and chaperone-mediated protein folding were reduced
    explanation: The result is a cortical transcriptional signature at 12 months, not a direct measurement of protein-folding capacity.
  downstream: []
- name: Delayed Cortical Spine Development
  description: A 2025 preprint reports lower dendritic spine density and increased spine formation in adolescent constitutive Chd8 heterozygous mice. Adult spine density and dynamics are normal. This is a transient structural phenotype and does not establish persistent synapse loss in patients.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:40501938
    reference_title: Persistent cortical excitatory neuron dysregulation in adult Chd8 haploinsufficient mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Adolescent Chd8+/− mice had lower spine density on the apical dendritic tufts of L5 PyrNs
    explanation: In vivo imaging in a 2025 preprint found reduced P30 spine density and increased formation, with normal P90 spine density and dynamics.
  downstream:
  - target: Abnormal Neural Development
    description: Altered adolescent spine development is a candidate contributor to circuit function; this link is provisional and based on a preprint.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
mechanistic_hypotheses:
- hypothesis_group_id: chd8_canonical_haploinsufficiency
  hypothesis_label: Canonical CHD8 haploinsufficiency
  status: CANONICAL
  description: >-
    Heterozygous loss of functional CHD8 dosage perturbs developmental transcriptional programs. Genetic cohorts, engineered models and a characteristic methylation episignature support haploinsufficiency. The downstream response depends on allele, dosage, cell type, developmental stage and genetic background.
- hypothesis_group_id: chd8_remodeling_independent_missense
  hypothesis_label: Remodelling-independent mechanism for a subset of missense alleles
  status: EMERGING
  description: >-
    Selected missense alleles produce experimental phenotypes with or without loss of chromatin-remodeling activity. This does not establish the clinical pathogenicity or benignity of every tested allele. A mirror methylation pattern in one person with p.Gly1322Arg suggests an alternative mechanism, but that variant remained uncertain and gain of function was not functionally demonstrated.
  evidence:
  - reference: PMID:38438524
    reference_title: "The complex etiology of autism spectrum disorder due to missense mutations of CHD8."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Furthermore, we found that mutations with high scores cause ASD by mechanisms either dependent on or independent of loss of chromatin-remodeling function.
    explanation: >-
      The experimental study supports mechanistic heterogeneity among tested missense alleles; mouse behavior does not itself classify human variants.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      one analysis was inconclusive, and one showing a possible gain-of-function signature instead of the expected haploinsufficiency signature was observed
    explanation: >-
      A single uncertain variant produced a mirror methylation pattern; gain of function remains a hypothesis.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
phenotypes:
- category: Growth
  name: Macrocephaly
  description: >-
    Head circumference may be enlarged from birth or increase during infancy. An 80% ever-macrocephalic rate in the founding series and a 52% rate at examination in the later aggregation use different definitions and overlapping patients.
  phenotype_term:
    preferred_term: Macrocephaly
    term:
      id: HP:0000256
      label: Macrocephaly
  frequency: FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The most common findings are the development of macrocephaly (most often during infancy) and tall stature (most typically during puberty), which is often accompanied by ASD and/or DD/ID.
    explanation: >-
      GeneReviews names macrocephaly as one of the two most common findings of the
      syndrome.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:31001818
    reference_title: "The clinical presentation caused by truncating CHD8 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a pattern of common features: macrocephaly (62.5%), tall stature (47%), developmental delay and/or intellectual disability (81%), ASDs (84%), sleep difficulties (50%), gastrointestinal problems (40%), and distinct facial features
    explanation: >-
      Quantifies macrocephaly at 62.5% in a 25-person CHD8 protein-truncating-variant cohort. This is the quantitative basis for the FREQUENT (30-79%) band; VERY_FREQUENT is deliberately NOT used because cohort figures range from about 52% to 80% depending on ascertainment (see the phenotype description and the frequency-ascertainment discussion).
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:24998929
    reference_title: "Disruptive CHD8 mutations define a subtype of autism early in development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In addition to a high likelihood of an ASD diagnosis among patients bearing CHD8 mutations, characteristics enriched in this group included macrocephaly, distinct faces, and gastrointestinal complaints.
    explanation: >-
      The founding CHD8-ascertained cohort supports macrocephaly enrichment; later literature aggregations include overlapping patients.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      macrocephaly is a striking feature that was common, at birth (53%, 8/15) and at the age of examination (52%, 46/88)
    explanation: >-
      The largest assembled cohort quantifies macrocephaly at 52% (46/88) at
      examination, the lower of the two directly quantified series and the reason
      the band is FREQUENT rather than VERY_FREQUENT. The 53% at-birth figure has a
      denominator of only 15 and is not used for banding.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  phenotype_contexts:
  - population: 'Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded)'
    frequency: FREQUENT
    notes: 'Macrocephaly at examination: 46/88; birth measurements available in only 15. Published cohorts overlap and missing documentation can represent absence or nonreporting.'
    evidence:
    - reference: PMID:36182950
      reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        macrocephaly is a striking feature that was common, at birth (53%, 8/15) and at the age of examination (52%, 46/88)
      explanation: >-
        The largest assembled cohort quantifies macrocephaly at 52% (46/88) at
        examination, the lower of the two directly quantified series and the reason
        the band is FREQUENT rather than VERY_FREQUENT. The 53% at-birth figure has a
        denominator of only 15 and is not used for banding.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
- category: Growth
  name: Tall Stature
  description: >-
    Tall stature is variable and may become more apparent near puberty. Height, weight and head circumference do not have to be simultaneously increased. A deterministic HELIC-domain severity relationship is not established.
  phenotype_term:
    preferred_term: Tall stature
    term:
      id: HP:0000098
      label: Tall stature
  frequency: FREQUENT
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The most common findings are the development of macrocephaly (most often during infancy) and tall stature (most typically during puberty), which is often accompanied by ASD and/or DD/ID.
    explanation: >-
      GeneReviews identifies tall stature as one of the two most common findings,
      qualified by pubertal timing.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:31001818
    reference_title: "The clinical presentation caused by truncating CHD8 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a pattern of common features: macrocephaly (62.5%), tall stature (47%), developmental delay and/or intellectual disability (81%), ASDs (84%), sleep difficulties (50%), gastrointestinal problems (40%), and distinct facial features
    explanation: >-
      Quantifies tall stature at 47%, within the FREQUENT (30-79%) band.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      macrocephaly is a striking feature that was common, at birth (53%, 8/15) and at the age of examination (52%, 46/88), as well as tall stature (50%, 39/78)
    explanation: >-
      The largest assembled cohort quantifies tall stature at 50% (39/78),
      independently reproducing the 47% figure from PMID:31001818 and placing the
      FREQUENT band on two concordant denominators rather than on one.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  phenotype_contexts:
  - population: 'Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded)'
    frequency: FREQUENT
    notes: Tall stature was reported in 39/78 evaluable individuals.
    evidence:
    - reference: PMID:36182950
      reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        macrocephaly is a striking feature that was common, at birth (53%, 8/15) and at the age of examination (52%, 46/88), as well as tall stature (50%, 39/78)
      explanation: >-
        The largest assembled cohort quantifies tall stature at 50% (39/78),
        independently reproducing the 47% figure from PMID:31001818 and placing the
        FREQUENT band on two concordant denominators rather than on one.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
- category: Growth
  name: Overweight
  description: >-
    Overweight was recorded in 24/71 individuals with available information in the 2022 aggregation. Missing reporting limits generalization, and overweight is not a required component of the syndrome.
  phenotype_term:
    preferred_term: Overweight
    term:
      id: HP:0025502
      label: Overweight
  frequency: FREQUENT
  evidence:
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      as well as tall stature (50%, 39/78) and being overweight (34%, 24/71)
    explanation: >-
      The full clinical series provides the available-data denominator; this is not an unbiased population prevalence.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  phenotype_contexts:
  - population: 'Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded)'
    frequency: FREQUENT
    notes: Overweight was recorded in 24/71; unreported findings were not uniformly assessed.
    evidence:
    - reference: PMID:36182950
      reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        as well as tall stature (50%, 39/78) and being overweight (34%, 24/71)
      explanation: >-
        The full clinical series provides the available-data denominator; this is not an unbiased population prevalence.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
- category: Neurologic
  name: Global Developmental Delay
  description: >-
    Multiple developmental domains can be delayed. Aggregate estimates combining developmental delay with intellectual disability do not quantify global developmental delay specifically.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Most, if not all, affected individuals have some degree of DD, most commonly speech and motor delays.
    explanation: >-
      "Most, if not all" maps to VERY_FREQUENT in the project's prose-to-enum table.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
- category: Neurologic
  name: Delayed Speech and Language Development
  description: >-
    Speech and language development is often delayed, but severity ranges from mild delay to absent speech. General developmental-delay frequency should not be assigned to the speech domain.
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Most, if not all, affected individuals have some degree of DD, most commonly speech and motor delays.
    explanation: >-
      GeneReviews identifies speech delay as one of the two most common developmental
      domains within a near-universal developmental delay.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
- category: Neurologic
  name: Motor Delay
  description: Motor milestones may be delayed, with variable ongoing coordination and fine-motor difficulties. Published frequencies depend on the milestone definition and completeness of reporting.
  phenotype_term:
    preferred_term: Motor delay
    term:
      id: HP:0001270
      label: Motor delay
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: When reported, delayed early motor milestones are present in 90% of affected individuals.
    explanation: The review explicitly conditions this percentage on reporting.
  phenotype_contexts:
  - population: GeneReviews synthesis of published CHD8 cases
    frequency: VERY_FREQUENT
    notes: GeneReviews reports 90% when motor milestones are reported; this is not an unselected cohort estimate.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
      reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      directness: DIRECT
      snippet: When reported, delayed early motor milestones are present in 90% of affected individuals.
      explanation: The review explicitly conditions this percentage on reporting.
- category: Neurologic
  name: Intellectual Disability
  description: >-
    Intellectual disability varies from mild to severe and can be absent. The 2022 cohort categorized affected individuals as mild (48%), moderate (24%) or severe (28%); an individual severity cannot be inferred from variant domain alone.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  frequency: FREQUENT
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      When present, ID is most often in the mild-to-moderate range.
    explanation: >-
      GeneReviews qualifies ID as present in a subset ("when present") with
      mild-to-moderate severity, so the band is set below the near-universal
      developmental delay.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:30670789
    reference_title: "A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Children with the disorder present with developmental delay, intellectual disability, and/or autism spectrum disorder in addition to characteristic facies.
    explanation: Independent clinical series confirming intellectual disability.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed, as well as a wide variety of behavioural abnormalities (88%).
    explanation: >-
      The largest assembled cohort (n=106) quantifies intellectual disability at 68%, within the FREQUENT (30-79%) band.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31721432
    reference_title: "The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients presented with intellectual disability, with 85% in the mild or moderate range
    explanation: >-
      Supports the mild-to-moderate severity characterisation. Note this cohort was ascertained through overgrowth clinics, so the 100% ID figure reflects ascertainment and is not used for the frequency band.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  phenotype_contexts:
  - population: 'Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded)'
    frequency: FREQUENT
    notes: The main analysis reports intellectual disability in 68%; 70 previously published and 36 new individuals were assembled before excluding five uncertain-variant cases.
    evidence:
    - reference: PMID:36182950
      reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed, as well as a wide variety of behavioural abnormalities (88%).
      explanation: >-
        The largest assembled cohort (n=106) quantifies intellectual disability at 68%, within the FREQUENT (30-79%) band.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
- category: Behavioral
  name: Autism Spectrum Disorder
  description: >-
    Autism is common but not obligatory. Some cohorts combine formal autism diagnoses with autistic traits; these outcomes must be distinguished from clinical diagnostic prevalence.
  phenotype_term:
    preferred_term: Autism
    term:
      id: HP:0000717
      label: Autism
  diagnostic: true
  evidence:
  - reference: PMID:24998929
    reference_title: "Disruptive CHD8 mutations define a subtype of autism early in development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation.
    explanation: >-
      Establishes CHD8 disruption as defining a distinct, monogenic autism subtype.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31001818
    reference_title: The clinical presentation caused by truncating CHD8 variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: developmental delay and/or intellectual disability (81%), ASDs (84%), sleep difficulties (50%)
    explanation: The truncating-variant clinical series reports an 84% autism rate.
  phenotype_contexts:
  - population: Douzgou 2019 truncating-variant cohort
    frequency: VERY_FREQUENT
    notes: Autism spectrum disorders reported in 84% of this clinically ascertained truncating-variant cohort. It overlaps later literature aggregations.
    evidence:
    - reference: PMID:31001818
      reference_title: The clinical presentation caused by truncating CHD8 variants.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: developmental delay and/or intellectual disability (81%), ASDs (84%), sleep difficulties (50%)
      explanation: The truncating-variant clinical series reports an 84% autism rate.
- category: Behavioral
  name: Sleep Disturbance
  description: >-
    Problems include delayed sleep onset and frequent or prolonged awakenings. Reported prevalence ranges from 29% in a retrospective aggregation to 50% in a truncating-variant series and 67% in GeneReviews; definitions and reporting completeness differ.
  phenotype_term:
    preferred_term: Sleep disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
  frequency: FREQUENT
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Sleep disturbance is characterized by difficulty with both initiation (delayed sleep onset) and maintenance (frequent night awakenings) of sleep.
    explanation: >-
      GeneReviews characterises the sleep phenotype qualitatively (initiation and
      maintenance) but does not quantify it; the FREQUENT band comes from the 50%
      figure in PMID:31001818 below, not from this source.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:30670789
    reference_title: "A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Gastrointestinal and sleep problems are notable.
    explanation: Independent clinical series flagging sleep problems as notable.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31001818
    reference_title: "The clinical presentation caused by truncating CHD8 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      ASDs (84%), sleep difficulties (50%), gastrointestinal problems (40%), and distinct facial features
    explanation: >-
      Quantifies sleep difficulties at 50%, the basis for the FREQUENT band.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Most frequently observed behavioural problems included autism spectrum disorder (76%), short attention span (32%), abnormal social behaviour (31%), sleep disturbance (29%) and impaired social interactions (28%).
    explanation: >-
      The largest cohort reports a substantially lower figure (29%). This retrospective HPO-coded aggregation almost certainly undercounts sleep problems relative to prospectively questioned cohorts; the discrepancy is recorded rather than hidden. See the frequency-ascertainment discussion.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  phenotype_contexts:
  - population: 'Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded)'
    frequency: OCCASIONAL
    notes: The retrospective series reports sleep disturbance in 29%; absence of documentation is not uniform assessment.
    evidence:
    - reference: PMID:36182950
      reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Most frequently observed behavioural problems included autism spectrum disorder (76%), short attention span (32%), abnormal social behaviour (31%), sleep disturbance (29%) and impaired social interactions (28%).
      explanation: >-
        The largest cohort reports a substantially lower figure (29%). This retrospective HPO-coded aggregation almost certainly undercounts sleep problems relative to prospectively questioned cohorts; the discrepancy is recorded rather than hidden. See the frequency-ascertainment discussion.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
- category: Gastrointestinal
  name: Constipation
  description: >-
    Recurrent constipation is a common gastrointestinal manifestation and may alternate with loose stools. Reduced enteric innervation in zebrafish suggests a mechanism, but it has not been demonstrated in affected people.
  phenotype_term:
    preferred_term: Constipation
    term:
      id: HP:0002019
      label: Constipation
  frequency: FREQUENT
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The most common gastrointestinal issue is constipation with or without periods of diarrhea.
    explanation: >-
      GeneReviews identifies constipation as the most common GI issue in a disorder
      in which GI issues are a listed core domain; "most common" maps to FREQUENT.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Constipat ion (33%, 22/66) and diarrhoea (15%, 10/66) are ... reported recurrent abnormalities.
    explanation: The full text gives separate symptom-specific frequencies.
  - reference: PMID:24998929
    reference_title: Disruptive CHD8 mutations define a subtype of autism early in development.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: 12 patients (80%) reported significant GI problems, with 60% reporting specific difficulties characterized as recurrent and consistent problems with constipation.
    explanation: The founding 15-person series distinguishes constipation from all gastrointestinal complaints.
  phenotype_contexts:
  - population: 'Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded)'
    frequency: FREQUENT
    notes: 'Constipation: 22/66 (33%) in the main clinical analysis.'
    evidence:
    - reference: PMID:36182950
      reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Constipat ion (33%, 22/66) and diarrhoea (15%, 10/66) are ... reported recurrent abnormalities.
      explanation: The full text gives separate symptom-specific frequencies.
- category: Gastrointestinal
  name: Diarrhea
  description: >-
    Periods of diarrhoea may alternate with constipation in affected individuals.
  phenotype_term:
    preferred_term: Diarrhea
    term:
      id: HP:0002014
      label: Diarrhea
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The most common gastrointestinal issue is constipation with or without periods of diarrhea.
    explanation: >-
      GeneReviews records diarrhoea as an intermittent accompaniment; no frequency is
      stated, so none is asserted.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Constipat ion (33%, 22/66) and diarrhoea (15%, 10/66) are ... reported recurrent abnormalities.
    explanation: The full text gives separate symptom-specific frequencies.
  frequency: OCCASIONAL
  phenotype_contexts:
  - population: 'Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded)'
    frequency: OCCASIONAL
    notes: 'Diarrhea: 10/66 (15%); it need not be accompanied by constipation.'
    evidence:
    - reference: PMID:36182950
      reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Constipat ion (33%, 22/66) and diarrhoea (15%, 10/66) are ... reported recurrent abnormalities.
      explanation: The full text gives separate symptom-specific frequencies.
- category: Neurologic
  name: Hypotonia
  description: Decreased muscle tone, reported in roughly 30% of affected individuals.
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare).
    explanation: >-
      GeneReviews gives an approximate 30% figure, sitting exactly on the
      OCCASIONAL/FREQUENT boundary.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed
    explanation: >-
      Largest cohort reports 29%.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31001818
    reference_title: "The clinical presentation caused by truncating CHD8 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      some had regression of speech (37%), seizures (27%) and hypotonia (27%)
    explanation: >-
      Second independent cohort reports 27%. Two independent quantified cohorts both fall below 30%, so the OCCASIONAL (5-29%) band is used rather than rounding GeneReviews' "about 30%" upward.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Neurologic
  name: Seizures
  description: >-
    Epileptic seizures occur in a minority of affected individuals (10%-15%).
    Seizures are not a defining feature and their presence should not by itself
    redirect testing towards the epilepsy-associated CHD paralogue CHD2.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare).
    explanation: >-
      GeneReviews gives 10%-15%, which falls in the 5-29% OCCASIONAL band.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:31001818
    reference_title: "The clinical presentation caused by truncating CHD8 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      some had regression of speech (37%), seizures (27%) and hypotonia (27%)
    explanation: >-
      An independent cohort reports 27%, at the upper end of but still within the OCCASIONAL band.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31526516
    reference_title: "Clinical Phenotypes of Carriers of Mutations in CHD8 or Its Conserved Target Genes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      less severe adaptive deficits in communication skills, similar functional language, more social motivation challenges in those with ASD, larger head circumference, higher weight, and lower seizure prevalence relative to the other gene group
    explanation: >-
      CHD8 carriers have LOWER seizure prevalence than other autism-risk-gene carriers, reinforcing that epilepsy is not a defining feature of this disorder.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Neurologic
  name: Dystonia
  description: >-
    Dystonia ranges from focal or exercise-dependent symptoms to generalized progressive disease. Two women reported in 2021 and three further women in 2024 had variable cognitive involvement; later cases expand the spectrum. Case reports do not supply a numerical population frequency.
  phenotype_term:
    preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare).
    explanation: >-
      GeneReviews describes dystonia as rare, mapping to the VERY_RARE band.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:38441608
    reference_title: "CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This work validates our previous observation that dystonia is part of the phenotypic spectrum of CHD8-related
    explanation: >-
      Dedicated case series validating dystonia as part of the CHD8-NDD spectrum.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:34415117
    reference_title: "Childhood-onset progressive dystonia associated with pathogenic truncating variants in CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We further expand the CHD8-related phenotype with the description of two unrelated patients who presented with childhood-onset progressive dystonia.
    explanation: >-
      The original report establishing childhood-onset progressive dystonia as a CHD8 presentation. Note this is the one phenotype in the entry described as progressive.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Neurologic
  name: Chiari Type I Malformation
  description: >-
    Chiari I malformation is a rare structural finding in CHD8-NDD. GeneReviews
    recommends assessing for signs of cerebrospinal fluid obstruction and spinal
    cord dysfunction, and considering serial imaging when a Chiari I malformation is
    known.
  phenotype_term:
    preferred_term: Chiari type I malformation
    term:
      id: HP:0007099
      label: Chiari type I malformation
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare).
    explanation: >-
      GeneReviews describes Chiari I malformation as rare, mapping to VERY_RARE.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
- category: Behavioral
  name: Anxiety
  description: >-
    Anxiety warrants ongoing assessment. In a cross-sectional CHD8 subgroup of 18 participants, anxiety scores correlated with age (r=0.55), but this does not demonstrate within-person progression. Questionnaire symptoms are not interchangeable with a formal anxiety diagnosis.
  phenotype_term:
    preferred_term: Anxiety
    term:
      id: HP:0000739
      label: Anxiety
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      monitor for signs and symptoms of anxiety, attention-deficit/hyperactivity disorder, and aggressive or self-injurious behavior
    explanation: >-
      GeneReviews surveillance guidance identifies anxiety as an expected
      manifestation; no frequency is given, so none is asserted.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:38622540
    reference_title: "Shared and divergent mental health characteristics of ADNP-, CHD8- and DYRK1A-related neurodevelopmental conditions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patterns of mental health features varied by group, with anxiety most prominent for CHD8
    explanation: >-
      Genotype-first CBCL comparison across ADNP, CHD8 and DYRK1A identifies anxiety
      as the psychiatric feature most characteristic of CHD8 specifically. The CHD8
      subgroup is n=18, so this establishes the qualitative profile, not a frequency.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:38622540
    reference_title: Shared and divergent mental health characteristics of ADNP-, CHD8- and DYRK1A-related neurodevelopmental conditions.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: our data are cross-sectional in nature ... data will be needed to confirm these patterns
    explanation: The primary report explicitly limits inference about change over time.
- category: Behavioral
  name: Attention Deficit Hyperactivity Disorder
  description: >-
    Attention-deficit/hyperactivity disorder is a recognized psychiatric manifestation. A transmitting father in the 2025 report had ADHD-like traits, without a documented formal diagnosis or proof that those traits were caused by the variant.
  phenotype_term:
    preferred_term: Attention deficit hyperactivity disorder
    term:
      id: HP:0007018
      label: Attention deficit hyperactivity disorder
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      monitor for signs and symptoms of anxiety, attention-deficit/hyperactivity disorder, and aggressive or self-injurious behavior
    explanation: >-
      GeneReviews surveillance guidance identifies ADHD as an expected manifestation.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:41407309
    reference_title: "Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural Analyses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      who exhibited a subtle feature, including traits consistent with attention-deficit/hyperactivity disorder
    explanation: >-
      Illustrates ADHD traits as the minimal expression in a transmitting parent.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Behavioral
  name: Self-Injurious Behavior
  description: >-
    Self-injury has been reported and should prompt assessment of behavioral, communication and medical contributors. An abdominal-pain association in a mixed-gene cohort is not a CHD8-specific causal result.
  phenotype_term:
    preferred_term: Self-injurious behavior
    term:
      id: HP:0100716
      label: Self-injurious behavior
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Aggression and self-injury have also been noted in several individuals
    explanation: The clinical synthesis documents both behaviors in affected individuals.
- category: Craniofacial
  name: Hypertelorism
  description: >-
    Widely spaced eyes are part of the recognisable CHD8 facies and are reproduced
    in Chd8 heterozygous mice.
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  evidence:
  - reference: PMID:30670789
    reference_title: "A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      similar dysmorphic features, including widely-spaced eyes, short nose with flat nasal bridge, long philtrum, prominent Cupid's bow of the upper lip, full lower lip, and auricular anomalies
    explanation: Clinical series describing widely spaced eyes in the CHD8 facies.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:29668850
    reference_title: "Altered Neocortical Gene Expression, Brain Overgrowth and Functional Over-Connectivity in Chd8 Haploinsufficient Mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Chd8 heterozygous mice display increased brain size, motor delay, hypertelorism, pronounced hypoactivity, and anomalous responses to social stimuli
    explanation: Hypertelorism is recapitulated in the mouse heterozygote.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Craniofacial
  name: Broad Forehead
  description: >-
    A broad forehead is part of the variable facial appearance; prominent supraorbital ridges are recorded separately.
  phenotype_term:
    preferred_term: Broad forehead
    term:
      id: HP:0000337
      label: Broad forehead
  evidence:
  - reference: PMID:31980904
    reference_title: "De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      dysmorphic features, including broad forehead with prominent supraorbital ridges, flat nasal bridge, telecanthus and large ears
    explanation: Clinical series describing the forehead and supraorbital features.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Craniofacial
  name: Prominent Supraorbital Ridges
  description: >-
    Prominent supraorbital ridges accompany the broad forehead in the CHD8 facies.
  phenotype_term:
    preferred_term: Prominent supraorbital ridges
    term:
      id: HP:0000336
      label: Prominent supraorbital ridges
  evidence:
  - reference: PMID:31980904
    reference_title: "De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      dysmorphic features, including broad forehead with prominent supraorbital ridges, flat nasal bridge, telecanthus and large ears
    explanation: Clinical series naming prominent supraorbital ridges.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Craniofacial
  name: Depressed Nasal Bridge
  description: A flat or depressed nasal bridge, often with a short nose.
  phenotype_term:
    preferred_term: Depressed nasal bridge
    term:
      id: HP:0005280
      label: Depressed nasal bridge
  evidence:
  - reference: PMID:30670789
    reference_title: "A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      similar dysmorphic features, including widely-spaced eyes, short nose with flat nasal bridge, long philtrum, prominent Cupid's bow of the upper lip, full lower lip, and auricular anomalies
    explanation: Clinical series describing the flat nasal bridge.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Craniofacial
  name: Long Philtrum
  description: A long philtrum, frequently with a prominent Cupid's bow and full lower lip.
  phenotype_term:
    preferred_term: Long philtrum
    term:
      id: HP:0000343
      label: Long philtrum
  evidence:
  - reference: PMID:30670789
    reference_title: "A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      similar dysmorphic features, including widely-spaced eyes, short nose with flat nasal bridge, long philtrum, prominent Cupid's bow of the upper lip, full lower lip, and auricular anomalies
    explanation: Clinical series describing the long philtrum.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Craniofacial
  name: Large Ears
  description: Large ears and other auricular anomalies are part of the CHD8 facies.
  phenotype_term:
    preferred_term: Macrotia
    term:
      id: HP:0000400
      label: Macrotia
  evidence:
  - reference: PMID:31980904
    reference_title: "De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      dysmorphic features, including broad forehead with prominent supraorbital ridges, flat nasal bridge, telecanthus and large ears
    explanation: Clinical series naming large ears.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Craniofacial
  name: Downslanted Palpebral Fissures
  description: >-
    Downslanting of the palpebral fissures accompanies the wide-set eyes in the
    CHD8 facial gestalt.
  phenotype_term:
    preferred_term: Downslanted palpebral fissures
    term:
      id: HP:0000494
      label: Downslanted palpebral fissures
  evidence:
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      wide-set eyes with down slanted palpebral ﬁssures
    explanation: >-
      Named as a typical dysmorphic feature of the entity. This sentence summarises
      the prior literature in the introduction of the largest cohort paper rather
      than reporting that cohort's own counts, so no frequency is asserted.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Craniofacial
  name: Pointed Chin
  description: A pointed chin completes the lower-face element of the CHD8 gestalt.
  phenotype_term:
    preferred_term: Pointed chin
    term:
      id: HP:0000307
      label: Pointed chin
  evidence:
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a broad nose with full nasal tip, and a pointed chin
    explanation: >-
      Named as a typical dysmorphic feature of the entity. As above, this is a
      literature-summary sentence, so no frequency is asserted.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Behavioral
  name: Behavioral Abnormality
  description: >-
    A composite of behavioral findings was recorded in 88% of the 2022 aggregation and 78% of a 27-person overgrowth cohort. The composite includes several diagnoses and traits and is not the frequency of any individual psychiatric diagnosis.
  phenotype_term:
    preferred_term: Atypical behavior
    term:
      id: HP:0000708
      label: Atypical behavior
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed, as well as a wide variety of behavioural abnormalities (88%).
    explanation: >-
      Quantifies composite behavioural abnormality at 88% in the largest cohort,
      supporting the VERY_FREQUENT (80-100%) band.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31721432
    reference_title: "The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Behavioral problems were reported in the majority of patients (78%), with over half (56%) either formally diagnosed with an autistic spectrum disorder or described as having autistic traits.
    explanation: >-
      Independent cohort reporting behavioural problems in 78%.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  phenotype_contexts:
  - population: 'Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded)'
    frequency: VERY_FREQUENT
    notes: 'Composite behavioral findings: 88% in the main phenotype analysis.'
    evidence:
    - reference: PMID:36182950
      reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed, as well as a wide variety of behavioural abnormalities (88%).
      explanation: >-
        Quantifies composite behavioural abnormality at 88% in the largest cohort,
        supporting the VERY_FREQUENT (80-100%) band.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
- category: Neurologic
  name: Developmental Regression
  description: >-
    Loss of previously acquired speech, social or motor skills has been reported, particularly in infancy and early childhood. This does not establish ongoing neurodegeneration in every patient.
  phenotype_term:
    preferred_term: Developmental regression
    term:
      id: HP:0002376
      label: Developmental regression
  frequency: FREQUENT
  evidence:
  - reference: PMID:31001818
    reference_title: "The clinical presentation caused by truncating CHD8 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      some had regression of speech (37%), seizures (27%) and hypotonia (27%)
    explanation: >-
      Quantifies speech regression at 37%, inside the FREQUENT (30-79%) band. Note
      the source measures regression of speech specifically; regression of social and
      motor skills is described qualitatively elsewhere and is not separately banded.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Developmental regression of social, speech, and/or motor skills in infancy and early childhood is reported in up to half of affected individuals
    explanation: The chapter expands the reported domains of regression.
- category: Musculoskeletal
  name: Musculoskeletal Abnormality
  description: >-
    Reported musculoskeletal findings span pes planus, scoliosis, fifth-finger clinodactyly and other skeletal or limb anomalies. The 79% composite frequency reflects the assessed subset in a retrospective aggregation, not the prevalence of any single skeletal feature.
  phenotype_term:
    preferred_term: Abnormality of the musculoskeletal system
    term:
      id: HP:0033127
      label: Abnormality of the musculoskeletal system
    coarse_binding_basis: VARIABLE_SPECTRUM
  frequency: FREQUENT
  evidence:
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Furthermore, abnormalities in the digestive (53%), musculoskeletal (79%) and genitourinary systems (18%) were noted.
    explanation: >-
      Quantifies composite musculoskeletal involvement at 79%, the top of the
      FREQUENT band.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31721432
    reference_title: "The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma
    explanation: >-
      Enumerates the individual musculoskeletal findings that make up the composite,
      each individually uncommon.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  phenotype_contexts:
  - population: 'Dingemans 2022: 101 individuals in the main phenotype analysis (106 assembled; five uncertain variants excluded)'
    frequency: FREQUENT
    notes: A heterogeneous musculoskeletal category was recorded in 79% of individuals with information.
    evidence:
    - reference: PMID:36182950
      reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Furthermore, abnormalities in the digestive (53%), musculoskeletal (79%) and genitourinary systems (18%) were noted.
      explanation: >-
        Quantifies composite musculoskeletal involvement at 79%, the top of the
        FREQUENT band.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
- name: Aggressive Behavior
  category: Behavioral
  phenotype_term:
    preferred_term: Aggressive behavior
    term:
      id: HP:0000718
      label: Aggressive behavior
  description: Aggression is reported in some affected individuals and warrants assessment alongside communication, psychiatric and medical needs.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Aggression and self-injury have also been noted in several individuals
    explanation: The clinical synthesis documents both behaviors in affected individuals.
- name: Pes Planus
  category: Musculoskeletal
  phenotype_term:
    preferred_term: Pes planus
    term:
      id: HP:0001763
      label: Pes planus
  description: Reported in the 27-person clinical overgrowth cohort; the study places each of these less frequent findings at 15% or below, without defining a single frequency band.
  evidence:
  - reference: PMID:31721432
    reference_title: 'The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma
    explanation: The primary cohort identifies this individual skeletal manifestation.
- name: Scoliosis
  category: Musculoskeletal
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  description: Reported in the 27-person clinical overgrowth cohort; the study places each of these less frequent findings at 15% or below, without defining a single frequency band.
  evidence:
  - reference: PMID:31721432
    reference_title: 'The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma
    explanation: The primary cohort identifies this individual skeletal manifestation.
- name: Fifth-Finger Clinodactyly
  category: Musculoskeletal
  phenotype_term:
    preferred_term: Clinodactyly of the 5th finger
    term:
      id: HP:0004209
      label: Clinodactyly of the 5th finger
  description: Reported in the 27-person clinical overgrowth cohort; the study places each of these less frequent findings at 15% or below, without defining a single frequency band.
  evidence:
  - reference: PMID:31721432
    reference_title: 'The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Additional clinical features included neonatal hypotonia (33%), and less frequently seizures, pes planus, scoliosis, fifth finger clinodactyly, umbilical hernia, and glabellar hemangioma
    explanation: The primary cohort identifies this individual skeletal manifestation.
- name: Hyperbilirubinemia
  category: Metabolic
  phenotype_term:
    preferred_term: Hyperbilirubinemia
    term:
      id: HP:0002904
      label: Hyperbilirubinemia
  description: Hyperbilirubinemia was reported in 6/53 documented individuals in the assembled cohort. The authors advise attention to neonatal jaundice when the diagnosis is known prenatally.
  evidence:
  - reference: PMID:36182950
    reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: hyperbilirubinemia was described in six of 53 individuals (11%)
    explanation: The assembled cohort reports 6/53; this is not a prospective incidence estimate.
  phenotype_contexts:
  - population: Dingemans 2022 main phenotype cohort, with trait-specific available records
    frequency: OCCASIONAL
    notes: Published cases overlap earlier cohorts and completeness of reporting varies by trait.
    evidence:
    - reference: PMID:36182950
      reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: hyperbilirubinemia was described in six of 53 individuals (11%)
      explanation: The assembled cohort reports 6/53; this is not a prospective incidence estimate.
- name: Genitourinary Abnormality
  category: Genitourinary
  phenotype_term:
    preferred_term: Abnormality of the genitourinary system
    term:
      id: HP:0000119
      label: Abnormality of the genitourinary system
    coarse_binding_basis: SOURCE_UNSPECIFIED
  description: Genitourinary abnormalities were recorded in 10/55 individuals; 9/55 had genital or reproductive-system morphology findings. This aggregate is not a frequency estimate for renal malformations.
  evidence:
  - reference: PMID:36182950
    reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Genitourinary abnormalities, now observed in 18% of the individuals
    explanation: The assembled cohort reports 10/55, with genital findings accounting for most reports; no specific anatomy can represent the entire group.
  phenotype_contexts:
  - population: Dingemans 2022 main phenotype cohort, with trait-specific available records
    frequency: OCCASIONAL
    notes: Published cases overlap earlier cohorts and completeness of reporting varies by trait.
    evidence:
    - reference: PMID:36182950
      reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Genitourinary abnormalities, now observed in 18% of the individuals
      explanation: The assembled cohort reports 10/55, with genital findings accounting for most reports; no specific anatomy can represent the entire group.
- name: Respiratory Distress
  category: Respiratory
  phenotype_term:
    preferred_term: Respiratory distress
    term:
      id: HP:0002098
      label: Respiratory distress
  description: Respiratory distress was recorded in three individuals. Respiratory data were available for only ten members of the aggregated cohort, making the apparent 3/10 rate unsuitable as a general disease frequency.
  evidence:
  - reference: PMID:36182950
    reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: mainly respiratory distress (in three individuals)
    explanation: Respiratory findings were documented in only ten individuals; three had distress, so the selected denominator cannot estimate syndrome-wide frequency.
genetic:
- name: CHD8
  gene_term:
    preferred_term: CHD8
    term:
      id: hgnc:20153
      label: CHD8
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >-
    Heterozygous truncating, splice-disrupting, deletion and selected missense variants cause CHD8-NDD. Most arise de novo, but inherited variants show substantial intrafamilial variability. The 2020 HELIC-domain severity association was not reproduced as a clear domain correlation in the 2022 aggregation. The latter assembled 106 individuals and excluded five uncertain variants from its main phenotype/severity analyses; its missense-severity association is not proof of dilution by benign variants.
  evidence:
  - reference: PMID:22495309
    reference_title: "Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In proband exomes, recurrent protein-altering mutations were observed in two genes: CHD8 and NTNG1.
    explanation: >-
      Gene-discovery evidence: the original sporadic-autism exome study that
      identified recurrent de novo CHD8 mutations. Cited for discovery only, not for
      CHD8-specific phenotype frequencies.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:24998929
    reference_title: "Disruptive CHD8 mutations define a subtype of autism early in development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we resequenced the ASD-associated gene CHD8 in 3,730 children with developmental delay or ASD. We identified a total of 15 independent mutations; no truncating events were identified in 8,792 controls, including 2,289 unaffected siblings.
    explanation: >-
      Establishes the mutational burden and the absence of truncating CHD8 events in
      controls.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31980904
    reference_title: "De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      HELIC domain mutations were associated with a severe phenotype defined by a greater number of clinical features, lower verbal IQ, and a prominent, consistent pattern of overgrowth as measured by weight, height and head circumference.
    explanation: The small 2020 study proposed a domain association; the larger subsequent study did not establish a clear domain correlation.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified 29 unique nonsense, 25 frameshift, 24 missense, and 12 splice site variants. Furthermore, two unique inframe deletions, one larger deletion (exons 26-28), and one translocation were observed.
    explanation: >-
      The assembled variant spectrum includes nonsense, frameshift, missense, splice and structural alleles; uncertain variants were separately assessed.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although no significant difference in severity was observed between males and females, individuals with a missense variant were less severely affected.
    explanation: >-
      A modest difference in the analyzed pathogenic/likely pathogenic groups does not validate individual prognosis; five uncertain-variant cases were excluded from the main analysis.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:25257502
    reference_title: "Recurrent ∼100 Kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The minimal critical region, considering present and previous cases, contains the SUPT16H and CHD8 genes.
    explanation: >-
      Recurrent 14q11.2 microdeletion route to CHD8 haploinsufficiency; note the
      minimal region also contains SUPT16H, so deletion cases are not a pure CHD8
      lesion.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:41407309
    reference_title: Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural Analyses.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We describe the case of IDDAM caused by a paternally inherited CHD8 variant.
    explanation: The variant was transmitted with a much milder paternal presentation.
variants:
- name: CHD8 helicase-C (HELIC) domain truncating and missense variants
  gene:
    preferred_term: CHD8
    term:
      id: hgnc:20153
      label: CHD8
  description: >-
    The 2020 clinical study proposed greater severity for HELIC-domain variants. The larger 2022 aggregation did not show a clear domain-level correlation, so location alone should not determine prognosis or variant classification.
  evidence:
  - reference: PMID:31980904
    reference_title: "De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we compiled a comprehensive list of CHD8 variants from the literature and databases, which revealed constitutive and somatic truncating variants in the HELIC (Helicase-C) domain in ASD and in cancer patients, respectively, but not in the general population.
    explanation: >-
      Documents the HELIC-domain variant class and its absence from the general
      population.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: CHD8 missense variants of uncertain causality
  gene:
    preferred_term: CHD8
    term:
      id: hgnc:20153
      label: CHD8
  description: >-
    A CHD8 missense variant requires clinical and genetic interpretation. Biochemical assays, cellular phenotypes, segregation and methylation signatures can contribute; computational scores or mouse behavior alone do not prove pathogenicity or benignity. Tested alleles can act with or without loss of remodeling activity.
  evidence:
  - reference: PMID:38438524
    reference_title: "The complex etiology of autism spectrum disorder due to missense mutations of CHD8."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Only mutations with high prediction scores gave rise to ASD-like phenotypes in mice, suggesting that not all CHD8 missense mutations detected in ASD patients are directly responsible for the development of ASD.
    explanation: >-
      This experimental study demonstrates heterogeneity among tested alleles, not a diagnostic rule for every human missense variant.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
diagnosis:
- name: Molecular Genetic Diagnosis of CHD8-NDD
  description: >-
    Diagnosis rests on a heterozygous pathogenic or likely pathogenic CHD8 variant interpreted with the phenotype. Broad neurodevelopmental/overgrowth panels, exome or genome sequencing, and copy-number analysis are appropriate routes; single-gene testing is rarely the preferred initial approach. A variant of uncertain significance does not establish or exclude the diagnosis. Episignature testing can provide adjunctive evidence; 11 positive results among 13 selected samples in the 2022 study are not a diagnostic sensitivity estimate. Protein structural modeling is computational evidence, not measured functional loss.
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The diagnosis of CHD8-NDD is established in a proband by identification of a heterozygous pathogenic (or likely pathogenic) variant in CHD8 by molecular genetic testing.
    explanation: GeneReviews diagnostic criterion.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:41407309
    reference_title: "Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural Analyses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Pathogenicity was confirmed through epigenetic signature testing (EpiSign), demonstrating characteristic methylation patterns and structural biology analysis, predicting significant protein destabilization.
    explanation: >-
      The report combines an inherited missense variant, characteristic methylation findings and computational structural analysis; the latter is not a protein assay.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: "The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Methylation analysis was performed for 13 patients, 11 of which showed the previously established episignature for IDDAM (85%) associated with CHD8 haploinsufficiency
    explanation: >-
      This selected-sample result supports an adjunctive role, not validated sensitivity or specificity.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: Targeted Neurological and Developmental Assessment
  description: Characterize developmental domains and psychiatric, sleep, gastrointestinal and movement symptoms. GeneReviews recommends brain MRI for head circumference at least 3 SD above the mean, rapidly increasing head circumference or signs of obstruction/compression; MRI may also be considered above 2 SD without symptoms. Obtain EEG when seizure symptoms warrant it and spine imaging for suspected cord dysfunction.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: To incl brain MRI if HC ... 3 SDs above mean
    explanation: The full evaluation table ties MRI to head growth and neurological indications.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: To incl EEG if history of signs/symptoms suggestive of seizures
    explanation: EEG is symptom-directed.
treatments:
- name: Sleep Disturbance Management
  description: >-
    Behavioral sleep assessment and intervention are recommended; GeneReviews includes cognitive behavioral approaches and sleep restriction therapy. Medication may be considered individually, but the chapter does not establish a CHD8-specific drug. Fly sleep rescue is mechanistic evidence, not a human treatment trial.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: behavioral counseling
    term:
      id: NCIT:C181743
      label: Behavioral Counseling
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: For example, cognitive behavioral therapy, including sleep restriction therapy
    explanation: The full management table explicitly includes these behavioral approaches.
  target_phenotypes:
  - preferred_term: Sleep disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
- name: Management of Bowel Dysfunction
  description: >-
    Constipation management may include fluids, dietary fiber and individualized bulk, osmotic, stimulant or emollient laxatives. Ongoing clinical assessment guides treatment; an enteric-neuron deficit is not established in patients and does not dictate a specific regimen.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Fluids, dietary fiber, bulk laxatives, osmotic agents, stimulant laxatives, or emollients as needed
    explanation: The full chapter specifies standard bowel-management options.
  target_phenotypes:
  - preferred_term: Constipation
    term:
      id: HP:0002019
      label: Constipation
- name: Developmental and Educational Intervention
  description: >-
    Early intervention, individualized education and speech-language therapy address developmental and adaptive needs. Augmentative and alternative communication assessment can support individuals with expressive-language difficulties.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: speech and language therapy
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy
    explanation: The chapter recommends multidisciplinary developmental support.
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Consider evaluation for alternative means of communication
    explanation: The communication section discusses individualized AAC assessment.
  target_phenotypes:
  - preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  - preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
- name: Antiseizure Pharmacotherapy
  description: >-
    Seizures receive standard individualized management by an experienced neurologist. No antiseizure medicine is established as preferentially effective for CHD8-NDD.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Anticonvulsant Therapy
    term:
      id: NCIT:C64172
      label: Anticonvulsant Therapy
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Many ASMs may be effective; none has been demonstrated effective specifically
    explanation: The chapter notes the absence of demonstrated CHD8-specific antiseizure efficacy.
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
- name: Surgical Treatment of Chiari I Malformation
  description: >-
    Symptomatic Chiari I malformation may require neurosurgical treatment, including foramen-magnum and C1 decompression. Imaging and intervention depend on symptoms and specialist assessment.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      if Chiari I malformation is present, surgical treatment may be required
    explanation: GeneReviews management recommendation for Chiari I malformation.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  target_phenotypes:
  - preferred_term: Chiari type I malformation
    term:
      id: HP:0007099
      label: Chiari type I malformation
- name: Growth and Neurologic Surveillance
  description: >-
    Monitor growth including head circumference into adulthood, development, sleep, bowel and feeding symptoms, psychiatric symptoms and new neurological or movement findings. MRI and EEG are indication-driven. The 2022 clinical series also proposes a one-time renal ultrasound after diagnosis and attention to skeletal and dental findings; these are author recommendations rather than outcome-tested screening protocols.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      At each visit: measurement of growth parameters (including head circumference); assessment of developmental progress and educational needs
    explanation: GeneReviews surveillance schedule.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      assess for new manifestations, such as seizures, changes in tone, and signs/symptoms of cerebrospinal fluid obstruction and/or spinal cord dysfunction
    explanation: GeneReviews surveillance for new neurologic manifestations.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:36182950
    reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We also recommend a single renal ultrasound for abnormalities of the genitourinary system.
    explanation: The authors propose renal assessment after diagnosis.
- name: Deep Brain Stimulation for Refractory Dystonia
  description: >-
    Two women with childhood-onset progressive dystonia underwent pallidal deep brain stimulation at ages 50 and 17. Both improved, but benefit was partial: approximately 30% over three years in the older patient and modest scale changes after six months in the adolescent. These uncontrolled cases do not establish comparative superiority or a universal response.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: deep brain stimulation
    term:
      id: NCIT:C21024
      label: Deep Brain Stimulation
  target_phenotypes:
  - preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  evidence:
  - reference: PMID:34415117
    reference_title: "Childhood-onset progressive dystonia associated with pathogenic truncating variants in CHD8."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Deep brain stimulation led to clinical improvement in both cases.
    explanation: >-
      Both reported individuals with CHD8-related progressive dystonia improved with
      deep brain stimulation.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: Genetic Counseling
  description: >-
    Parental testing distinguishes inherited from apparently de novo variants and informs recurrence counseling. Each child of a variant carrier has a 50% chance of inheriting the variant, with variable expression. When neither parent has the variant in blood, GeneReviews gives an estimated sibling recurrence risk of 1% because of possible germline mosaicism; this is an estimate rather than an observed CHD8-specific rate. Prenatal and preimplantation testing can be discussed once the familial variant is known.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Each child of an individual with CHD8-NDD has a 50% chance of inheriting the CHD8 pathogenic variant. Once the CHD8 pathogenic variant has been identified in an affected family member, prenatal and preimplantation genetic testing are possible.
    explanation: GeneReviews genetic counselling guidance.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
- name: Physical Therapy
  description: Individualized physical therapy and appropriate mobility aids support gross-motor function.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Physical Therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Physical therapy is recommended to maximize mobility.
    explanation: The full chapter explicitly recommends this functional intervention.
  target_phenotypes:
  - preferred_term: Motor delay
    term:
      id: HP:0001270
      label: Motor delay
- name: Occupational Therapy
  description: Occupational therapy addresses fine-motor and adaptive activities such as feeding, dressing and writing.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Occupational Therapy
    term:
      id: NCIT:C121351
      label: Occupational Therapy
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function
    explanation: The full chapter explicitly recommends this functional intervention.
  target_phenotypes:
  - preferred_term: Motor delay
    term:
      id: HP:0001270
      label: Motor delay
- name: Levodopa Trial for Dystonia
  description: Responses are inconsistent. The 2024 series records partial benefit in one child and no benefit in another patient; both 2021 DBS cases had failed levodopa. A 2025 child had carbidopa-levodopa-responsive intermittent dystonia. These observations support individualized specialist assessment, not syndrome-wide efficacy.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: Levodopa
      term:
        id: CHEBI:15765
        label: L-dopa
  evidence:
  - reference: PMID:38441608
    reference_title: 'CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: she was thus treated with levodopa (with partial response)
    explanation: One child with mild CSF dopamine/biopterin deficiency had partial benefit.
  - reference: PMID:34415117
    reference_title: Childhood-onset progressive dystonia associated with pathogenic truncating variants in CHD8.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Dystonic symptoms did not respond to levodopa, trihexyphenidyl, and tetrabenazine.
    explanation: A separate patient had no benefit from these drugs.
  - reference: PMID:41407309
    reference_title: Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural Analyses.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She also exhibited intermittent dystonia responsive to carbidopa‐levodopa therapy
    explanation: The case reports benefit from the combination, without controlled efficacy testing.
  target_phenotypes:
  - preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
- name: Tizanidine and Botulinum Toxin Symptomatic Treatment
  description: One woman in the 2024 series received tizanidine for spasticity and intramuscular botulinum toxin for dystonia, with a positive symptomatic response. Concurrent treatment and uncontrolled observation prevent attribution of an independent effect size to either agent.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: Tizanidine
      term:
        id: CHEBI:63629
        label: tizanidine
    - preferred_term: Botulinum Toxin
      description: Botulinum toxin formulation and serotype are unspecified in the clinical report; a type-A-specific chemical binding would overstate the source.
  evidence:
  - reference: PMID:38441608
    reference_title: 'CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She received symptomatic treatment with tizanidine and botulinum toxin injections, with positive response.
    explanation: The primary case records combined symptomatic care; it is not a controlled efficacy comparison.
  target_phenotypes:
  - preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
animal_models:
- name: Chd8 exon-3 heterozygous mouse
  species: Mus musculus
  genotype: Constitutive exon-3 frameshift heterozygote on C57BL/6 background
  publication: PMID:29668850
  description: Approximately half-normal full-length protein, modest brain enlargement, delayed early motor reflexes and adult hypoactivity. The study reports heightened sociability, with no clear anxiety or repetitive-behavior phenotype; this is not uniform recapitulation of human autism.
  modeled_mechanisms:
  - target: Brain Overgrowth and Megalencephaly
    description: Models modest volumetric enlargement.
    evidence:
    - reference: PMID:29668850
      reference_title: "Altered Neocortical Gene Expression, Brain Overgrowth and Functional Over-Connectivity in Chd8 Haploinsufficient Mice."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Here, we report that Chd8 heterozygous mice display increased brain size, motor delay, hypertelorism, pronounced hypoactivity, and anomalous responses to social stimuli.
      explanation: Mouse heterozygote recapitulates brain overgrowth and hypertelorism.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Total brain increase is approximately 2.7% and depends on statistical threshold; body weight is reduced rather than generalized overgrowth.
    fidelity: MODERATE
  - target: Aberrant Long-Range Functional Connectivity
    description: Measures regional resting-state synchronization.
    evidence:
    - reference: PMID:29668850
      reference_title: "Altered Neocortical Gene Expression, Brain Overgrowth and Functional Over-Connectivity in Chd8 Haploinsufficient Mice."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Resting-state functional MRI identified increased synchronized activity in cortico-hippocampal and auditory-parietal networks in Chd8 heterozygous mutant mice, implicating altered connectivity as a potential mechanism underlying the behavioral phenotypes.
      explanation: >-
        Provides the functional-imaging evidence for altered long-range connectivity.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Regional mouse fMRI under experimental conditions; no established human biomarker or causal behavioral mediation.
    fidelity: MODERATE
  - target: Increased Neural Progenitor Proliferation
    description: Tests ventricular proliferation in the heterozygous cortex.
    evidence:
    - reference: PMID:29668850
      reference_title: Altered Neocortical Gene Expression, Brain Overgrowth and Functional Over-Connectivity in Chd8 Haploinsufficient Mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: we did not detect any significant differences in cortical ventricular zone (VZ) proliferation
      explanation: The study reports no detected ventricular proliferation difference.
    relationship: FAILS_TO_RECAPITULATE
    model_scale: CELLULAR
    limitations: Negative at the examined developmental stages and compartments; other cell populations or time windows may differ.
    fidelity: MODERATE
- name: Chd8 long-isoform and combined-isoform heterozygous mice
  species: Mus musculus
  genotype: Chd8+/ΔL (exons 11–13) or Chd8+/ΔSL
  publication: PMID:27602517
  description: Katayama et al. report brain enlargement and selected behavioral abnormalities, with enhanced REST-associated repression. Their extended data also show behavioral tests without abnormalities.
  modeled_mechanisms:
  - target: REST-Mediated Repression of Neuronal Genes
    description: Models enhanced REST-associated repression during brain development.
    evidence:
    - reference: PMID:27602517
      reference_title: "CHD8 haploinsufficiency results in autistic-like phenotypes in mice."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        reduced expression of CHD8 was associated with abnormal activation of RE-1 silencing transcription factor (REST), which suppresses the transcription of many neuronal genes
      explanation: >-
        Identifies REST derepression of the neuronal programme as a CHD8-dosage
        consequence.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
    relationship: PARTIALLY_RECAPITULATES
    model_scale: MOLECULAR
    limitations: Strongest around E14.5; this mechanism does not explain every allele, developmental stage or model.
    fidelity: MODERATE
  - target: Abnormal Neural Development
    description: Assesses behavioral and transcriptional consequences.
    evidence:
    - reference: PMID:27602517
      reference_title: CHD8 haploinsufficiency results in autistic-like phenotypes in mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: mice heterozygous for Chd8 mutations manifest ASD-like behavioural characteristics including increased anxiety, repetitive behaviour, and altered social behaviour
      explanation: The primary report supports selected behavioral abnormalities in these specific lines.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: ORGANISM
    limitations: Social and repetitive readouts differ across published Chd8 lines; mouse tests do not establish a human autism diagnosis.
    fidelity: MODERATE
- name: Embryonic cortical Chd8 knockdown mouse
  species: Mus musculus
  genotype: In utero cortical shRNA electroporation at E13 or E15
  publication: PMID:27694995
  description: Restricted embryonic cortical knockdown reduces proliferation and accelerates early differentiation. CHD8 or stabilized beta-catenin expression rescues selected developmental and adult outcomes.
  modeled_mechanisms:
  - target: Reduced Cortical Progenitor Proliferation
    description: Perturbs embryonic progenitor maintenance.
    evidence:
    - reference: PMID:27694995
      reference_title: Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: chd8 knockdown resulted in a premature depletion of the neural progenitor pool in the developing mouse cortex
      explanation: The primary cortical knockdown depletes the progenitor pool.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Spatially restricted knockdown differs from a constitutional heterozygous allele.
    fidelity: MODERATE
  - target: Premature Neuronal Differentiation
    description: Measures early neuronal differentiation.
    evidence:
    - reference: PMID:27694995
      reference_title: Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: This was accompanied by a concomitant increase in the percentage of cells positive for neuronal marker Tuj1
      explanation: The embryonic cortical experiment establishes the direction of the differentiation change.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: The direction differs from delayed excitatory-neuron generation in engineered human organoids.
    fidelity: MODERATE
  - target: Impaired Wnt/beta-Catenin Signal Transduction
    description: Tests Wnt contribution through beta-catenin rescue.
    evidence:
    - reference: PMID:27694995
      reference_title: "Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        knockdown of Chd8 disrupts the expression of key transducers of Wnt signaling, and enhancing Wnt signaling rescues the transcriptional and behavioral deficits caused by Chd8 knockdown
      explanation: >-
        Rescue by Wnt enhancement establishes the causal role of the Wnt branch.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
    relationship: PARTIALLY_RECAPITULATES
    model_scale: MOLECULAR
    limitations: Wnt effects are cell- and stage-dependent; this is not evidence for a human Wnt-directed treatment.
    fidelity: MODERATE
- name: Chd8 hypomorphic allelic-series mouse
  species: Mus musculus
  genotype: Chd8+/−, Chd8neo/neo, Chd8neo/−; separate Sox1-Cre conditional knockout
  publication: PMID:33627187
  description: Approximately 50%, 36% and 9% residual protein produce nonmonotonic effects. Mild hypomorphs enlarge the brain and increase basal progenitor proliferation; severe hypomorphs and neural knockouts produce hypoplasia. Reduced Trp53 partially rescues the conditional-knockout cell-loss phenotype.
  modeled_mechanisms:
  - target: Increased Neural Progenitor Proliferation
    description: Models increased TBR2-positive basal proliferation at the mild hypomorphic dose.
    evidence:
    - reference: PMID:33627187
      reference_title: Distinct, dosage-sensitive requirements for the autism-associated factor CHD8 during cortical development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: a significant increase in the proliferation of non-ventricular (or basal) progenitors was observed
      explanation: The full results localize increased proliferation to mild hypomorphs.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Increased proliferation was not detected at the heterozygous or severe hypomorphic doses; mild hypomorphs are below a usual haploinsufficient dosage.
    fidelity: MODERATE
  - target: Brain Overgrowth and Megalencephaly
    description: Tests brain growth across CHD8 dosage.
    evidence:
    - reference: PMID:33627187
      reference_title: Distinct, dosage-sensitive requirements for the autism-associated factor CHD8 during cortical development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: with heterozygotes and mild hypomorphs ... brain overgrowth, and severe hypomorphs ... brain hypoplasia
      explanation: The primary results establish the direction reversal at severe depletion.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Brain hypoplasia and p53-mediated cell loss after severe depletion are not equivalent to the typical human overgrowth presentation.
    fidelity: MODERATE
- name: Chd8 mouse genetic-background panel
  species: Mus musculus
  genotype: B6 Chd8 heterozygous females crossed with 33 inbred paternal strains
  publication: PMID:36738737
  description: A panel of 1,041 F1 animals of both sexes tests variation in behavior, growth and other traits. Effects and their direction depend on strain, sex and measured trait.
  modeled_mechanisms:
  - target: Abnormal Neural Development
    description: Tests background dependence of developmental and behavioral consequences.
    evidence:
    - reference: PMID:36738737
      reference_title: Mouse population genetics phenocopies heterogeneity of human Chd8 haploinsufficiency.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Trait disruptions mimicked those seen clinically, with robust strain and sex differences.
      explanation: The designed panel tests effects beyond a single inbred background.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: ORGANISM
    limitations: Resilience applies to particular traits; no corresponding human modifier locus was identified.
    fidelity: MODERATE
- name: Chd8L systemic and intestinal epithelial heterozygous mice
  species: Mus musculus
  genotype: Systemic Chd8L+/− or Villin-Cre intestinal epithelial Chd8L conditional heterozygote
  publication: PMID:37783686
  description: Male mice show genotype- and tissue-specific intestinal and behavioral findings. Systemic mutants have increased permeability and unchanged stool transit. Conditional epithelial mutants have selected anxiety changes but preserved sociability. Antibiotics were tested in systemic mutants.
  modeled_mechanisms:
  - target: Altered Intestinal Epithelial Differentiation
    description: Measures tuft and goblet cell populations.
    evidence:
    - reference: PMID:37783686
      reference_title: "CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        The current study found that mice haploinsufficient for the large isoform of Chd8 (Chd8L) exhibited increased intestinal permeability, transcriptomic dysregulation in gut epithelial cells, reduced tuft cell and goblet cell counts in the gut, and an overall increase in microbial load.
      explanation: >-
        Mammalian replication of the gut epithelial defect at a haploinsufficient
        Chd8 dose.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Affected cell types and intestinal segments differ between systemic and conditional mutants.
    fidelity: MODERATE
  - target: Intestinal Barrier Impairment
    description: Measures tracer permeability.
    evidence:
    - reference: PMID:37783686
      reference_title: CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: exhibited increased intestinal permeability, transcriptomic dysregulation in gut epithelial cells
      explanation: The systemic heterozygous mouse has a measured barrier defect.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Male mouse assay; the corresponding human lesion is unverified.
    fidelity: MODERATE
  - target: Gastrointestinal Dysmotility
    description: Tests stool transit.
    evidence:
    - reference: PMID:37783686
      reference_title: CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: no differences in colon length ... or in stool transit time were measured between the genotypes
      explanation: The negative transit result supports failure to reproduce this readout.
    relationship: FAILS_TO_RECAPITULATE
    model_scale: TISSUE
    limitations: Increased permeability occurs without the transit delay found in zebrafish morphants.
    fidelity: MODERATE
- name: chd8 zebrafish morphants
  species: Danio rerio
  genotype: Splice-blocking morpholinos; founding study also used mosaic F0 CRISPR disruption
  publication: PMID:24998929
  description: Transient suppression produces enlarged head size, reduced enteric-neuron abundance and delayed gut transit. Sugathan et al. additionally quantified increased proliferating cells. These manipulations do not assign a stable heterozygous genotype to every larva.
  modeled_mechanisms:
  - target: Gastrointestinal Dysmotility
    description: Measures microgavage transit and enteric innervation.
    evidence:
    - reference: PMID:24998929
      reference_title: Disruptive CHD8 mutations define a subtype of autism early in development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: impairment of gastrointestinal motility due to a reduction in postmitotic enteric neurons
      explanation: The fish experiment connects altered innervation with impaired transit.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Morpholino dose and transient suppression differ from human constitutional heterozygosity.
    fidelity: MODERATE
  - target: Increased Neural Progenitor Proliferation
    description: Measures proliferating cells in the developing brain.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/pmc/articles/PMC4210312/
      reference_title: CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors - PMC
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: We counted an average of 408 p-histone H3 ... cells for controls compared with 518 p-histone H3 ... cells in embryos injected with ... MO1
      explanation: The zebrafish experiment reports increased proliferating-cell counts after morpholino suppression.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Proliferating-cell counts and head size support a developmental effect; cell-specific causal mediation was not isolated.
    fidelity: MODERATE
- name: Stable chd8 p.Glu223* zebrafish
  species: Danio rerio
  genotype: chd8sa19827/+ and chd8sa19827/sa19827
  publication: PMID:36375841
  description: Stable first-coding-exon mutants reproduce enlarged head size and reduced enteric neurons. Heterozygous larvae have an early neural crest deficit with later migration preserved. Adult immune single-cell profiling used homozygous males, which must not be treated as a heterozygous human-dose assay.
  modeled_mechanisms:
  - target: Reduced Vagal Neural Crest Cell Pool
    description: Measures early emigrating neural crest cells.
    evidence:
    - reference: PMID:36375841
      reference_title: Loss of autism-candidate CHD8 perturbs neural crest development and intestinal homeostatic balance.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: We observed a significant decrease in the number of NCCs released from the neural tube
      explanation: The early progenitor deficit is directly measured.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Early induction and migration are difficult to separate; later migration reaches the distal intestine.
    fidelity: MODERATE
  - target: Reduced Enteric Neuron Abundance
    description: Measures enteric-neuron abundance.
    evidence:
    - reference: PMID:36375841
      reference_title: Loss of autism-candidate CHD8 perturbs neural crest development and intestinal homeostatic balance.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: a significant decrease in the number of enteric neurons in the heterozygous
      explanation: The stable heterozygous fish shows reduced enteric-neuron abundance.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Approximately 24% reduction in the cited heterozygote comparison, rather than the approximately 50% morphant reduction.
    fidelity: MODERATE
  - target: Altered Intestinal Epithelial Differentiation
    description: Models altered epithelial, goblet-cell and mucus organization.
    evidence:
    - reference: PMID:36375841
      reference_title: Loss of autism-candidate CHD8 perturbs neural crest development and intestinal homeostatic balance.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: The tissue examination of chd8 mutants revealed a thinner intestinal epithelium accompanied by an accumulation of neutrophils and the decreased numbers of goblet cells and eosinophils.
      explanation: The study documents structural and cellular intestinal abnormalities.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Several adult findings are strongest in homozygotes. Barrier permeability and excessive Th17 activity were proposed, not directly established.
    fidelity: MODERATE
- name: Embryo-edited CHD8 cynomolgus monkeys
  species: Macaca fascicularis
  genotype: CRISPR founder M1 biallelic fetus, M2 heterozygous +16 stillborn, M3 heterozygous −1 surviving male
  publication: PMID:36878905
  description: The three founders differ in allele and developmental outcome. Histology compares individual edited and control brains; serial imaging concerns one surviving male. More glial markers and white-matter changes support a candidate primate mechanism.
  modeled_mechanisms:
  - target: Increased Gliogenesis
    description: Measures glial abundance in edited brain tissue.
    evidence:
    - reference: PMID:36878905
      reference_title: CHD8 mutations increase gliogenesis to enlarge brain size in the nonhuman primate.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: CHD8 mutations selectively increased glial proteins but not neuronal proteins
      explanation: Brain tissue measurements distinguish glial from neuronal marker changes.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Very small independent-animal numbers; section counts are not biological replication. Genotype and developmental-stage differences confound a species comparison.
    fidelity: LOW
  - target: White Matter Expansion
    description: Assesses white matter in histology and imaging.
    evidence:
    - reference: PMID:36878905
      reference_title: CHD8 mutations increase gliogenesis to enlarge brain size in the nonhuman primate.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: with enlarged white matter labeled by immunostaining of GFAP
      explanation: The stillborn edited monkey had enlarged brain tissue and white matter.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: No corresponding cellular demonstration in human CHD8-NDD; brain editing of the surviving founder is incompletely characterized.
    fidelity: LOW
- name: Kismet-deficient fly glial model
  species: Drosophila melanogaster
  genotype: kis heterozygotes and temporally restricted glial/subperineurial-glial RNAi
  publication: PMID:34088660
  description: Developmental glial knockdown causes adult sleep fragmentation, whereas adult-only knockdown does not. Developmental serotonin manipulation and adult sleep restriction probe different portions of the phenotype.
  modeled_mechanisms:
  - target: Developmental Glial Sleep Regulation Defect
    description: Localizes a developmental glial requirement.
    evidence:
    - reference: PMID:34088660
      reference_title: "The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        We show that Kismet is required in glia for early developmental and adult sleep architecture. This role localizes to subperineurial glia constituting the blood-brain barrier.
      explanation: >-
        Localises the sleep requirement to blood-brain-barrier glia in the sole
        CHD8/CHD7 ortholog.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Kismet is the shared ortholog of CHD7 and CHD8; the human gene-specific mechanism remains uncertain.
    fidelity: MODERATE
  - target: Sleep Fragmentation
    description: Measures sleep architecture and behavioral rescue.
    evidence:
    - reference: PMID:34088660
      reference_title: "The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Despite their developmental origin, Kismet's sleep architecture defects can be reversed in adulthood by a behavioral regime resembling human sleep restriction therapy.
      explanation: >-
        Sleep restriction reverses selected sleep-architecture defects in Kismet-deficient flies. This supports a preclinical possibility of reversibility; efficacy in humans with CHD8-NDD has not been demonstrated.
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
    relationship: PARTIALLY_RECAPITULATES
    model_scale: ORGANISM
    limitations: Mutant sleep latency is normal; restriction improves fragmentation and efficiency but not total sleep duration. Patient evidence is mainly questionnaire-based.
    fidelity: MODERATE
- name: Timed and ventral-lineage Chd8 mutation and restoration mice
  species: Mus musculus
  genotype: Nestin-CreERT2/Chd8+/F and conditional Chd8+/LSL restoration with Nestin-Cre or Olig1-Cre
  publication: PMID:42203765
  description: A 2026 study pairs timed neural deletion with restoration at the endogenous locus. Midfetal ventral differentiation and later social-contact/anxiety measures improve after early or ventral-lineage rescue. Macrocephaly remains after the timed E14.5 and Olig1-lineage rescues; these are developmental prevention experiments, not demonstrated treatment of established human disease.
  modeled_mechanisms:
  - target: Premature Ventral Progenitor Differentiation
    description: Models accelerated ventral cell-cycle exit.
    evidence:
    - reference: PMID:42203765
      reference_title: Defective ventral neurogenesis due to midfetal Chd8 mutation drives autistic-like behavior in mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: a significantly higher proportion of Ki67-negative EdU+ cells (cells that had exited the cell cycle) in the ganglionic eminence but not in the cortex
      explanation: E14.5-induced heterozygous deletion accelerates cell-cycle exit in ventral progenitors at E16.5.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Mouse developmental timing does not define a human therapeutic window.
    fidelity: MODERATE
  - target: Premature Ventral Progenitor Differentiation
    description: Restores ventral differentiation genetically.
    evidence:
    - reference: PMID:42203765
      reference_title: Defective ventral neurogenesis due to midfetal Chd8 mutation drives autistic-like behavior in mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: restoration of Chd8 expression in ventral progenitor cells by Olig1-Cre resulted in normalization of the differentiation of progenitors of both interneurons and oligodendrocytes
      explanation: The genetic rescue supports a requirement for ventral CHD8 dosage.
    relationship: RESCUES
    model_scale: CELLULAR
    limitations: Olig1-Cre includes interneuron and oligodendrocyte progenitors.
    fidelity: MODERATE
  - target: Abnormal Neural Development
    description: Tests time-dependent prevention of behavioral phenotypes.
    evidence:
    - reference: PMID:42203765
      reference_title: Defective ventral neurogenesis due to midfetal Chd8 mutation drives autistic-like behavior in mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: The genetic rescue of Chd8 expression at E14.5 or before, but not at E17.5 or after, ameliorated autistic-like behavior
      explanation: Prenatal genetic restoration prevents selected mouse behavioral abnormalities; later restoration in the tested windows did not reproduce the benefit.
    relationship: RESCUES
    model_scale: ORGANISM
    limitations: Behavior improves after restoration at E14.5 or earlier, not E17.5 or later in the tested paradigms; macrocephaly is not corrected by these timed rescues.
    fidelity: MODERATE
- name: Olig1-lineage Chd8 heterozygous myelination and imaging mouse
  species: Mus musculus
  genotype: Olig1-Cre/Chd8L+/F
  publication: PMID:32142125
  description: Lineage-targeted mice have myelination and conduction abnormalities. A separate 2020 male-mouse MRI study identifies regional DTI changes and exploratory connectivity associations, without reproducing a group difference in social-contact time.
  modeled_mechanisms:
  - target: Impaired Myelination
    description: Models defective myelination.
    evidence:
    - reference: PMID:32142125
      reference_title: Oligodendrocyte dysfunction due to Chd8 mutation gives rise to behavioral deficits in mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Ablation of Chd8 specifically in oligodendrocytes of mice impaired myelination, slowed action potential propagation
      explanation: The primary mouse study reports myelination and conduction abnormalities; Olig1 lineage specificity requires caution in light of its ventral interneuron progenitor expression.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Olig1-Cre also marks ventral interneuron progenitors; behavioral effects are not exclusively attributable to oligodendrocytes.
    fidelity: MODERATE
  - target: Aberrant Long-Range Functional Connectivity
    description: Measures regional functional connectivity.
    evidence:
    - reference: PMID:33228730
      reference_title: Chd8 mutation in oligodendrocytes alters microstructure and functional connectivity in the mouse brain.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Although these differences did not survive multiple corrections, uncorrected statistics supported the alterations of functional connectivity
      explanation: Regional connectivity findings are exploratory; anatomical DTI results used separate corrected analyses.
    relationship: MEASURES
    model_scale: TISSUE
    limitations: Connectivity comparisons did not survive multiple-testing correction; correlations do not establish behavioral causality.
    fidelity: MODERATE
- name: Chd8 p.Val986* lifespan mouse
  species: Mus musculus
  genotype: Chd8V986*/+ on C57BL/6J
  publication: PMID:33023670
  description: A heterozygous stop allele corresponding to human p.Val984* reduces brain CHD8 by half. Male cortical transcriptomes were compared at E14.5 and 1, 6 and 12 months; older animals show a reduced proteostasis-response transcriptional signature.
  modeled_mechanisms:
  - target: Reduced Aged-Cortex Proteostasis Response Signature
    description: Measures an age-dependent cortical transcriptional signature.
    evidence:
    - reference: PMID:33023670
      reference_title: Chd8 haploinsufficiency impairs early brain development and protein homeostasis later in life.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Pathways associated with the unfolded protein response (UPR), endoplasmic reticulum (ER) stress, and chaperone-mediated protein folding were reduced
      explanation: The result is a cortical transcriptional signature at 12 months, not a direct measurement of protein-folding capacity.
    relationship: MEASURES
    model_scale: MOLECULAR
    limitations: Gene-set inference and phospho-S6 do not establish misfolded-protein accumulation or human neurodegeneration.
    fidelity: MODERATE
- name: Constitutive exon-5 and postmitotic Chd8 excitatory neuron mice
  species: Mus musculus
  genotype: Chd8+/5bpdel on C57BL/6N; Camk2a-Cre Chd8+/flox on C57BL/6J
  publication: PMID:40501938
  description: A 2025 preprint combines constitutive mutation with postmitotic excitatory-neuron deletion. The conditional model was studied for bulk transcription only. Constitutive mice show enlarged cortex without extra neurons, transient adolescent spine changes, and altered sleep states. Slice calcium activity is less correlated despite unchanged overall activity.
  modeled_mechanisms:
  - target: Brain Overgrowth and Megalencephaly
    description: Separates cortical size from neuron number.
    evidence:
    - reference: PMID:40501938
      reference_title: Persistent cortical excitatory neuron dysregulation in adult Chd8 haploinsufficient mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: We did not find significant differences in total neuron number in either the full cohort or sex-stratified analyses
      explanation: Stereology in the constitutive exon-5 mouse supports model-specific dissociation of cortical volume and neuron count; the source is a preprint.
    relationship: MEASURES
    model_scale: TISSUE
    limitations: Preprint; volume increases without additional neurons or larger somata.
    fidelity: MODERATE
  - target: Delayed Cortical Spine Development
    description: Measures age-dependent spine structure in vivo.
    evidence:
    - reference: PMID:40501938
      reference_title: Persistent cortical excitatory neuron dysregulation in adult Chd8 haploinsufficient mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Adolescent Chd8+/− mice had lower spine density on the apical dendritic tufts of L5 PyrNs
      explanation: In vivo imaging in a 2025 preprint found reduced P30 spine density and increased formation, with normal P90 spine density and dynamics.
    relationship: MEASURES
    model_scale: CELLULAR
    limitations: Preprint; P90 spine density and dynamics are normal. Conditional mice were not tested for the structural or behavioral outcomes.
    fidelity: MODERATE
experimental_models:
- name: Control-donor iPSC-derived CHD8-knockdown neural progenitors
  experimental_model_type: IPSC_DERIVED_MODEL
  publication: PMID:25294932
  description: Six shRNAs in a control-donor iPSC neural progenitor line reduce CHD8 RNA by 38–69%. RNA sequencing and control-cell ChIP-seq distinguish transcriptional changes from binding. Morphology and selected neural ectoderm markers remain unchanged.
  modeled_mechanisms:
  - target: Dysregulation of Neurodevelopmental Gene Networks
    description: Measures dose-associated transcriptional changes.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/pmc/articles/PMC4210312/
      reference_title: CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors - PMC
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: 1,756 genes were differentially expressed ... 369 of which were significant
      explanation: The full text distinguishes nominal and multiple-testing-adjusted differential expression.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: MOLECULAR
    limitations: Stable knockdown from one donor; 1,756 nominal changes versus 369 false-discovery-adjusted changes. Enrichment does not directly measure synapse formation.
    fidelity: MODERATE
- name: Engineered CHD8 exon-1 iPSC cerebral organoids
  experimental_model_type: ORGANOID
  publication: PMID:28321286
  description: Four engineered heterozygous frameshift clones and two control clones derive from one healthy donor. The model shows approximately halved protein and altered developmental transcription, including DLX6-AS1 and DLX1 upregulation.
  modeled_mechanisms:
  - target: Dysregulation of Neurodevelopmental Gene Networks
    description: Measures organoid transcription after engineered CHD8 loss.
    evidence:
    - reference: PMID:28321286
      reference_title: CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: there were 559 DEGs when the CHD8+/+ organoids were compared with CHD8+/−
      explanation: The primary RNA-sequencing result replaces the former title-only evidence.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: MOLECULAR
    limitations: One donor background, heterogeneous organoids and expression-based pathway inference; physiological excitation/inhibition was not measured.
    fidelity: MODERATE
- name: Engineered H9 hESC CHD8 cerebral organoids
  experimental_model_type: ORGANOID
  publication: PMID:35385734
  description: Female H9 embryonic stem cells carry isogenic S62X, E1114X or exon-20 disruption alleles. These are engineered patient-associated alleles, not patient-derived iPSCs. Mosaic cultures test cell autonomy.
  modeled_mechanisms:
  - target: Excitatory-Inhibitory Neuronal Trajectory Imbalance
    description: Measures stage-dependent neuronal lineage proportions.
    evidence:
    - reference: PMID:35385734
      reference_title: "CHD8 haploinsufficiency links autism to transient alterations in excitatory and inhibitory trajectories."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        we find that CHD8 haploinsufficiency disrupted neurodevelopmental trajectories with an accelerated and delayed generation of, respectively, inhibitory and excitatory neurons that yields, at days 60 and 120, symmetrically opposite expansions in their proportions.
      explanation: >-
        Directly demonstrates the excitatory-inhibitory trajectory imbalance in a
        human isogenic model of CHD8 haploinsufficiency.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: No direct physiological E/I assay; inhibitory expansion around day 60 is followed by excitatory expansion at day 120.
    fidelity: MODERATE
  - target: Brain Overgrowth and Megalencephaly
    description: Models organoid enlargement in selected alleles.
    evidence:
    - reference: PMID:35385734
      reference_title: "CHD8 haploinsufficiency links autism to transient alterations in excitatory and inhibitory trajectories."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        This imbalance is consistent with an enlargement of cerebral organoids as an in vitro correlate of patients' macrocephaly.
      explanation: >-
        Human cerebral organoid model links the cellular imbalance to enlargement,
        the in vitro correlate of macrocephaly.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: The long-isoform-specific S62X allele does not enlarge organoids at day 120; a single female genetic background limits generalization.
    fidelity: MODERATE
  evidence:
  - reference: url:https://research-explorer.ista.ac.at/download/11160/11164/2022_CellReports_Villa.pdf
    reference_title: https://research-explorer.ista.ac.at/download/11160/11164/2022_CellReports_Villa.pdf
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Human H9 embryonic stem (ES) cells (WA09) are available from commercial sources (WiCell).
    explanation: The institutional PDF of Villa et al. (PMID:35385734) supplies the methods statement identifying the commercial H9 embryonic stem-cell line.
- name: Newborn cynomolgus organotypic brain slices
  experimental_model_type: OTHER
  publication: PMID:36878905
  description: CRISPR-mediated CHD8 perturbation in newborn monkey brain slices provides an ex vivo glial-proliferation assay distinct from the edited-founder animals.
  modeled_mechanisms:
  - target: Increased Gliogenesis
    description: Measures glial proliferation in cultured primate brain tissue.
    evidence:
    - reference: PMID:36878905
      reference_title: CHD8 mutations increase gliogenesis to enlarge brain size in the nonhuman primate.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: knocking down CHD8 via CRISPR/Cas9 in organotypic monkey brain slices from newborn monkeys also enhanced the proliferation of glial cells
      explanation: Slice culture supplies a separate experimental glial readout.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: CELLULAR
    limitations: Short ex vivo developmental window; slice replicates do not replace independent donor animals.
    fidelity: MODERATE
- name: Chd8 heterozygous nucleus accumbens slices
  experimental_model_type: OTHER
  publication: PMID:28402856
  description: Acute slices allow recordings from medium spiny neurons. Increased spontaneous excitatory currents coexist with unchanged miniature excitatory currents and lower miniature inhibitory-current amplitude, suggesting a circuit-dependent effect.
  modeled_mechanisms:
  - target: Striatal Circuit Dysfunction
    description: Measures accumbens synaptic physiology.
    evidence:
    - reference: PMID:28402856
      reference_title: Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: We also find altered synaptic physiology in medium spiny neurons of the nucleus accumbens.
      explanation: The electrophysiological component is an ex vivo tissue assay.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Mouse regional physiology is not a direct readout of human autism, dystonia or developmental motor delay.
    fidelity: MODERATE
- name: H9 E11 CHD8-heterozygous neural progenitor cell-cycle model
  experimental_model_type: OTHER
  publication: DOI:10.1242/bio.058941
  description: Coakley-Youngs et al. (Biology Open, 2022) used a single H9 hESC clone with a heterozygous exon-4 one-base insertion differentiated into cortical neural progenitors. FUCCI imaging measures single-cell cycle timing; independent clones and a genetic rescue were not presented. Assay details are supported by the institutional full-text PDF.
  modeled_mechanisms:
  - target: Shortened Neural Progenitor G1 Phase
    description: Directly measures cell-cycle phase duration.
    evidence:
    - reference: url:https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf
      reference_title: https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Comparative analysis of phase duration across genotypes revealed a marked shortening of G1
      explanation: FUCCI imaging compared a single H9-derived heterozygous exon-4 frameshift clone with wild type; G1 medians were 517 and 1,408 minutes, respectively.
    relationship: MEASURES
    model_scale: CELLULAR
    limitations: One engineered clone; proposed cell-fate and organ-growth consequences are not direct measurements.
    fidelity: MODERATE
- name: Conditional CHD8 human excitatory neuron chromatin model
  experimental_model_type: OTHER
  publication: PMID:36575212
  description: Engineered hESC and iPSC conditional alleles permit heterozygous or homozygous CHD8 deletion in induced excitatory neurons. ATAC-seq, RNA-seq and ELK1 perturbation distinguish occupancy, accessibility and transcription. Standard intrinsic and excitatory synaptic physiology was unchanged.
  modeled_mechanisms:
  - target: Reduced Neuronal Chromatin Accessibility
    description: Measures genotype-dependent accessibility effects.
    evidence:
    - reference: PMID:36575212
      reference_title: The autism risk factor CHD8 is a chromatin activator in human neurons and functionally dependent on the ERK-MAPK pathway effector ELK1.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: many more sites lost accessibility (1,481 peaks in homozygous KO) than gained accessibility (106 peaks in homozygous KO)
      explanation: ATAC-seq measures accessibility; the numerical result applies to complete deletion.
    - reference: PMID:36575212
      reference_title: The autism risk factor CHD8 is a chromatin activator in human neurons and functionally dependent on the ERK-MAPK pathway effector ELK1.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: The ATAC-seq peaks in the heterozygous knockout experiment at sites with moderate change (no statistical significance) also revealed similar results for ETS motif enrichment
      explanation: The heterozygous result is weaker and does not establish genome-wide closure in human disease.
    relationship: MEASURES
    model_scale: MOLECULAR
    limitations: Strong closure is observed after complete deletion; heterozygous changes are weaker. ELK1 overexpression did not significantly improve CHD8 binding.
    fidelity: MODERATE
  evidence:
  - reference: PMID:36575212
    reference_title: The autism risk factor CHD8 is a chromatin activator in human neurons and functionally dependent on the ERK-MAPK pathway effector ELK1.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: evoked excitatory postsynaptic currents (EPSCs) were unchanged in heterozygous and homozygous mutant cells
    explanation: Negative cultured-neuron physiology constrains extrapolation from transcriptional changes.
- name: Enhancer-targeted CHD8 CRISPR activation in human neural cultures
  experimental_model_type: ORGANOID
  publication: DOI:10.1101/2024.03.13.584921
  description: The March 2026 version of a preprint describes enhancer-targeted CRISPR activation in hPSC-derived excitatory neurons and forebrain organoids. CHD8 and SCN2A are separate targets. Increased CHD8 expression supports an experimental dosage-restoration approach; pooled abstract claims about physiological rescue cannot be assigned specifically to CHD8. Human safety and efficacy are untested in this study.
  modeled_mechanisms:
  - target: CHD8 Haploinsufficiency
    description: Tests restoration of expression from an endogenous wild-type allele.
    evidence:
    - reference: DOI:10.1101/2024.03.13.584921
      reference_title: Enhancer-targeted CRISPR-A rescues haploinsufficiency and mutant phenotypes in organoid models of autism
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: We found that CRISPR-A induced a sustained increase in CHD8 and SCN2A expression in neurons and organoids
      explanation: The preprint abstract directly supports expression upregulation but does not separate gene-specific physiological endpoints.
    relationship: RESCUES
    model_scale: MOLECULAR
    limitations: Preprint evidence; rescue is limited here to the directly supported expression endpoint, not clinical benefit.
    fidelity: MODERATE
differential_diagnoses:
- name: Autism Spectrum Disorder (multifactorial)
  disease_term:
    preferred_term: autism spectrum disorder
    term:
      id: MONDO:0005258
      label: autism spectrum disorder
  description: >-
    Autism has many genetic and non-genetic contributors. A pathogenic CHD8 variant identifies a molecularly defined neurodevelopmental disorder that may include autism, overgrowth, sleep and gastrointestinal findings.
  distinguishing_features:
  - A pathogenic or likely pathogenic CHD8 variant, interpreted with the phenotype, distinguishes this disorder; macrocephaly and tall stature are useful but not obligatory clues.
  evidence:
  - reference: PMID:24998929
    reference_title: "Disruptive CHD8 mutations define a subtype of autism early in development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation.
    explanation: >-
      Explicitly frames CHD8 disruption as defining a distinct subtype separable
      from autism at large.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: CHARGE Syndrome (CHD7)
  disease_term:
    preferred_term: CHARGE syndrome
    term:
      id: MONDO:0008965
      label: CHARGE syndrome
  description: >-
    This distinct disorder involves the paralogous gene CHD7. Similar gene names and overlapping developmental features do not make its evidence interchangeable with CHD8-NDD.
  distinguishing_features:
  - Molecular confirmation of the responsible CHD7 variant distinguishes this diagnosis from a CHD8-associated disorder.
- name: CHD2-Related Developmental and Epileptic Encephalopathy
  disease_term:
    preferred_term: CHD2-related developmental and epileptic encephalopathy
    term:
      id: MONDO:0014150
      label: developmental and epileptic encephalopathy 94
  description: >-
    This distinct disorder involves the paralogous gene CHD2. Similar gene names and overlapping developmental features do not make its evidence interchangeable with CHD8-NDD.
  distinguishing_features:
  - Molecular confirmation of the responsible CHD2 variant distinguishes this diagnosis from a CHD8-associated disorder.
  evidence:
  - reference: PMID:36302072
    reference_title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Less common features are hypotonia (about 30% of affected individuals), seizures (10%-15%), dystonia (rare), and Chiari I malformation (rare).
    explanation: >-
      Quantifies seizures as a minority feature in CHD8-NDD, distinguishing it from
      a primary epilepsy gene.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
- name: Sifrim-Hitz-Weiss Syndrome (CHD4)
  disease_term:
    preferred_term: Sifrim-Hitz-Weiss syndrome
    term:
      id: MONDO:0014946
      label: Sifrim-Hitz-Weiss syndrome
  description: >-
    This distinct disorder involves the paralogous gene CHD4. Similar gene names and overlapping developmental features do not make its evidence interchangeable with CHD8-NDD.
  distinguishing_features:
  - Molecular confirmation of the responsible CHD4 variant distinguishes this diagnosis from a CHD8-associated disorder.
- name: 14q11.2 Microdeletion Syndrome
  description: >-
    A contiguous deletion that includes CHD8 can produce CHD8 haploinsufficiency while additional deleted genes contribute to the presentation.
  distinguishing_features:
  - Copy-number analysis defines the deletion and other affected genes, including SUPT16H in the recurrent small interval. This is a route to CHD8 loss with potential additional effects, rather than an exclusion from the CHD8 spectrum.
  evidence:
  - reference: PMID:25257502
    reference_title: "Recurrent ∼100 Kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The minimal critical region, considering present and previous cases, contains the SUPT16H and CHD8 genes.
    explanation: >-
      Defines the minimal critical region and shows it is not CHD8 alone.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: 14q11.2 Microduplication (CHD8-SUPT16H) Syndrome
  disease_term:
    preferred_term: 14q11.2 microduplication syndrome
    term:
      id: MONDO:0016835
      label: 14q11.2 microduplication syndrome
  description: >-
    The reciprocal dosage disorder. Duplication of the same 14q11.2 segment
    containing CHD8 and SUPT16H also produces a neurodevelopmental phenotype, which
    is why CHD8 is described as requiring tight dosage control in both directions.
    Duplication cases are a separate entity and must not be folded into this entry.
  distinguishing_features:
  - >-
    Detected as a copy-number GAIN on chromosomal microarray rather than a
    loss-of-function sequence variant; neurodevelopmental severity is variable and
    at least one reported individual had normal intelligence; the duplication also
    spans SUPT16H so single-gene CHD8 triplosensitivity is not established.
  evidence:
  - reference: PMID:31823155
    reference_title: "Neurodevelopmental phenotype associated with CHD8-SUPT16H duplication."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Recently, a 14q11.2 microduplication syndrome, encompassing CHD8 and SUPT16H, has been described, highlighting the importance of a tight control of at least CHD8 gene-dosage for a normal development.
    explanation: >-
      Establishes the duplication entity and the bidirectional dosage sensitivity.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:31823155
    reference_title: "Neurodevelopmental phenotype associated with CHD8-SUPT16H duplication."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report on two patients with 14q11.2 microduplication encompassing CHD8 and SUPT16H, one of whom had normal intelligence.
    explanation: >-
      Documents the milder end of the duplication phenotype, distinguishing it from
      the deletion/loss-of-function disorder.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: PTEN Hamartoma Tumor Syndrome
  disease_term:
    preferred_term: PTEN hamartoma tumor syndrome
    term:
      id: MONDO:0017623
      label: PTEN hamartoma tumor syndrome
  description: >-
    PTEN-related disease can also present with macrocephaly and autism and carries an established tumor-predisposition phenotype.
  distinguishing_features:
  - PTEN-related hamartomas and characteristic tumor risk distinguish the condition. CHD8 overgrowth is variable and may be disproportionately cranial; head-to-height proportionality is not a reliable exclusion rule. An increased germline malignancy risk has not been established for CHD8-NDD.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
    reference_title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: there is no current evidence that individuals with ... are at increased risk for developing cancer
    explanation: The chapter distinguishes somatic cancer observations from established germline risk.
- name: Other Overgrowth-with-Intellectual-Disability Syndromes
  description: >-
    Sotos, Weaver, Tatton-Brown-Rahman and Malan syndromes are overlapping overgrowth/neurodevelopmental diagnoses. Beckwith-Wiedemann syndrome is an overgrowth differential with a different characteristic phenotype; intellectual disability is not its defining feature.
  distinguishing_features:
  - Molecular diagnosis and syndrome-specific findings distinguish these conditions. Lateralized overgrowth, macroglossia and embryonal tumor risk particularly support Beckwith-Wiedemann syndrome. Methylation testing can contribute in appropriate cases but is not uniformly diagnostic across this differential.
  evidence:
  - reference: PMID:31001818
    reference_title: "The clinical presentation caused by truncating CHD8 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CHD8 is one of the causative genes for OGID (overgrowth and ID)
    explanation: >-
      Places CHD8 explicitly within the overgrowth-and-intellectual-disability
      disease group that constitutes this differential.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
discussions:
- discussion_id: chd8_nec_boundary_vs_multifactorial_asd
  kind: INTERPRETATION
  prompt: >-
    Where exactly is the boundary between this monogenic CHD8 entity and the broad
    multifactorial autism spectrum disorder entry that also lists CHD8 as a risk
    gene?
  rationale: >-
    Pathogenic CHD8 variants define a molecular neurodevelopmental disorder with variable autism penetrance. Broad autism studies support gene discovery but cannot supply CHD8-specific phenotype frequencies without a separable genotype subgroup. CHD7, CHD2 and CHD4 disorders require their own evidence.
- discussion_id: chd8_brain_overgrowth_causality_for_behaviour
  kind: KNOWLEDGE_GAP
  prompt: >-
    Is brain overgrowth causally upstream of the autistic and cognitive phenotype in
    CHD8-NDD, or are the two parallel consequences of the same progenitor lesion?
  attaches_to:
  - pathophysiology#Brain Overgrowth and Megalencephaly
  rationale: >-
    Brain enlargement and neurobehavioral differences coexist in several models, but neither the human clinical cohorts nor the cited experiments establish brain size as the causal mediator. They are therefore represented as potentially parallel consequences; a causal edge from brain overgrowth to autism is not asserted.
  proposed_experiments:
  - experiment_id: chd8_exp_brain_size_vs_behaviour_rescue
    name: Temporally restricted CHD8 restoration in a Chd8+/- mouse that normalises brain size after the neurogenic window, testing whether behaviour is rescued independently of size.
  - experiment_id: chd8_exp_imaging_genetics_ohc_vs_severity
    name: Human imaging-genetics comparison of CHD8 variant carriers stratified by head circumference against behavioural severity.
- discussion_id: chd8_gut_brain_axis_human_translation
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    Does the gut-to-brain contribution to behaviour demonstrated in Chd8
    haploinsufficient mice operate in humans with CHD8-NDD?
  attaches_to:
  - pathophysiology#Intestinal Barrier Impairment
  - pathophysiology#Gastrointestinal Dysmotility
  rationale: >-
    Gut-epithelial conditional Chd8 loss increases selected anxiety measures while preserving sociability. Antibiotics improve selected behaviors in a separate systemic heterozygous model. Neither experiment establishes human gut-to-brain causality, a human barrier lesion, or antibiotic treatment efficacy. Stool transit is unchanged in the mouse permeability study.
  proposed_experiments:
  - experiment_id: chd8_exp_human_gut_brain_cohort
    name: Prospective characterisation of GI symptom burden, intestinal permeability and microbiome composition in a CHD8-NDD cohort with paired behavioural measures.
- discussion_id: chd8_dystonia_female_preponderance
  kind: KNOWLEDGE_GAP
  prompt: >-
    Why do the reported CHD8-related dystonia cases show an apparent female
    preponderance, and how frequent is dystonia in unselected CHD8-NDD cohorts?
  rationale: >-
    The 2021 and 2024 movement-disorder reports describe five women with variable cognitive involvement. Their ascertainment does not determine population frequency or an exclusive sex effect. The 2025 inherited-variant case includes dystonia with substantial developmental difficulties, further broadening the presentation.
  evidence:
  - reference: PMID:38441608
    reference_title: "CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This work validates our previous observation that dystonia is part of the phenotypic spectrum of CHD8-related
    explanation: Source of the dystonia observation and the female-preponderance suggestion.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- discussion_id: chd8_megalencephaly_rodent_vs_primate_mechanism
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    How much do progenitor proliferation, neuronal production and gliogenesis each contribute to human CHD8-related brain overgrowth?
  attaches_to:
  - pathophysiology#Increased Gliogenesis
  - pathophysiology#White Matter Expansion
  - pathophysiology#Brain Overgrowth and Megalencephaly
  rationale: >-
    Primate results support a glial contribution in a very small, heterogeneous edited series. Mouse effects vary with dosage and timing, and some heterozygotes show enlargement without detectable progenitor proliferation changes. These experiments do not isolate species as the explanation or establish a dominant glial mechanism in humans.
  proposed_experiments:
  - experiment_id: chd8_exp_human_postmortem_glia_neuron_ratio
    name: Cell-type-resolved quantification (single-nucleus RNA-seq or stereology) of glial versus neuronal number in post-mortem cortex from CHD8 variant carriers versus matched controls.
  - experiment_id: chd8_exp_human_white_matter_imaging
    name: Systematic volumetric and white-matter MRI characterisation of a CHD8-NDD cohort, testing whether white-matter expansion accounts for the increased head circumference as it does in the monkey.
  evidence: []
- discussion_id: chd8_frequency_ascertainment_discrepancy
  kind: INTERPRETATION
  prompt: >-
    Which phenotype frequencies should this entry assert, given that CHD8 cohorts
    were ascertained in systematically different ways and report materially
    different numbers for the same features?
  rationale: >-
    The cohorts overlap and differ in recruitment, age, definitions and available-data denominators. Ever-macrocephalic status differs from macrocephaly at examination; combined autism/traits differs from formal diagnosis. The 2022 study assembled 106 individuals but excluded five uncertain variants from its main analysis. Context-specific frequencies preserve these distinctions instead of treating the estimates as independent population measurements.
  evidence:
  - reference: PMID:31001818
    reference_title: "The clinical presentation caused by truncating CHD8 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a pattern of common features: macrocephaly (62.5%), tall stature (47%), developmental delay and/or intellectual disability (81%), ASDs (84%), sleep difficulties (50%), gastrointestinal problems (40%), and distinct facial features
    explanation: >-
      The protein-truncating-variant cohort figures used as the primary quantitative
      anchor for several bands in this entry.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- discussion_id: chd8_neoplasia_not_established
  kind: KNOWLEDGE_GAP
  prompt: >-
    Does CHD8-NDD carry an increased tumour risk, and should tumour surveillance be
    recommended?
  rationale: >-
    The 2022 aggregation explicitly lists six neoplasms among 54 individuals with information: three glabellar hemangiomas, one fibroma, one fibrosarcoma and one uterine leiomyoma. Thus the tumor types are known, but an excess incidence or causal germline predisposition is not established. GeneReviews reports no evidence of increased malignancy risk and no published tumor-screening guidelines; this is not an explicit recommendation against surveillance. Somatic CHD8 alterations in cancer require separate interpretation.
  proposed_experiments:
  - experiment_id: chd8_exp_cancer_incidence_registry_linkage
    name: Registry linkage of a molecularly confirmed CHD8-NDD cohort to national cancer registries, with age- and sex-standardised incidence ratios against population baseline.
  evidence:
  - reference: PMID:36182950
    reference_title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: 'Neoplasia was seen in six individuals (11%, 6/54): glabellar hemangioma in three, fibroma in one, fibrosarcoma in one, and uterine leiomyoma in one individual.'
    explanation: The full text identifies the lesions; the retrospective count does not establish increased cancer incidence.
- discussion_id: chd8_genetic_background_modifier
  kind: OPEN_QUESTION
  prompt: >-
    Is the marked clinical variability of CHD8-NDD - which extends from severe
    intellectual disability with autism to an isolated adult focal dystonia in a
    cognitively intact individual - driven by genetic background rather than chance?
  rationale: >-
    A single Chd8 allele tested across 33 mouse genetic backgrounds produces sex- and trait-dependent effects, including opposite directions and resilience for particular traits. This demonstrates model modifiers without identifying a human modifier locus or showing that every discrepancy between models is genetic background. Human allele, age, ascertainment and developmental differences also remain relevant.
  proposed_experiments:
  - experiment_id: chd8_exp_human_polygenic_modifier_analysis
    name: Polygenic background and rare-variant modifier analysis within a molecularly confirmed CHD8-NDD cohort phenotyped on a common severity instrument.
  evidence:
  - reference: PMID:36738737
    reference_title: "Mouse population genetics phenocopies heterogeneity of human Chd8 haploinsufficiency."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Some strains exhibited large effect-size trait disruptions, sometimes in opposite directions, and-remarkably-others expressed resilience.
    explanation: >-
      Demonstrates background-dependent modification of the same Chd8 lesion,
      including resilience.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- discussion_id: chd8_pain_self_injury_specificity
  kind: KNOWLEDGE_GAP
  prompt: Does gastrointestinal pain contribute to self-injury specifically in CHD8-NDD?
  attaches_to:
  - phenotypes#Self-Injurious Behavior
  rationale: A 112-person mixed-gene cohort found an association between severe abdominal pain and self-injury, but did not establish a CHD8-specific effect or causal direction. Prospective symptom and pain assessment within CHD8 cohorts could test this possibility.
  evidence:
  - reference: PMID:33175317
    reference_title: 'Brief Report: Associations Between Self-injurious Behaviors and Abdominal Pain Among Individuals with ASD-Associated Disruptive Mutations.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: History of severe abdominal pain was associated with SIB status and severity in a cohort of 112 individuals with disruptive mutations to ASD-associated genes.
    explanation: The pooled association motivates a CHD8-specific question without answering it.
- discussion_id: chd8_developmental_rescue_window
  kind: KNOWLEDGE_GAP
  prompt: Which CHD8-dependent outcomes remain reversible after neurodevelopment?
  attaches_to:
  - pathophysiology#Premature Ventral Progenitor Differentiation
  - pathophysiology#CHD8 Haploinsufficiency
  rationale: Mouse endogenous-locus restoration prevents selected behavioral abnormalities when performed during midfetal development or in ventral progenitors. This does not establish postnatal reversal. A separate human neural-culture preprint supports enhancer-targeted dosage restoration. Human delivery, dosage control, developmental timing and outcome-specific reversibility remain open questions.
  evidence:
  - reference: PMID:42203765
    reference_title: Defective ventral neurogenesis due to midfetal Chd8 mutation drives autistic-like behavior in mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The genetic rescue of Chd8 expression at E14.5 or before, but not at E17.5 or after, ameliorated autistic-like behavior
    explanation: Prenatal genetic restoration prevents selected mouse behavioral abnormalities; later restoration in the tested windows did not reproduce the benefit.
clinical_trials:
- name: NCT01238250
  status: RECRUITING
  description: >-
    Simons Searchlight is an observational international research program for people with rare genetic changes, including CHD8. It collects medical, behavioral, learning and developmental information; it is not a CHD8-directed interventional treatment trial.
  target_phenotypes:
  - preferred_term: Autism
    term:
      id: HP:0000717
      label: Autism
  - preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: clinicaltrials:NCT01238250
    reference_title: "Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism.
    explanation: >-
      Describes the registry that provides longitudinal natural-history data for
      CHD8 variant carriers.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
references:
- reference: PMID:36302072
  title: "CHD8-Related Neurodevelopmental Disorder with Overgrowth."
  tags:
  - GeneReviews
- reference: PMID:30670789
  title: "A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8."
- reference: PMID:41407309
  title: Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural Analyses.
- reference: PMID:29668850
  title: Altered Neocortical Gene Expression, Brain Overgrowth and Functional Over-Connectivity in Chd8 Haploinsufficient Mice.
- reference: PMID:36575212
  title: The autism risk factor CHD8 is a chromatin activator in human neurons and functionally dependent on the ERK-MAPK pathway effector ELK1.
- reference: url:https://www.ncbi.nlm.nih.gov/sites/pmc/articles/PMC4210312/
  title: CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors - PMC
- reference: PMID:25752243
  title: The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment.
- reference: PMID:27694995
  title: "Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling."
- reference: PMID:27602517
  title: CHD8 haploinsufficiency results in autistic-like phenotypes in mice.
- reference: url:https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf
  title: https://gala.gre.ac.uk/id/eprint/42417/1/42417_GETTI_Autism_associated_CHD8_keeps_proliferation_of_human_neural_progenitors.pdf
- reference: PMID:33627187
  title: Distinct, dosage-sensitive requirements for the autism-associated factor CHD8 during cortical development.
- reference: PMID:42203765
  title: Defective ventral neurogenesis due to midfetal Chd8 mutation drives autistic-like behavior in mice.
- reference: PMID:35385734
  title: "CHD8 haploinsufficiency links autism to transient alterations in excitatory and inhibitory trajectories."
- reference: PMID:36878905
  title: CHD8 mutations increase gliogenesis to enlarge brain size in the nonhuman primate.
- reference: PMID:40501938
  title: Persistent cortical excitatory neuron dysregulation in adult Chd8 haploinsufficient mice.
- reference: PMID:33228730
  title: Chd8 mutation in oligodendrocytes alters microstructure and functional connectivity in the mouse brain.
- reference: PMID:28402856
  title: Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits.
- reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK585456/
  title: CHD8-Related Neurodevelopmental Disorder with Overgrowth - GeneReviews® - NCBI Bookshelf
  tags:
  - GeneReviews
- reference: PMID:36375841
  title: Loss of autism-candidate CHD8 perturbs neural crest development and intestinal homeostatic balance.
- reference: PMID:24998929
  title: "Disruptive CHD8 mutations define a subtype of autism early in development."
- reference: PMID:37783686
  title: CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis.
- reference: PMID:34088660
  title: "The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects."
- reference: PMID:32142125
  title: Oligodendrocyte dysfunction due to Chd8 mutation gives rise to behavioral deficits in mice.
- reference: PMID:33023670
  title: Chd8 haploinsufficiency impairs early brain development and protein homeostasis later in life.
- reference: PMID:38438524
  title: "The complex etiology of autism spectrum disorder due to missense mutations of CHD8."
- reference: PMID:36182950
  title: The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
- reference: PMID:31001818
  title: "The clinical presentation caused by truncating CHD8 variants."
- reference: PMID:31721432
  title: 'The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients.'
- reference: PMID:31526516
  title: "Clinical Phenotypes of Carriers of Mutations in CHD8 or Its Conserved Target Genes."
- reference: PMID:38441608
  title: "CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes."
- reference: PMID:34415117
  title: Childhood-onset progressive dystonia associated with pathogenic truncating variants in CHD8.
- reference: PMID:38622540
  title: Shared and divergent mental health characteristics of ADNP-, CHD8- and DYRK1A-related neurodevelopmental conditions.
- reference: PMID:31980904
  title: "De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth."
- reference: PMID:22495309
  title: "Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations."
- reference: PMID:25257502
  title: "Recurrent ∼100 Kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly."
- reference: PMID:36738737
  title: "Mouse population genetics phenocopies heterogeneity of human Chd8 haploinsufficiency."
- reference: PMID:25294932
  title: CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors.
- reference: PMID:28321286
  title: CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells.
- reference: url:https://research-explorer.ista.ac.at/download/11160/11164/2022_CellReports_Villa.pdf
  title: https://research-explorer.ista.ac.at/download/11160/11164/2022_CellReports_Villa.pdf
- reference: DOI:10.1101/2024.03.13.584921
  title: Enhancer-targeted CRISPR-A rescues haploinsufficiency and mutant phenotypes in organoid models of autism
- reference: PMID:31823155
  title: "Neurodevelopmental phenotype associated with CHD8-SUPT16H duplication."
- reference: PMID:33175317
  title: 'Brief Report: Associations Between Self-injurious Behaviors and Abdominal Pain Among Individuals with ASD-Associated Disruptive Mutations.'
- reference: clinicaltrials:NCT01238250
  title: "Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight"
- reference: DOI:10.1242/bio.058941
  title: Autism-associated CHD8 keeps proliferation of human neural progenitors in check by lengthening the G1 phase of the cell cycle
notes: >-
  Phenotype estimates come from small, differently ascertained and partly overlapping cohorts. The 2022 aggregation assembled 106 individuals, including 70 previously published and 36 new individuals, and excluded five uncertain variants from its main clinical analysis. Missing feature documentation may indicate either absence or nonreporting. GeneReviews summarizes management, while model-specific mechanisms require separate human validation. The Villa full text is the official institutional PDF of the 2022 Cell Reports article (PMID:35385734).

📚